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Abstract 
 
Due to a constantly growing world population, food security has become an 
increasingly important issue. Controlling diseases in aquaculture can significantly 
increase food production while minimising the need for new infrastructures. 
Vaccination has been a major success story in the global aquaculture industry, 
revolutionising disease control and almost eliminating antibiotic use in modern fish 
farms. However, there are some infections that remain difficult to control by 
vaccination including diseases caused by highly variable bacterial pathogens such 
as Streptococcus species. In Australia, for example, barramundi (Lates calcarifer, 
also known as Asian sea bass) are a significant aquaculture fish but the industry is 
hindered by the hypervariable bacterium Streptococcus iniae. Antigen presentation 
by the cellular immune system is essential for development of a protective adaptive 
immune response, therefore, understanding it is critical to improve vaccine efficacy. 
In mammals, antigen presentation is coordinated by dendritic cells (DCs), and the 
recent identification of dendritic-like cells in rainbow trout and zebrafish strongly 
suggests the existence of those cells in teleosts. However, some antigens such as 
lipopolysaccharides (LPS), a bacterial sugar often used to stimulate cells in 
mammalian systems, do not seem to trigger a strong primary inflammatory response 
in teleosts. Nevertheless, it has also been shown that vaccination with LPS in fish 
induced the production of specific antibodies, warranting further investigation into the 
kinetics of antibody production in teleosts. The main objective of my project was thus 
to gain a better understanding of the early adaptive immunity, such as pathogen 
recognition, and how it links to antibody production as well as the role of dendritic 
cells in teleosts, using both functional in vitro assays and new technologies such as 
Illumina sequencing and bioinformatics analysis.  
To do so, I used barramundi as an industry relevant study organism. Following the 
generation of an immune transcriptome for barramundi, pathogen recognition 
receptors (PRRs) were identified for a number of pathogen associated molecular 
patterns (PAMPs), including peptidoglycans and nucleic acids. However, the PRR 
mainly associated with LPS recognition, the Toll-Like Receptor (TLR)-4 was not 
found in the immune transcriptome, and neither were the molecules classically 
associated with LPS recognition through TLR-4. Potential LPS receptors were thus 
investigated further in barramundi. The C-type lectin receptor Mincle was identified 
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as a partial LPS receptor in barramundi, as LPS stimulation did induce some 
cytokine transcription through the Mincle pathway (Chapter 2).  
Caspases and NOD-like receptor inflammasomes were also investigated but they did 
not seem to be conserved in barramundi, or were missing molecular domains crucial 
to pathogen binding, suggesting that they were not participating in LPS recognition in 
barramundi. Beta2-integrin, on the other hand, were well conserved in barramundi 
compared with mammalian and other teleosts. Moreover, barramundi cells adhered 
to substrates specific to those β2-integrins and were bound by specific anti-integrin 
antibodies, suggesting that the αMβ2 and αLβ2 integrin molecules identified in the 
transcriptome were folding correctly and displayed binding sites similar to those of 
their mammalian counterpart (Chapter 3). 
Cells that were morphologically and functionally similar to DCs were identified from 
barramundi primary cell cultures. Those cells were shown to migrate out of the 
spleen and head kidney of barramundi after injection of bacterial components in the 
peritoneum, before returning to the spleen, where they probably induce the adaptive 
immune response. Interestingly though, those cells did not seem to react strongly to 
LPS alone (Chapter 4). 
Finally, immunoglobulin was investigated further due to its role in pathogen 
clearance, and the genomic region coding for variable, junction and constant 
immunoglobulin genes was identified and annotated in barramundi. A vaccine trial 
with subsequent challenge was also performed to assess the kinetics and amplitude 
immunoglobulin production in barramundi, and different adjuvants were used to 
assess their potential role on the quality and quantity of immunoglobulin produced. 
Overall, all adjuvants increased the number of antibodies produced, and one 
adjuvant was identified to significantly improve the secondary production of 
antibodies (Chapter 5).  
Globally, the present work investigated pathogen recognition, in particular LPS 
recognition, in barramundi as well as the onset of immune memory with a focus on 
the role of DCs and the mechanisms underlying immunoglobulin production. The 
results highlighted in this thesis suggest that barramundi, and likely other teleost 
species, use a combination of non-classical molecular pathways to process LPS. 
Moreover, it was demonstrated that the quantity and quality of antibodies could be 
improved with the use of adjuvants in barramundi, providing invaluable information to 
improve vaccines for warm water species aquaculture in the future.  
 4 
  
 5 
Declaration by author 
 
This thesis is composed of my original work, and contains no material previously 
published or written by another person except where due reference has been made 
in the text. I have clearly stated the contribution by others to jointly-authored works 
that I have included in my thesis. 
 
I have clearly stated the contribution of others to my thesis as a whole, including 
statistical assistance, survey design, data analysis, significant technical procedures, 
professional editorial advice, financial support and any other original research work 
used or reported in my thesis. The content of my thesis is the result of work I have 
carried out since the commencement of my higher degree by research candidature 
and does not include a substantial part of work that has been submitted to qualify for 
the award of any other degree or diploma in any university or other tertiary institution. 
I have clearly stated which parts of my thesis, if any, have been submitted to qualify 
for another award. 
 
I acknowledge that an electronic copy of my thesis must be lodged with the 
University Library and, subject to the policy and procedures of The University of 
Queensland, the thesis be made available for research and study in accordance with 
the Copyright Act 1968 unless a period of embargo has been approved by the Dean 
of the Graduate School.  
 
I acknowledge that copyright of all material contained in my thesis resides with the 
copyright holder(s) of that material. Where appropriate I have obtained copyright 
permission from the copyright holder to reproduce material in this thesis and have 
sought permission from co-authors for any jointly authored works included in the 
thesis. 
 
 6 
Publications during candidature 
 
Peer-reviewed papers 
 
Zoccola E, Delamare-Deboutteville J, Barnes AC (2015) Identification of Barramundi 
(Lates calcarifer) DC-SCRIPT, a Specific Molecular Marker for Dendritic Cells in 
Fish. PLoS ONE 10(7): e0132687. doi:10.1371/journal.pone.0132687 
 
Zoccola E, Kellie S, Barnes AC (2017) Immune transcriptome reveals the mincle C-
type lectin receptor acts as a partial replacement for TLR4 in lipopolysaccharide-
mediated inflammatory response in barramundi (Lates calcarifer). Molecular 
Immunology, 83, 33-45 
 
Conference abstracts 
 
Zoccola E, Delamare-Deboutteville J, Barnes AC. Identification of Barramundi 
(Lates calcarifer) DC-SCRIPT, a Specific Molecular Marker for Dendritic Cells in 
Fish. Presented at the third FRDC Australasian Aquatic Animal Health Scientific 
Conference, Cairns, 6-10 July 2015. 
 
Zoccola E, Kellie S, Barnes AC. Lates calcarifer transcriptome reveals the Mincle 
CLR as an alternative to the classical LPS recognition pathway. Presented at the 
ASFB-OCS joint conference, Hobart, 4-7 September 2016. 
 
Zoccola E, Li A, Barnes AC. Linking antibody response and efficacy of the adaptive 
immunity in vaccine development: How adjuvants modulate the immune response in 
barramundi. Presented at the fourth FRDC Australasian Aquatic Animal Health 
Scientific Conference, Cairns, 10-14 July 2017. 
 
Zoccola E, Kellie S, Barnes AC. Mechanisms of lipopolysaccharide recognition and 
processing in barramundi (Lates calcarifer). Presented at the 18th International 
Conference on Diseases of Fish and Shellfish, Belfast, 4-7 September 2017. 
 
Conference abstracts for the above references can be found in Appendix 1. 
 7 
  
 8 
Publications included in this thesis 
 
Chapter 2: Zoccola E, Kellie S, Barnes AC (2017) Immune transcriptome reveals the 
mincle C-type lectin receptor acts as a partial replacement for TLR4 in 
lipopolysaccharide-mediated inflammatory response in barramundi (Lates calcarifer). 
Molecular Immunology, 83, 33-45  
 
Contributor Statement of contribution 
Emmanuelle Zoccola 
(Candidate) 
Conceived experiments (40%) 
Designed experiments (70%) 
Conducted the work and analysed the data (70%) 
Wrote the paper (70%) 
Stuart Kellie Conceived experiments (20%) 
Designed experiments (10%) 
Helped with analysis of the data (10%) 
Wrote and edited paper (10%) 
Andrew C. Barnes Conceived experiments (40%) 
Designed experiments (20%) 
Helped with analysis of the data (20%) 
Wrote and edited the paper (20%) 
 
Chapter 4: Zoccola E, Delamare-Deboutteville J, Barnes AC (2015) Identification of 
Barramundi (Lates calcarifer) DC-SCRIPT, a Specific Molecular Marker for Dendritic 
Cells in Fish. PLoS ONE 10(7): e0132687. doi:10.1371/journal.pone.0132687 
 
Contributor Statement of contribution 
Emmanuelle Zoccola 
(Candidate) 
Conceived experiments (20%) 
Designed experiments (40%) 
Conducted the work and analysed the data (60%) 
Wrote the paper (60%) 
Jérôme Delamare-
Deboutteville 
Designed experiments (40%) 
Conducted the work and analysed the data (30%) 
Wrote and edited paper (15%) 
 9 
Andrew C. Barnes Conceived experiments (80%) 
Designed experiments (20%) 
Conducted the work (10%) 
Wrote and edited the paper (25%) 
 10 
Contributions by others to the thesis  
 
Associate Professor Andrew Barnes (primary supervisor) helped to conceive and 
design the experiments, helped with some of the technical work, and helped to write 
and review the papers and this thesis. He provided guidance throughout this project. 
Associate Professor Stuart Kellie (secondary supervisor) helped conceive and 
design some of the experiments, and helped to write and review the papers and this 
thesis. Dr. Jérôme Delamare-Debouteville assisted with the conception and design 
of some of the experiments, helped with some of the technical work, and helped 
write and review Chapter 4. Angus Li (Honours student) conducted some of the 
technical work and data analysis for Chapter 5 under my supervision and helped 
write and review Chapter 5. 
 
Statement of parts of the thesis submitted to qualify for the award of another 
degree 
 
For chapter four, the functional and morphological assays were submitted for BMarSt 
Honours, The University of Queensland, 2013, degree awarded with Class I 
December 2013. The resulting publication was included in this thesis as most of the 
work which was needed for publication was conducted during the early stages of my 
PhD.  
Zoccola E, Delamare-Deboutteville J, Barnes AC (2015) Identification of Barramundi 
(Lates calcarifer) DC-SCRIPT, a Specific Molecular Marker for Dendritic Cells in 
Fish. PLoS ONE 10(7): e0132687. doi:10.1371/journal.pone.0132687 
For chapter five, the ELISAs, avidity and immunoglobulin composition assays were 
performed under my co-supervision by Angus Li and submitted for BSc Honours, 
The University of Queensland, 2017, degree awarded with Class I December 2017. 
The work was included in the present PhD thesis as I designed most of the 
experiments and performed the main vaccination trial, as well as all the sampling on 
which those assays were performed.  
 
Research Involving Human or Animal Subjects 
NEWMA 078/15 Understanding the early onset of adaptive immunity in fish. 
 11 
SBS/037/16/ARC/ELANCO Effective vaccination of barramundi against 
Streptococcosis. 
SBS/056/13/ARC Cellular immunity in fish: Robust defence against infection or 
Achilles heel? 
 12 
Acknowledgements 
Firstly, I would like to thank associate professor Andrew Barnes, my main supervisor, 
for all his support during my PhD. Thanks Andy for being such an inspiring 
supervisor, for always taking the time to read my (many) drafts for papers/milestones 
and for always having your door open to discuss immunology and bacteriology, 
tutoring, experiments, thesis plans and superheroes. Thank you above all for your 
continued support and for believing in me and my future in research. I would also 
really like to thank associate professor Stuart Kellie, my co-supervisor, for agreeing 
to embark on the journey that was my PhD. Thanks Stuart for all the coffee meetings 
and for your invaluable advice and insight into mammalian immunology. Having you 
in my advisory team really has been a privilege. 
 
Secondly, I would like to thank all my colleagues from the Barnes Lab over the 
years. You all have made my experience as a PhD student so much better, so thank 
you all so much for sharing this part of my life. In particular, I’d like to thanks Dr 
Jérôme Delamare-Deboutteville for being such a good mentor and for becoming 
such a great friend. Jerome, thanks for helping me with all the cellular assays I had 
to do and thanks for speaking French with me every day, I’m sure my parents 
appreciate that I didn’t forget my native language! Thanks also for always organising 
the best lab outings, especially at Nombei. I’d also like to thank my fellow PhD 
students and friends, Kelly-Anne Masterman, Minami Kawasaki and Oleksandra 
Silayeva. Kelly-Anne, thanks for sharing an office with me for the best part of our 
PhDs and thanks for always being a great friend. Minami, thanks for showing me 
how to do SDS-PAGE and Western Blots and ありがとう for teaching me some 
Japanese. Alex, thanks for encouraging me to take up tutoring and for always 
sharing great conversations with me. Thanks also to my first student, Angus Li, for 
being so motivated and making me proud by getting first class honours. 
 
This PhD would have been much harder without the support from my friends and 
family, so I’d like to thank them wholeheartedly. Thanks to my two best friends 
overseas, Diane Dall’Osso and Alexandra Jacques-Henning, I love you girls and 
these years would have been much harder without your love and support. Thanks to 
my friends in Australia Arnault Gauthier and Tahsha Say for all the science and PhD 
 13 
discussions, the Friday drinks and the weekends away at the Sunshine coast. 
Arnault, thanks again so much for letting me stay at your place and for being such a 
supportive friend over the years. I’d also like to thank my parents, grand-parents, 
aunty and brother for coming to visit me from so far away and for their unwavering 
support. Especially, I’d like to thank my dad, Didier Zoccola, for all his help with the 
bioinformatics and for not minding me always wanting to talk about work with him 
during our weekly Skype sessions. Thanks as well to my family in law for welcoming 
me with open arms and for making me feel so at home in Australia.  
 
Finally, I’d like to thank my wonderful husband and partner in crime, Dylan 
McFarlane, and our beautiful baby boy Clark. To Clark, thank you for bringing so 
much love into my life and for ‘helping’ me go through my corrections. To Dylan, 
thanks for going through this crazy adventure of doing our PhDs at the same time 
and for sharing lunches each day at uni while we were both working on our 
experiments and theses. Thanks for letting me go to your lab’s paper discussions 
with you, I learnt so much during those sessions and thanks for reading all my drafts 
and listening to all my practise talks for conferences over the years. Lastly, thanks 
for your undying love and support during the rough days at the lab and the craziness 
of bioinformatics analysis, I don’t know if I would have made it without you keeping 
me sane.   
 14 
Financial support 
 
The University of Queensland International Scholarship – for providing tuition fee 
offset and living allowance for the duration of my PhD 
 
Global Challenges University Alliance Summer School "Aquaculture - local solutions 
to a global challenge" scholarship – for financing my attendance to the summer 
school in Uppsala, Sweden, where I gained valuable leadership training and 
knowledge on the aquaculture industry as a whole 
 
John Glover Travel Fund from the Australian Fisheries Research and Development 
Corporation – for financing my travel to the Australian Society for Fish Biology 
conference in Hobart, Tasmania, Australia 
 
European Association of Fish Pathologists Student Award – for financing my travel 
and conference fees to the 18th EAFP conference in Belfast, Northern Ireland  
  
 15 
Keywords 
Immunology, pathogen recognition, aquaculture, fish health, lipopolysaccharide 
processing, immune pathway, immune cells, molecular immunology 
 
Australian and New Zealand Standard Research Classifications  
ANZSRC code: 070404, Fish Pests and Diseases, 30% 
ANZSRC code: 070705, Veterinary immunology, 70% 
 
Fields of Research (FoR) Classification 
FoR code: 0704, Fisheries Sciences, 30% 
FoR code: 0707, Veterinary Sciences, 70% 
  
 16 
Table of Contents 
Abstract ...................................................................................................................... 2	
Declaration by author................................................................................................ 5	
Publications during candidature .............................................................................. 6	
Publications included in this thesis ........................................................................ 8	
Contributions by others to the thesis .................................................................... 10	
Statement of parts of the thesis submitted to qualify for the award of another 
degree ....................................................................................................................... 10	
Research Involving Human or Animal Subjects ................................................... 10	
Acknowledgements ................................................................................................. 12	
Financial support ..................................................................................................... 14	
Keywords ................................................................................................................. 15	
Australian and New Zealand Standard Research Classifications ...................... 15	
Fields of Research (FoR) Classification ................................................................ 15	
List of Figures .......................................................................................................... 19	
List of Tables ........................................................................................................... 21	
List of Included Abbreviations ............................................................................... 22	
Chapter One – General Introduction ...................................................................... 26	
1.1. Innate vs. adaptive immunity ....................................................................... 26	
1.2. Vaccines against bacterial diseases in aquaculture ................................. 32	
1.3. Focus on the adaptive immunity of teleosts .............................................. 34	
1.4. Barramundi aquaculture overview .............................................................. 35	
1.5. Barramundi as an industry model species ................................................. 36	
1.6. Techniques overview and methods development ..................................... 37	
1.7. Objective and aims ....................................................................................... 37	
Chapter Two – Immune transcriptome reveals the Mincle C-Type Lectin 
Receptor acts as a partial replacement for TLR4 in lipopolysaccharide-
mediated inflammatory response in barramundi (Lates calcarifer) ................... 40	
2.1. Introduction ................................................................................................... 40	
 17 
2.2. Materials and Methods ................................................................................. 43	
2.3. Results ........................................................................................................... 48	
2.4. Discussion ..................................................................................................... 59	
Chapter Three – Leucocyte integrins, but not caspases or NLR inflammasome 
are associated with lipopolysaccharide recognition and response in 
barramundi (Lates calcarifer) ................................................................................. 64	
3.1. Introduction ................................................................................................... 64	
3.2. Materials and Methods ................................................................................. 66	
3.3. Results ........................................................................................................... 71	
3.4. Discussion ..................................................................................................... 77	
Chapter Four – Identification of barramundi (Lates calcarifer) DC-SCRIPT, a 
specific molecular marker for dendritic cells in fish ........................................... 81	
4.1. Introduction ................................................................................................... 81	
4.2. Materials and Methods ................................................................................. 83	
4.3. Results ........................................................................................................... 91	
4.4. Discussion ..................................................................................................... 98	
Chapter Five – Evidence for affinity selection of IgM in fish: A high avidity 
secondary antibody response to T-dependent antigen with antibody-mediated 
suppression ........................................................................................................... 103	
5.1. Introduction ................................................................................................. 103	
5.2. Materials and Methods ............................................................................... 106	
5.3 Results .......................................................................................................... 112	
5.4 Discussion .................................................................................................... 119	
Chapter Six – General Discussion ....................................................................... 123	
6.1 LPS recognition in teleosts ......................................................................... 125	
6.2 Antibody production and implications for immune memory in fish ....... 128	
6.3 The future of vaccines for warm water fish aquaculture .......................... 135	
Appendices ............................................................................................................ 170	
Appendix 1.1. Conference abstract for the research presented at the third 
FRDC Australasian Aquatic Animal Health Scientific Conference, Cairns, 6-
10 July 2015 ........................................................................................................ 170	
 18 
Appendix 1.2. Conference abstract for the research presented at the ASFB-
OCS joint conference, Hobart, 4-7 September 2016 ....................................... 171	
Appendix 1.3. Conference abstract for the research presented at the fourth 
FRDC Australasian Aquatic Animal Health Scientific Conference, Cairns, 10-
14 July 2017 ........................................................................................................ 172	
Appendix 1.4. Conference abstract for the research presented at the 18th 
International Conference on Diseases of Fish and Shellfish, Belfast, 4-7 
September 2017 .................................................................................................. 174	
Appendix 2.2. Supplementary information for chapter 2 ............................... 176	
Appendix 2.3. Supplementary information for chapter 3 ............................... 180	
Appendix 2.4. Supplementary information for chapter 4 ............................... 185	
Appendix 2.5. Supplementary information for chapter 5 ............................... 187	
 
  
 19 
List of Figures 
 
Figure 1.1: Schematic representation of innate and adaptive immunities adapted 
from Banchereau et al., 2000 [1]. ……………………………………………………………… 
 
31 
Figure 2.1. KEGG pathway transcriptome annotation. ……………………………………. 51 
Figure 2.2. Functional annotation of Lates calcarifer transcripts using BLAST2GO. . 52 
Figure 2.3. Differential gene expression analysis. ………………………………………… 53 
Figure 2.4. Maximum likelihood phylogenetic relationships of the TLR transcripts 
identified in the Lates calcarifer immune transcriptome. ………………………………… 
 
54 
Figure 2.5. Maximum likelihood phylogenetic relationships of the CLR transcripts 
identified in the Lates calcarifer immune transcriptome. ………………………………… 
 
55 
Figure 2.6. Effect of LPS on DCs maturation assessed by flow cytometry reading of 
DC- SCRIPT FISH probe. ……………………………………………………………………….. 
 
56 
Figure 2.7. Comparison between putative barramundi Mincle and human Mincle. …. 57 
Figure 2.8. Differential expression of cytokines in response to LPS by qRT-PCR. …. 59 
Figure 3.1. Characterisation of human and barramundi caspases. …………………….. 71 
Figure 3.2. Phylogenetic relationship between human, murine and barramundi (in 
bold) NLRs based on their NACHT domain. ………………………………………………… 
 
73 
Figure 3.3. Phylogenetic relationship between human, murine, teleost and 
barramundi (bold) α- and 𝛽2-integrin subunits. …………………………………………….  74 
Figure 3.4. Adherence of barramundi spleen cells to different substrates. …………... 75 
Figure 3.5. Micrographs of leukocytes adhering to each substrate. …………………… 76 
Figure 3.6. Differential expression of cytokines and transcription factor in response 
to LPS stimulation. ………………………………………………………………………………. 
 
77 
Figure 4.1. Amino-acid sequence alignment, domain organisation, gene 
organisation and phylogeny of DC-SCRIPT from L. calcarifer. …………………………. 
 
92 
Figure 4.2. Antibody labelling of putative DCs. ……………………………………………. 94 
Figure 4.3. DC-SCRIPT expression in barramundi spleen and HK following a time 
course post-injection with LPS and PTG. …………………………………………………… 
 
94 
Figure 4.4. Barramundi DC morphology and isopycnic enrichment. …………………... 95 
Figure 4.5. Barramundi DCs migration towards different chemical cues. …………….. 96 
Figure 4.6. Phagocytic capability of bDCs. …………………………………………………. 97 
Figure 4.7. Histograms showing the fluorescence of CFSE stained T-cells. …………. 98 
 20 
Figure 5.1. Kinetics of primary (green) and secondary (red) antibodies following 
vaccination. ……………………………………………………………………………………….. 
 
114 
Figure 5.2. Avidity of primary (green) and secondary (red) antibodies following 
vaccination. ……………………………………………………………………………………….. 
 
115 
Figure 5.3. Isomer composition of barramundi immunoglobulin. ………………………. 116 
Figure 5.4. Antibody titres post vaccination with either LPS or DNP-KLH. …………… 117 
Figure 5.5. Gene arrangement of the barramundi igh locus. ……………………………. 118 
Figure 5.6. Phylogenetic arrangement of constant immunoglobulin genes from 
different teleost and avian species. ………………………………………………………….. 
 
118 
Figure 6.1. Graphical representation of an antibody. ……………………………………... 129 
Figure A2.2.1. Gene ontology trees for ‘Immune system process’ (green boxes) 
from BLAST2GO. ………………………………………………………………………………… 
 
179 
Figure A2.3.1. Gene organisation of barramundi caspases. …………………………….. 182 
Figure A2.3.2. Gene organisation of barramundi NLRs. ………………………………….. 183 
Figure A2.3.3. Gene organisation of barramundi integrins. ……………………………… 183 
Figure A2.3.4. Differential expression of immune genes in cells stimulated by 
different antibodies. ……………………………………………………………………………... 
 
184 
Figure A2.4.1. E-rosettes. ………………………………………………………………………. 185 
Figure A2.4.2. Rabbit Anti-zebrafish MHCIIa (Sapphire Bioscience). …………………… 186 
Figure A2.5.1. SDS-PAGE gel of barramundi IgM showing separation into tetramers, 
trimers, dimers and monomers. ………………………………………………………………. 
 
187 
 
  
 21 
List of Tables 
 
Table 1.1. Different nomenclatures for β2-integrins. ……………………………………… 29 
Table 2.1. Summary of Lates calcarifer transcriptome transcripts, assembly and 
annotation. ………………………………………………………………………………………… 
 
49 
Table 3.1. List of primers for qRT-PCR. ……………………………………………………… 70 
Table 5.1. Vaccine treatment groups in the prime-boost experiment. …………………… 114 
Table A2.2.1. TLRs accession numbers from NCBI database. ………………………….. 176 
Table A2.2.2. CLRs accession numbers from NCBI database. ………………………….. 177 
Table A.2.2.3. Primers used for qRT-PCR. …………………………………………………... 178 
Table A2.3.1. NCBI accession numbers used to identify barramundi caspases and 
to infer phylogeny. ………………………………………………………………………………. 
 
180 
Table A2.3.2. NCBI accession numbers used to identify barramundi NLRs and to 
infer phylogeny. ………………………………………………………………………………….. 
 
180 
Table A2.3.3. NCBI accession numbers used to identify barramundi leukocyte 
integrins and to infer phylogeny. ……………………………………………………………... 
 
182 
 
  
 22 
List of Included Abbreviations 
18S – 18S ribosomal RNA 
α-tub – alpha tubulin 
aa – amino acid 
Ab – antibody  
Ag – antigen  
AGRF – Australian Genome Research Facility 
AID – activation-induced cytidine deaminase 
ANOVA – analysis of variance 
APC – antigen presenting cell 
BCPI/NBT – 5-bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium 
BCR – B-cell receptor 
BIR – baculovirus inhibitor of apoptosis protein repeat 
BLAST – Basic Local Alignment Search Tool 
bp – base pair 
BSA – bovine serum albumin 
CARD – caspase activation and recruitment domain 
CD – conserved domain 
cDNA – complementary DNA 
CFSE – carboxyfluorescein succinimidyl ester  
CIITA – class II major histocompatibility complex transactivator 
CLEC – C-type lectin domain 
CLR – C-type lectin receptor 
CpG-ODN – cystidine-phosphate guanosine oligodeoxynucleotides 
CPS – capsular polysaccharide 
CRD – carbohydrate-recognition domain 
DAPI – 4',6-diamidino-2-phenylindole 
DC – dendritic cell 
DC-SCRIPT – dendritic cell-specific transcript 
DED – death effector domain 
DNA – deoxyribonucleic acid 
DNP – 2,4-dinitrophenol 
EAFP – European Association of Fish Pathologists 
ef1α – elongation factor 1 alpha 
 23 
ELISA – enzyme-linked immunosorbent assay 
ELISPOT – enzyme -linked immunospot 
ESM1 – endothelial cell-specific molecule 1 
EST – expressed sequence tag 
FAO – Food and Agriculture Organisation 
FBS – foetal bovine serum 
Fc – fragment crystallisable 
FIIND – function to find domain 
FISH – fluorescent in situ hybridisation  
FISNA – Fish-specific NACHT associated domain 
FPKM – fragment per kilo-base of transcript per million fragments mapped 
GC – germinal centre 
gDNA – genomic DNA 
GO – gene ontology 
HI – heat inactivated 
HK – head kidney 
ICC – immunocytochemistry  
IHC – immunohistochemistry  
ICE – interleukin-1beta converting enzyme 
IFN – interferon  
Ig – immunoglobulin  
IL – interleukin  
IMGT – ImMunoGeneTics  
IPAF – ICE protease-activating factor 
ITAM – immunoreceptor tyrosine-based activation motif 
ITGAL – integrin alpha L 
ITGAM – integrin alpha M 
KASS – KEGG automatic annotation server 
KEGG – Kyoto Encyclopedia of Genes and Genomes 
KLH – keyhole limpet hemocyanin 
LBP – lipopolysaccharide binding protein 
LPS - lipopolysaccharide 
LRR – leucine rich repeat 
m.y.a – million years ago  
 24 
MAPK – mitogen-activated protein kinase 
MD-2 – myeloid differentiation protein 2 
MHC – major histocompatibility complex 
MLR – mixed leucocyte reaction 
MLT – maximum-likelihood tree 
MMC – melano-macrophage centre  
MOI – multiplicity of infection 
N – Nystatin  
NAIP – NLR family apoptosis inhibitor protein 
NCBI – National Center for Biotechnology Information 
NF-κB – nuclear factor kappa B 
NK – natural killer 
NLR – NOD-like receptor 
NLRC – NOD-like receptor CARD 
NLRP – NOD-like receptor PYD 
NOD – nucleotide-binding oligomerization domain 
nt – nucleotide  
OD – optic density  
PAMP – pathogen associated molecular pattern 
PBS – phosphate buffered saline 
PCR – Polymerase chain reaction 
PFA – paraformaldehyde  
pH – potential of hydrogen 
PI – propidium iodine 
pNPP – p-Nitrophenyl Phosphate 
ppt – part per thousand 
PRR – pattern recognition receptor 
PS – penicillin streptomycin 
PTG – peptidoglycan  
PYD – pyrin domain 
qRT-PCR – quantitative reverse transcription polymerase chain reaction 
RACE – Rapid amplification of cDNA ends 
RBC – red blood cell 
REST – relative expression software tool 
 25 
RIG-I – retinoic acid-inducible gene I 
RIN – RNA integrity number 
RLR – RIG-I-like receptor 
RNA – Ribonucleic acid 
rpm – round per minute 
RPMI – Roswell Park Memorial Institute 
RT – room temperature 
SDS-PAGE – sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SHM – somatic hypermutation 
SMART – simple modular architecture research tool 
SOP – standard operating procedure  
spp. – species  
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TBS – tris-buffered saline 
TBST – tris-buffered saline tween 
TD – T-cell dependent 
TDB – trehalose-6,6-dibehenate 
Tfh – follicular helper T-cell 
TI – T-cell independent 
TigGER – Tool for Immunoglobulin Genotype Elucidation via Rep-Seq 
TIR – toll/interleukin-1 receptor 
TLR – toll-like receptor 
TNF – tumour necrosis factor 
UK – United Kingdom  
UQ – the University of Queensland 
USA – United States of America 
V(D)J – Variable (Diverse) Junction  
VNN – viral nervous necrosis 
VWA – Von Willebrand factor type A 
ZNF – zinc finger protein 
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Chapter One – General Introduction 
 
1.1. Innate vs. adaptive immunity 
1.1.1. Basic concepts 
Both the innate and the adaptive immune systems, which are respectively 
responsible for the clearance of pathogens and the development of immune 
memory, have been extensively studied in mammals. The key effector cells of the 
innate immune system engulf non-self substances, non-specifically, and work 
towards breaking them down in order to clear potential infections. However, the 
innate immune system can be by-passed by pathogens and, as no memory of the 
pathogens is developed, re-infections can occur easily. The adaptive immune 
system, on the other hand, facilitates pathogen clearance through specific labelling 
of “non-self” particles and the formation of immune memory [1]. Antigen recognition 
and antigen-presentation are the processes that form the junction between innate 
and adaptive immunity, and are largely coordinated by dendritic cells (DCs). DCs are 
known as “professional” antigen-presenting cells (APCs), due to their ability to prime 
naïve lymphocytes, leading to the establishment of the immune memory [1, 2]. In 
brief, by presentation of specific antigen, DCs initiate maturation of naïve T-cells into 
either cytotoxic or helper T-cells which, respectively, lyse infected cells or activate 
other immune cells through cytokines release. Subsequently, B-lymphocytes, 
activated via interaction with the same antigen, mature into plasma cells under 
direction of mature helper T-lymphocytes and produce specific antibodies that label 
foreign and infected cells [2]. A small subset of differentiated, mature B- and T-cells 
with receptors specific to the antigen remain active after the infection is cleared, and 
thereby form the basis of immune memory [1].  
 
1.1.2. Pathogen recognition 
For any immune response to be initiated, specific structures present on foreign 
micro-organisms (pathogen-associated molecular patterns (PAMPs)) have to be 
recognised by the host’s immune system, through pattern recognition receptors 
(PRRs). Of the four main categories of PRRs able to successfully induce a cellular 
response (Toll-like receptors (TLRs), C-type lectin receptors (CLRs), nucleotide-
binding, oligomerization domain (NOD)-like receptors (NLRs) and RIG-I-like 
receptors (RLRs) [3]), three have been described in fish: TLRs, CLRs and NLRs [4].  
 27 
 
TLRs are the most commonly studied PRRs in vertebrates due to their key ability to 
activate inflammation. TLR-mediated pathogen recognition occurs notably through 
the activation of the nuclear factor kappa-light-chain-enhancer of activated B-cells 
(NF-kB) and mitogen-activated protein kinase (MAPK) signalling pathways, which in 
turn initiate the production of pro-inflammatory molecules responsible for the 
activation of adaptive immunity, including tumour necrosis factor alpha (TNF-α), 
interleukin-1 (IL-1) and IL-6 [5-7]. Functional TLRs are transmembrane proteins 
comprising leucine-rich repeat (LRR) domains, a trans-membrane domain as well as 
a Toll/interleukin-1 receptor (TIR) domain [5]. TLRs can be grouped into two sub-
families depending on their ability to recognise and bind either cell surface elements 
(microbial sugars, lipids and proteomes) or nucleic acid [8]. TLRs have been 
identified in a number of cartilaginous and bony fish species with high levels of 
homology to mammalians TLRs, providing a foundation for further investigation in 
fish.  
 
Many of the lectin or lectin-like receptors found on APCs have been identified as 
members of the calcium dependant CLRs family [9], implicating CLRs as critical 
components in the onset of adaptive immunity. Indeed, pathogen recognition by 
CLRs is closely associated with antigen capture and presentation and several of the 
membrane-bound CLRs are specific to APCs, particularly DCs [10-12]. CLRs can be 
transmembrane or secreted proteins and use conserved carbohydrate recognition 
domains (CRDs) to bind sugars in a calcium dependant manner [9, 13]. Currently, 
two types of CLRs have been described, based on the orientation of their amino (N)-
terminus and on the amount of CRDs they possess [9]. Type I CLRs (mannose 
receptors) have their N-termini pointing outwards of the cell and contain several 
CRDs at the N-terminus, whereas type II CLRs (collectins) currently identified have 
their N-termini pointing inside of the cell’s cytoplasm and only one CRD at their 
carboxyl (C)-terminus [9]. CLRs have a central role in the initiation of fungal immunity 
in mammals (reviewed in [3]), can recognise viruses through mannose specificity 
[14], and also seem to play a critical part in bacterial clearance and recognition of 
non-self particles in marine invertebrates and vertebrates [8, 15-20]. Moreover, CLR 
activation seems to result in cytokine signalling either through direct nuclear factor 
kappa B (NF-kB) activation or through coinciding TLR activation [21]. It has also 
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become increasingly clear that CLRs play a part in DCs migration and in subsequent 
communication with lymphocytes [9], suggesting CLRs can regulate adaptive 
immune responses.  
 
NLRs constitute a large family of receptors involved in bacterial and viral recognition, 
as well as apoptosis and immune regulation. Proteins from this family share a 
domain organisation, with a nucleotide-binding domain at the N-terminus (such as a 
caspase activation and recruitment domain (CARDs) or a pyrin domain (PYD)) and 
leucine rich repeats (LRRs) at the C-terminus [22]. NLRs have been classified into 
three distinct subfamilies, the NODs, the NLRPs (also known as NALPs) and the 
IPAF subfamilies, based on the phylogeny of their NACHT domain [23], but other 
nomenclatures have also been proposed [24]. Many NLRs have been extensively 
studied, in particular NOD1 and NOD2, which are found abundantly on APCs and 
have been shown to recognise bacterial peptidoglycan (PTG) [22]. NOD1 and NOD2 
stimulated with PTG have also been shown to activate the production of 
inflammatory cytokines through NF-kB activation, although lipopolysaccharide (LPS), 
another bacterial component, seemed to greatly increase the production of 
inflammatory cytokines via NOD in mammals [25]. Although the role of many NLRs is 
yet to be elucidated, it is known that some of them can activate inflammatory 
caspases (see below) through the formation of inflammasomes [23, 26, 27]. Many 
NLRs belonging to all three mammalian NLR subfamilies have been identified in 
teleosts, and a NLR subfamily unique to teleosts was also identified [28], suggesting 
that those receptors are well conserved and have most likely a core function in the 
recognition of some pathogens. 
 
Other molecules such as enzymes also play an important part in the development of 
inflammation and the onset of adaptive immunity. Caspases are protease enzymes 
and play a significant role in mediating cell death and inflammation in mammals [29, 
30]. Caspases are composed of a CASc domain (comprised of a large p20 and a 
small p10 subunit), as well as a variable pro-domain. Typically, in humans, caspases 
can be grouped into three sub-categories, based on their function and phylogeny, 
and linked to the nature of their pro-domain: caspases responsible for cell death 
initiation (double death effector domain (DED) motif pro-domain or CARD motif pro-
domain, caspase-2, -8, -9 and -10), execution (short pro-domain, caspase-3, -6 and -
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7) and inflammation (CARD motif pro-domain, caspase-1, -4, -5, and -12). 
Inflammatory caspases are key activators of pro-inflammatory cytokines (IL-1β, IL-6, 
IL-18 and TNF among others) [27]. Moreover, caspase-4 and -5 have recently been 
shown to recognise and process intracellular lipopolysaccharide (LPS), a PAMP 
found in abundance on gram-negative bacteria  [26, 31]. Caspases have been 
identified in a range of organisms, from sponges to ascidians to mammals, and it is 
speculated that the function of caspases has been conserved through evolution, 
especially in regards to IL-1β processing by caspase-1 [29, 32].  
 
Finally, heterodimeric transmembrane glycoproteins termed leucocyte integrins have 
also been identified as PRRs in mammals. Members of the leucocyte integrins are 
composed of a unique α-subunit (αD / CD11d, αL / CD11a, αM / CD11b or αX / 
CD11c) and a shared β-subunit (β2 / CD18) (Table 1.1). Leucocyte integrins play a 
crucial role in leucocyte adhesion and each α-subunit has its own set of ligands, but 
it seems that their association with the β2-subunit is necessary for any adhesion to 
occur (reviewed in [33]). Moreover, although the αM/β2 and αX/β2 were identified as 
LPS receptors in the mid-1990s [34, 35], the binding sites for LPS were later actually 
identified on the β2-subunit [36]. Literature on β2-integrins in fish is limited, with β2 
molecules identified in zebrafish, carp and channel catfish [37-39], but as they have 
a pivotal role in LPS recognition and in inflammation in mammals [33, 40], it can be 
hypothesised that leucocyte integrins will be conserved in fish and should thus be 
investigated further. 
 
Table 1.1. Different nomenclatures for β2-integrins. 
Protein 
name 
           α-subunit names β-subunit names 
LFA-1 αL CD11a β2 CD18 
MAC-1 / 
CR3 
αM CD11b β2 CD18 
p150/95 αX CD11c β2 CD18 
- αD CD11d β2 CD18 
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1.1.3. Development of adaptive immunity 
PRRs’ primary purposes are to assist with the capture of foreign particles and to 
trigger inflammatory responses, but they also help with the activation and maturation 
of APCs, thereby linking innate and adaptive immunity [9]. Adaptive immunity is 
characterized by the development of an immune memory. This memory of previously 
encountered pathogens allows a fast and specific response when reinfection by the 
same pathogen occurs. Adaptive immunity involves antigen recognition by antigen 
presenting cells (APCs) and an associated antibody response and pathogen 
elimination, generally performed by previously primed specialist B and T-
lymphocytes [1]. B-lymphocytes are specialized in producing antibodies that label 
pathogens and make them easier to identify by phagocytic cells for elimination from 
the host [1]. T-lymphocytes, on the other hand, either help other white blood cell 
(leucocyte) activation or directly destroy tumorous and virus infected cells [1]. APCs 
present antigens via the major histocompatibility complex (MHC) molecules, which 
bind internalised foreign and local peptides produced by protein degradation and 
transport them for display on their surface via the endoplasmic reticulum [41]. After 
presentation of foreign antigens bound on MHC to naïve T-cells, those cells become 
activated [41]. Non-professional APCs, which can be any cell in the organism, can 
only activate cytotoxic T-cells via the display of antigenic structures on their internal 
MHC class I receptors or via stimulation by cytokines (cell-signalling molecule) [42]. 
Professional APCs, on the other hand, can activate both helper and cytotoxic T-cells 
by displaying antigenic structures on MHC class II receptors at their surface and by 
producing co-stimulatory molecules [43]. B-cell proliferation can also be indirectly 
activated by professional APCs. Indeed, some B-lymphocytes need a co-stimulation 
from helper T-lymphocytes (CD4+) to mature and proliferate [1]. B-cells in turn 
produce specific antibodies, which label the foreign particles and infected cells and 
direct other immune cells towards clearing the infection (Figure 1.1).  
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Figure 1.1. Schematic representation of innate and adaptive immunities 
adapted from Banchereau et al. [1].  
 
In mammals, the principal professional APCs are DCs, due to their extended ability 
to engulf pathogens, present antigens and activate potent helper lymphocyte T-cells 
[1, 44, 45]. Indeed, DCs interact directly with immature T-cells and induce them to 
produce interleukin-2 (IL-2), and to multiply and mature [46]. IL-2 is a type of 
cytokine that stimulates immature cell development and differentiation by binding to 
IL-2 receptors on T-cell surfaces, in both autocrine and paracrine fashions. This 
cytokine is also required for the maturation of T-cell immunological memory [1, 47].  
 
Understanding of innate and acquired immunity, and especially of the mechanisms 
leading to immune memory (antigen recognition and presentation), has enabled 
vaccination to revolutionise disease management, eradicating smallpox and 
rinderpest globally as well as preventing hundreds of millions of cases of illnesses 
such as measles, varicella and pneumococcus-related diseases [48, 49]. Moreover, 
since the implementation of the Vaccines for Children program in 1994, eligible 
children in the USA have been granted free routine immunisation, predicted to 
prevent over 732,000 deaths [50]. However, there are still gaps in our understanding 
of immunity, in particular in non-mammalian species, which, combined with fast 
 32 
evolving pathogens, lead to some vaccination failures, for example in the 
aquaculture industry. 
 
1.2. Vaccines against bacterial diseases in aquaculture 
Because of the high economic losses associated with disease emergence in 
aquaculture, due to fish mortality, lower growth rates and decrease of product 
quality, it is crucial to efficiently protect farmed fish stocks [51, 52]. Antibiotics were 
commonly used as a disease control method before the introduction of vaccines in 
the aquaculture industry. However, due to their detrimental commercial impact and 
the inevitable development of bacterial resistance, leading to a reduced antibiotic 
efficacy, antibiotic use has significantly decreased in fish farming [53, 54]. 
Vaccination, on the other hand, has been a major success story in the global 
aquaculture industry since its introduction in the 1970s, revolutionising disease 
control and almost eliminating antibiotic use in modern fish farms [53, 54]. In the 
Norwegian salmon industry, for example, vaccine use has allowed for a significant 
increase in production while reducing the use of antibiotics [55, 56]. However, there 
are some infections that remain difficult to control by vaccination including diseases 
caused by highly variable bacterial pathogens such as Streptococcus or Vibrio 
species.  
 
Streptococci are gram-positive cocci typically growing in chains or in pairs. 
Streptococcus iniae is a β-haemolytic aquatic pathogen identified in over 27 fish 
species and it affects economically important farmed species such as tilapia 
(Oreochromis niloticus), rainbow trout (Oncorhynchus mykiss), yellowtail (Seriola 
lalandi) and barramundi (Lates calcarifer) [57]. S. iniae is also a zoonotic pathogen 
that causes, amongst other symptoms, meningitis and septicaemia in farmed 
animals and can be transmitted to humans, especially to immuno-deficient 
individuals, through handling of infected animals [58, 59]. Vaccine failures against S. 
iniae have been reported in Israeli trout farms and in Australian farms, with re-
emergence of infections post vaccination [60]. Vaccination failure in Israel resulted in 
a massive disease outbreak in 1997 and was due to the emergence of a new S. 
iniae serotype, caused by capsular variations [60]. To date, no generic vaccine 
against S. iniae is registered in Australia, so the barramundi farming industry relies 
on an autogenous vaccine program (vaccines developed from bacteria strain(s) 
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isolated from an outbreak and used exclusively on the farm from which the 
pathogens were isolated) [57]. However, vaccinated fish are occasionally re-infected 
by different S. iniae serotypes with re-emergence of the pathogen resulting from 
mutation on the genes responsible for synthesis of the bacterial polysaccharide 
capsule [61]. It seems that S. iniae, through mutations that change the capsular 
polysaccharide, is able to effectively avoid detection and/or evade its hosts’ adaptive 
immune system, leading to diseases outbreaks in already vaccinated fish. Those 
disease outbreaks are highly problematic, as septicaemia caused by S. iniae often 
leads to over 50% mortality in 3 weeks or less in cultured animals [57].  
 
Vibrios are motile gram-negative bacteria possessing polar flagella and a curved rod 
shape. Vibrio species are typically marine bacteria and are hard to differentiate at the 
species level, due to their highly plastic overlapping genomes [62, 63]. Several 
species of Vibrio are pathogenic and are often associated with marine organisms 
such are crabs, prawns and fish but they can also be zoonotic, causing 
gastroenteritis and potentially septicaemia in marine mammals or even in humans, 
mostly after ingestion of raw seafood [64-66]. Many aquaculture species are affected 
by Vibrio, including but not limited to white shrimp (Litopenaeus vananmei) [67], 
Atlantic cod (Gadus morhua) [68], European seabass (Dicentrarchus labrax) [65] and 
Australian barramundi (Lates calcarifer) [69], and those bacteria currently are the 
leading disease causing agent in the industry. Losses due to vibriosis in prawns 
were estimated at approximately US $1 billions in 2011 in Viet Nam only, and those 
numbers have likely increased with the development of the industry [70]. Vibriosis 
caused by V. harveyi is also a recurring issue in fingerling barramundi culture in 
Australia, causing heavy mortalities over a short time frame [69].  
 
In order to improve the efficacy of vaccines, adjuvants are typically added to the 
injection mix. This practice is valuable both economically and immunologically, as 
adjuvants are usually cheap to produce, they allow for lower antigen concentrations 
in the vaccine, and they greatly enhance the antibody response [71]. For example, in 
chickens, the addition of cystidine-phosphate guanosine oligodeoxynucleotides 
(CpG-ODN) as an adjuvant increased the specific antibody response to Escherichia 
coli fimbrial adhesin F4 up to 480%, compared to Freund’s incomplete adjuvant [72]. 
There are currently two main types of adjuvants: depots or irritants. Depot adjuvants, 
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mostly composed of oil emulsions, attract effector cells to the injection site, 
increasing the delivery of antigen to APCs [73]. Oil emulsions also maximize the time 
during which the antigens are presented, thus maximizing the immune response. 
Irritant adjuvants cause the body to trigger and amplify the immune response. Many 
of the components found in adjuvants act on PRRs, which enhance and quicken 
APC maturation for a boosted immune protection. For example, a combination of 
CpG-ODN and polyI:C with an inactivated salmon alphavirus significantly increased 
the titres of neutralising antibodies against this antigen, which were maintained post 
cohabitation challenge [73]. Adjuvants have played a big part in the success of 
vaccines aquaculture, with vaccines in salmon only becoming commercially viable 
with the introduction of oil emulsions in the early 1990s [53]. However, although 
current adjuvants in aquaculture have been optimised for slow delivery of antigens in 
cold water species, new adjuvant formulations need to be tested in vaccine trials in 
order to optimize dose and antigen delivery for better vaccine release in warm water 
species. Moreover, additional work is necessary to understand not only the 
pathogens’ camouflage/evasion techniques, but also their hosts’ immune adaptive 
mechanisms.  
 
1.3. Focus on the adaptive immunity of teleosts 
Antigen-presentation by the cellular immune system is essential for the development 
of a protective adaptive immune response, therefore, understanding it is critical to 
improve vaccine efficacy. However, until recently, no equivalent of DCs, which are 
the main APCs in mammals, had been discovered in fish. For years, the existence of 
DCs in teleosts was debated, due to the differences between teleostean and 
mammalian immune systems and due to the lack of suitable identification tools, such 
as specific markers, in fish. One of the major differences between fish and mammals 
is the location of the main hematopoietic centres, where immune cells and their pre-
cursors are generated. Unlike mammalian bones, fish bones are not hollow and, 
consequently, they lack bone marrow, which is one of the main hematopoietic 
centres in mammals [74, 75]. Instead, immune cells in fish arise mainly in the 
pronephros or head-kidney (HK), which seems to effectively supplant bone marrow 
as the primary hematopoietic organ [74]. Moreover, as lymph nodes are also absent 
in fish, the spleen is considered to be the primary site for T-cells/ APCs interactions, 
including antigen processing and presentation [76]. Another significant difference 
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between the adaptive immunities of mammals and teleosts is the variety of 
immunoglobulin (Ig) classes they each possess. Igs are also known as antibodies or 
B-cell receptors which are secreted or membrane bound respectively [77]. In 
mammals, antibodies are classified into five main isotypes, namely IgA, IgD, IgE, 
IgM and IgG. IgG and IgM constitute the bulk of circulating antibodies, with 
pentameric IgM being the principal antibody during the primary innate response, then 
undergoing class switch to a monomeric IgG during the secondary adaptive 
response [78]. In teleost fish however, only three main isotypes have been 
described, IgD, IgM and IgT/Z, with the later thought to play a similar role to 
mammalian IgA [79, 80]. IgM, which is conserved in both fish and mammals, 
functionally defines B-lymphocyte lineages, and is thus an important component of 
the immune response [77]. Moreover, in teleosts, IgM is found from monomers to 
tetramers, and polymerisation seems to correlate with antibody affinity [81], unlike 
what is observed in mammals. Finally, there are important discrepancies in PAMPs 
recognition between mammals and fish. Indeed, some TLRs, such as TLR14, have 
only been identified in fish and still need functional characterisation [82]. On the 
other hand, an equivalent to mammalian TLR4 is yet to be found in teleosts [4]. Due 
to the differences between teleost and mammalian immunity and the challenging 
identification of immune cells in fish, complex processes such as antigen sampling 
and presentation are still poorly understood in teleosts. However, because putative 
DCs were recently discovered and characterised in rainbow trout (Oncorhynchus 
mykiss) and in zebrafish (Danio rerio) among other fish species [76, 83], further work 
is now warranted to investigate the role of those putative DCs in fish adaptive 
immunity. This will provide an excellent platform for understanding antigen 
presentation in fish and will subsequently enable a faster development of protective 
vaccines against complex fish pathogens such as S. iniae. To investigate the early 
onset of adaptive immunity and in particular putative DCs in teleosts, the Australian 
barramundi (Lates calcarifer) will be used as an industry-relevant model species.  
 
1.4. Barramundi aquaculture overview 
Barramundi (Lates calcarifer) is a tropical Australian native fish [84]. Because they 
are euryhaline organisms (they can migrate between fresh and saltwater) and have a 
fast growth rate, barramundi are relatively easy to farm and are therefore 
economically important to the aquaculture industry in Australia and throughout 
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South-East Asia [85]. In 2010, the barramundi industry had a gross value of $AU20.7 
million in Queensland alone, and the industry is still expanding [86]. Due to this 
expansion, the occurrence of diseases, including vibriosis, lymphocystis, viral 
nervous necrosis (VNN), Picorna-like virus, streptococcosis and gastrointestinal 
cryptosporidiosis, has considerably increased on barramundi farms and hatcheries 
[57, 87-90]. Several simple measures can be taken to reduce disease outbreaks, 
such as managing the water quality, keeping stressful conditions to a minimum and 
reducing fish density, but the most effective method of protection against bacterial 
pathogens in aquaculture remains vaccination [53, 91]. However, vaccine failures 
can occur, especially when targeting highly variable pathogens such as S. iniae and 
V. harveyi. 
 
 
1.5. Barramundi as an industry model species 
Barramundi belong to the Perciformes order, which include over 40% of all bony fish 
species identified to date. Perciformes also encompass other commercially important 
species such as tilapia, mackerel, grouper and European seabass, however, most 
research on teleosts focusses on the model species Danio rerio or on high value 
species such as salmonids. Moreover, Perciformes diverged much later that 
cyprinids (zebrafish, carps, koi) or than salmonids (trouts, salmons), which makes 
them a valuable link between the highly-studied zebrafish and terrestrial vertebrates 
in the evolutionary story of the immune system [92]. More importantly, barramundi 
are warm water fish, with an optimal growth temperature ranging between 25 and 
32°C [93]. With the development of aquaculture in tropical and subtropical areas and 
with global warming coming into play, it is increasingly important to understand how 
the immune system of warm water fish species functions. Investigating pathogen 
recognition and the onset of immune memory in barramundi would provide 
meaningful insight into the immune system of warm water fish and such research 
would also be applicable to many currently farmed species. Further, considering that 
most teleost species are classified as Perciformes, with over 10,000 species, it is 
likely that when considering new species for aquaculture, many of those will belong 
to this order. It is thus time to fill the knowledge gaps regarding warm water fish 
immunology, and in particular Perciformes’ immunology. By using barramundi as an 
industry relevant model species, the outcomes of this thesis are ensured to be 
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applicable to many aquaculture species, especially ones farmed in developing 
countries where the need for high yield and low loss protein sources is crucial. 
 
1.6. Techniques overview and methods development 
Although fish immunology has steadily developed and improved over the last few 
decades, specific tools and techniques are still scarce. With the development of 
aquaculture, there is an increased need for the study of fish immune system, 
following the emergence of new diseases.  
 
Transcriptomes are sets of RNA transcripts produced by the genome at a given time, 
and thus are used to study gene expression under specific circumstances [94]. 
Transcriptomes have been generated, sequenced and analysed for a large variety of 
fish species, including, but not limited to, grey bamboo shark (Chiloscyllium 
griseum), Miiuy croaker (Miichthys miiuy), pufferfish (Takifugu rubripes), zebrafish 
(Danio rerio), turbot (Scophthalmus maximus), African coelacanth (Latimeria 
chalumnae) and half-smooth tongue sole (Cynoglossus semilaevis) [95-101]. 
Transcriptomes from these fish species have mainly been used in order to identify 
their phylogenetic relationships with other vertebrates, in particular mammals, as well 
as to get a better understanding of chondrichthyan and teleostean immune 
processes. Moreover, they have increased the amount of expressed sequence tags 
(EST) available for fish species on databases such as the National Center for 
Biotechnology Information (NCBI), providing valuable data for further genetic and 
genomic research on ichthyes. However, the genomic data available for perciform 
fish, which represent about 40% of all bony fish and include several farmed species, 
is still limited. Hence, the generation of a spleen and head-kidney immune 
transcriptome (transcriptome generated during an immune response) for barramundi 
using de novo assembly would prove a valuable tool for future research on farmed 
fish immunology. Specifically, the processes underlying early stages of adaptive 
immunity are of particular importance as they set the base for the immune memory 
of pathogens, on which the development of vaccines relies. 
 
1.7. Objective and aims 
The main objective of this project was to gain a better understanding of the early 
onset of adaptive immunity and the role of dendritic cells in teleosts, using 
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barramundi (L. calcarifer) as an industry relevant study organism. To achieve this 
objective, the project was divided into the following aims: 
 
1- Generation and assembly of a transcriptome from the major immune organs 
in barramundi (Lates calcarifer), the head-kidney and spleen 
A spleen and head-kidney barramundi immune transcriptome was generated using 
next generation sequencing from RNA derived after immunisation with a mixture of 
lipopolysaccharide (LPS) and peptidoglycan, from gram-negative and gram-positive 
bacteria respectively. The immune transcriptome was assembled using de novo 
assembly and was annotated using gene ontology (GO) and the Kyoto Encyclopedia 
of Genes and Genomes (KEGG), in order to identify pathways of interest for further 
study into the recognition and presentation of key antigens in fish. LPS is of 
particular interest because teleosts have an attenuated innate response to LPS, but 
strong and type-specific adaptive response to LPS, which is critical to the efficacy of 
several vaccines. Particular attention was given to TLRs and CLRs identified in the 
immune transcriptome, as they are the main receptors involved in initiating 
presentation of major PAMPs in fish. The Mincle CLR was identified as a partial 
alternative to TLR4 recognition of LPS in barramundi. 
 
2- Identification of LPS receptors in barramundi (Lates calcarifer) through 
transcriptomic analysis and functional assessment of those receptors 
Interleukin-1β-converting enzymes (ICE)-caspases have recently been identified as 
intracellular LPS receptors in humans (caspase-4, -5) and in mice (caspase-11). 
Using the previously generated barramundi transcriptome, a range of caspases were 
identified in barramundi. Moreover, inflammasome complexes (combining caspase-1 
and diverse NLRs) were also investigated in barramundi transcriptome, due to their 
ability to recognise PAMPs and induce inflammation. Finally, two leucocyte integrins 
were identified in barramundi, with similar binding sites and functions to mammalian 
leucocyte integrins, suggesting a role in LPS recognition in barramundi. 
 
3- Identification and characterisation of dendritic cells in barramundi (Lates 
calcarifer) and first description of a specific molecular marker for dendritic 
cells in fish 
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As the key antigen presenting cells in higher animals, dendritic cells are at the 
primary link between innate and adaptive immunity. DC-SCRIPT, a protein 
specifically associated with dendritic-cells in humans and mice, was identified in 
barramundi (L. calcarifer) and its expression pattern were characterised in head-
kidney and spleen post injection with TLR-ligands. Using this protein as a molecular 
marker, DC-like cells were also morphologically and functionally identified in 
barramundi for the first time. 
 
4- Assessment of antibody response kinetics and affinity maturation potential 
to various adjuvanted vaccines in barramundi (Lates calcarifer) 
Different adjuvant formulations were tested in a large scale vaccine trial using a 
model antigen in the tropical farm species L. calcarifer (barramundi) to determine the 
feasibility of increasing speed of antigen release early in the farm cycle, whilst 
retaining longevity of protection. Primary and secondary response kinetics were 
measured, in terms of antibody-response to vaccination using several 
antigen/adjuvant formulations. The avidity of those antibodies was also quantified 
and the genomic region coding for heavy chain V(D)J region of immunoglobulin was 
identified in barramundi. 
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2.1. Introduction 
Teleost fishes are the most abundant extant vertebrates on the planet and are critical 
in the global food supply. Diverging from “bony vertebrates”, including birds, 
amphibians and mammals around 420 m.y.a., teleosts underwent an additional 
genome duplication event around 300 m.y.a. [102] that contributed to their high 
diversity through both accelerated gene loss [102, 103], and through sub- and neo-
functionalisation of genes under diversifying selection [92, 104]. They are also one of 
the earliest diverging animal infraclass with an adaptive immune system based on 
antigen recognition by MHC I and II molecules [105] and by immunoglobulins [106]. 
This trait has been exploited to great effect in the aquaculture industry through the 
development and implementation of mass vaccination programs for farmed fish [53]. 
The aquaculture industry currently supplies more than half of the fish for global 
human consumption, yet has only latterly been recognised as a key foundation for 
ensuring future food security for a growing population [70]. Increasing production to 
meet future demand in a sustainable manner is a challenging problem that requires a 
multifactorial approach, with reduction of stock losses to bacterial and viral diseases 
critical to increasing efficiency from existing aquaculture infrastructure. There has 
been some substantial success with the introduction of oil-adjuvanted injectable 
vaccines against major bacterial diseases in the Norwegian salmon industry since 
the early 1990s [53]. However, high loss to disease still occurs, especially where 
aquaculture is growing fastest, in the tropical and subtropical regions [54, 107], with 
many of the pathogens associated with disease in warm water species difficult to 
control by vaccination. For example, the gram-positive streptococcal pathogens 
Streptococcus iniae and Streptococcus agalactiae undergo rapid serotype switching 
under stress in the immune host [61, 108, 109], and the gram-negative pathogen 
Aeromonas hydrophila and other motile Aeromonads are also highly diverse, making 
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effective targeting of vaccines difficult [110]. Edwardsiella ictaluri, which causes 
devastating losses in the burgeoning Pangasius catfish industry in Vietnam, is 
facultatively intracellular, thus difficult to control with conventional killed vaccines 
whilst live attenuated vaccines are fraught with difficulties in the milieu of fish farm 
ponds where reversion to virulence has occurred [111-113]. In order to solve these 
complex problems through vaccination, a much more thorough understanding of how 
adaptive immunity develops in warm water fish species is required. This presents a 
challenge as teleosts represent the most diverse extant vertebrate infraclass. 
 
Vaccination relies upon the formation of immune memory, which is coordinated by 
specialist antigen presenting cells (APCs), particularly dendritic cells (DCs) [1, 2]. 
Putative DCs have recently been identified in several teleost species, including 
rainbow trout (Oncorhynchus mykiss), zebrafish (Danio rerio) and barramundi (Lates 
calcarifer) [76, 83, 114], representing respectively Salmonid, Cyprinid and Perciform 
orders, and providing a basis for improved understanding of acquired immunity in 
teleost fishes. In vertebrates, an immune response is initiated following the 
recognition of specific structures from invading microorganisms (pathogen-
associated molecular patterns (PAMPs)) by the host’s pattern recognition receptors 
(PRRs). PRRs not only play a major role in the initial capture of foreign particles and 
onset of inflammation, but also in the activation and maturation of DCs and other 
APCs, thereby providing a link between innate and adaptive immune responses [9]. 
There are four major types of PRRs capable of inducing cellular responses: Toll-like 
receptors (TLRs), C-type lectin receptors (CLRs), NOD-like receptors (NLRs) and 
RIG-I-like receptors (RLRs) such as MDA5 [3]. All of these PRRs have been 
described in teleost fish [4, 115].  
 
TLRs have a central role in the vertebrate immune response by activating 
inflammatory pathways such as the NF-kB and MAPK signalling cascades, 
responsible for the production of pro-inflammatory molecules and for the initiation of 
adaptive immunity [5-7]. Functional TLRs are transmembrane proteins presenting 
leucine-rich repeat (LRR) domains, a trans-membrane domain as well as a 
Toll/interleukin-1 receptor (TIR) domain [5]. TLRs can be grouped in two sub-families 
depending on their ability to recognise and bind either cell surface elements 
(microbial sugars, lipids and proteomes) or nucleic acid [8]. TLRs have been 
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identified in a number of cartilaginous and bony fish species, with close phylogenetic 
relationship to mammalian TLRs based on amino acid alignment [116, 117]. One 
exception is TLR4, responsible for lipopolysaccharide (LPS) recognition in mammals. 
Although tlr4 genes have been identified in cyprinids (including Danio rerio and 
Cyprinus carpio), a functional fish ortholog to human TLR4 protein has not yet been 
identified [4, 118] 
 
Bacterial polysaccharides and lipopolysaccharides can also be recognised by lectin 
receptors such as C-type lectin receptors (CLRs). CLRs can be transmembrane or 
secreted proteins and use conserved carbohydrate recognition domains to bind 
sugars in a calcium-dependant manner [9, 13]. Pathogen recognition by CLRs is 
closely associated with antigen capture and presentation and several of the 
membrane-bound CLRs are specific to APCs, particularly DCs [10-12]. CLRs have a 
central role in the initiation of anti-fungal immunity in mammals (reviewed in [3]), can 
recognise viruses through mannose specificity [14], and also seem to play a critical 
role in bacterial clearance and recognition of non-self particles in marine 
invertebrates and vertebrates [8, 15-20]. Moreover, CLR activation can result in 
cytokine signalling either through direct NF-kB activation or through coinciding TLR 
activation, suggesting CLRs can partially regulate adaptive immune responses and 
inflammation [21]. Some CLRs have been described in fish, though not in Perciforms 
[119-121], and the functional roles of CLRs in innate and adaptive immunity in 
teleosts remain unclear. 
 
In the present study, the recognition and processing of the carbohydrate-rich 
bacterial cell wall components (LPS and peptidoglycan (PTG)) are investigated in a 
perciform fish, the barramundi or Asian sea bass, Lates calcarifer, to elucidate 
potential pathways linking innate and adaptive immune responses to these essential 
pathogen-associated molecules. To achieve this, a broad immune transcriptome was 
initially generated from the major haematopoietic organ, the head-kidney (HK) or 
pronephros, and the major antigen processing organ, the spleen, of barramundi 
challenged with LPS and PTG. Subsequently, the role of the Mincle C-type lectin 
receptor pathway in processing of LPS by spleen and head-kidney leucocytes was 
further analysed in vitro. 
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2.2. Materials and Methods 
2.2.1. Experimental animals and husbandry 
Barramundi (Lates calcarifer) juveniles of approximately 30–100 g were obtained 
from a commercial aquaculture facility in Cairns, Queensland, Australia. Fish from 
this farm are specific pathogen free fish as the direct supply of filtered bore water to 
the hatchery and farm coupled with strict biosecurity prevent exposure to common 
fish pathogens. Fish were transported to The University of Queensland by air freight 
and acclimatised for 2 weeks in a recirculating system of eight 84 L cylindrical food-
grade plastic tanks with individual aeration, all connected to a 260 L sump equipped 
with a protein skimmer and a bio-filter. The water temperature and the salinity were 
maintained at 28 ± 2°C and 15 part per thousand (ppt) respectively. Water quality 
was checked regularly for ammonia, nitrite, nitrate and pH, and water exchanges 
were applied as required. Fish were fed to satiation twice daily with a commercial 
diet for barramundi (Ridley Aqua Feed). 
 
2.2.2. Fish immunisation, RNA isolation and preparation for Illumina sequencing 
Juvenile barramundi (all males) were injected in the peritoneal cavity with either 
phosphate buffer saline (PBS 1X) or with a cocktail of lipopolysaccharide (LPS from 
Escherichia coli 0111:B4, Sigma; 10 µg/mL) and peptidoglycan (PTG from 
Staphylococcus aureus, Sigma; 10 µg/mL) diluted in 100 µL PBS. LPS and PTG 
were chosen as they are bacterial polysaccharides often used to induce innate 
immune responses both in vivo and in vitro [122-124]. Moreover, LPS is both a 
requirement and type specific antigenic molecule used for full protection in some 
bacterial fish vaccines [125], and is therefore of significant interest in both adaptive 
and innate immunity in fish. At 6 h, 24 h, 72 h and 7 d, four fish were sampled from 
both control and treatment groups. From each fish, the spleen and head-kidney were 
dissected aseptically and kept in RNAlater until further processing.  
RNA was extracted using the RNeasy extraction kit (QIAGEN), according to the 
manufacturer’s instructions. Tissues kept in RNAlater were disrupted by reflux 
passage through a 25 x g needle mounted on a sterile 1 mL syringe before 
processing. RNA was eluted in 40 µL of nuclease free water. Prior to library 
preparation, samples were pooled to reach 3 µg of RNA into four different 
categories: control spleen (SC), control head-kidney (HKC), treatment spleen (ST), 
and treatment head-kidney (HKT). Pooled samples were then concentrated to 100 
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ng/µL using a sodium acetate and ethanol precipitation. Briefly, nuclease free water 
was added to the samples to bring the volume to 450 µL, and 50 µL of 3M sodium 
acetate and 1 mL of nuclease free ethanol were then added to the samples. The 
samples were then incubated at -20°C overnight. The next day, the samples were 
spun at 4°C for 30 min at max speed in a microcentrifuge (Eppendorf). The 
supernatant was carefully removed and the samples were washed in 500 µL ice-cold 
70% ethanol by centrifugation at 4°C for 10 min at max speed. The samples were 
then allowed to dry at room temperature by inversion of the tubes on tissue paper for 
1 h and re-diluted in nuclease free water. Quality was checked using a bioanalyser 
(Agilent, courtesy of the Australian Genome Research Facility (AGRF)) and RNA 
quantity was assessed by Qubit 2.0 fluorimetry (Invitrogen). RIN values from the 
bioanalyser analysis ranged from 6.1-9.4. Whilst the single sample with a RIN value 
of 6.1 was lower than normal (a cut-off of 7 is usually applied), the gel and trace 
output did not show evidence of significant degradation, merely lower peak heights 
reflecting the lower concentration of RNA in this sample. Samples were kept frozen 
at -80°C until TruSeq paired-end library preparation and sequencing using Illumina 
Hi-seq 2000 by the AGRF (Melbourne, Australia). Subsequent to sequencing, no 3’ 
bias was detected in the resulting Illumina reads in the low concentration (RIN 6.1) 
sample. 
 
2.2.3. De novo assembly and annotation 
Raw Illumina reads were uploaded to the NCBI database under the BioProject 
PRJNA307522 with the accession numbers SRR3170685, SRR3170702, 
SRR3170703 and SRR3170704. Illumina read quality was checked using the 
FastQC software on the Queensland Galaxy virtual interface (http://galaxy-
qld.genome.edu.au/). Sequences were quality trimmed with Trimmomatic before 
being processed through the Trinity assembly package (available at http://galaxy-
qld.genome.edu.au/workflow/list_published) using paired reads assembly and 
default parameters. Assembly was conducted for the four treatment groups 
independently as well as pooled in order to generate an immune transcriptome. The 
generated transcripts were then annotated using BLASTX against non-redundant 
NCBI database and mapped to gene ontology (GO) in the Blast2Go program, and 
KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways were generated 
using the KEGG automatic annotation server (KAAS, available at 
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http://www.genome.jp/kaas-bin/kaas_main) and the KEGG pathway reconstruction 
tool (http://www.kegg.jp/kegg/tool/map_pathway.html) [126-129].  
  
 
 
2.2.4. Differential expression and comparison of immune organ transcripts 
Using Bowtie2 in Galaxy, the trimmed high-quality reads from the four different 
categories (SC, HKC, ST and HKT) were mapped back to their corresponding 
assembled transcriptome in order to obtain a differential read count. The read count 
for each category was then normalised to FPKM (fragments per kilo-base of 
transcript per million fragments mapped) values and further analysed to identify 
differentially expressed genes between control and treatment groups as well as 
between organs using the Tuxedo pipeline (Cufflinks, Cuffmerge and Cuffdiff) and 
Edge R analysis on Galaxy. 
 
2.2.5. Phylogenetic analysis 
From the KEGG annotation, transcripts associated with the development of immunity 
were chosen. The TLRs and CLRs agonists were chosen for further phylogenetic 
analysis due to their role in the early onset of an immune response. Barramundi 
transcripts were compared to several mammalian and teleost sequences obtained 
on the NCBI database (GeneBank; accession numbers listed in Table A2.2.1 and 
A2.2.2). MEGA6.0.6 software was used to align sequences (ClustalW, codon) to 
infer phylogenetic relationships by maximum likelihood with node probability 
supported by 2000 boostrap replicates. 
 
2.2.6. LPS stimulation and bDCs maturation 
Spleen and HK were dissected aseptically from euthanised (anaesthetic overdose, 
Aqui-S, Upper Hutt, New Zealand) healthy juvenile barramundi and placed in 
supplemented L-15 medium (1 % penicillin-streptomycin (P/S, 10,000 U), 10 % foetal 
bovine serum (FBS, heat inactivated)). The organs were then gently pushed through 
a 100 µm cell strainer using the plunger from a sterile disposable syringe in order to 
obtain a cell suspension. Cells were then either incubated with LPS (E. coli 0111:B4, 
Sigma) at 0.01, 0.05, 0.1, 0.5 and 1 µg/mL, with PTG at 1 µg/mL or with nothing 
(control) for 5 days. Cells were sampled at day 5 and stained using a fluorescent in 
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situ hybridization (FISH) probe for DC-SCRIPT as previously described [114]. The 
sampled cells were then analysed by flow cytometry for CAL Fluor 590 (red 
fluorescence) and DAPI (blue fluorescence) for each treatment.  
 
2.2.7. Western blotting 
Barramundi Mincle/CLEC4E cDNA sequence was identified in the transcriptome by 
homology to human, murine and teleost Mincle using BLASTX. A primary mixed 
spleen and HK cell culture was obtained by sterile sampling of the spleen and HK 
post anaesthesia by overdose of Aqui-S. A single cell suspension was obtained by 
gently pushing the organs through a 100 µm cell strainer as described in paragraph 
2.6. Any erythrocytes still present in the suspension were removed by layering the 
cell suspension on a 34% / 51% Percoll density gradient (Sigma) and separating by 
centrifugation at 800 x g, 30 min, RT, acc. 6, no brake in an Eppendorf 5810R 
centrifuge. Cells at the interphase between the medium and the 34% Percoll layer 
(macrophages, neutrophils and granulocytes) and at the interphase between the two 
Percoll layers (lymphocytes and monocytes) were collected and washed twice in 1X 
PBS (400 x g, 10 min, RT, acc. 9, brake 9). The obtained leucocytes were either 
stimulated with the Mincle pathway inducer Trehalose-6,6-dibehenate (TDB, 1 
µg/mL) for 21 h (Integrated Sciences Pty Ltd) or were left unstimulated. Both 
stimulated and unstimulated cells were then lysed and the proteins were separated 
on a 15% SDS-PAGE gel. Subsequently, the proteins were transferred onto a PVDF 
membrane (Immobilon P, Millipore) using a semidry blotting apparatus (Transblot 
TE44, GE Healthcare Biosciences) in Towbin buffer at 80 mA for 1 h. The blots were 
probed for Mincle using monoclonal mouse IgG vs human Mincle antibody (clone 
15H5, InVivoGen via Integrated Sciences Pty Ltd), diluted to 1 µg/mL from 100 
µg/mL stock in tris-buffered saline-Tween (TBST),) for 3 h at room temperature, 
before using a conjugated alkaline phosphatase goat anti-mouse IgG secondary 
antibody (1:15000 dilution in TBST - Sigma) for 1 h at room temperature. A negative 
control (to test for non-specific secondary antibody binding) was performed by 
omission of the primary antibody (incubation in TBST alone). An immunoglobulin 
isotype control was performed by substituting the primary antibody with mouse anti-
S. agalactiae monoclonal IgG (Abcam AB21114), diluted in TBST to 1 µg/mL final 
concentration. Development was performed at room temperature for 15 min using 
BCPI/NBT Liquid Substrate (Sigma).  
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2.2.8. Cytokine regulation by the Mincle pathway assessed by qRT-PCR 
Spleen and HK were sampled aseptically from healthy juvenile barramundi and a cell 
suspension was obtained as described in paragraph 2.2.6. After 5 days of incubation 
at 28°C, cells were incubated with LPS (E. coli 0111:B4) at 0.05 and 0.5 µg/mL for 1 
h at 28°C. The blank controls consisted in cells alone, the negative controls 
consisted of cells incubated with 1 µg/mL of mouse anti-human Mincle blocking 
antibody for 1 h at 28°C followed by a 1 h incubation with 1 µg/mL of TDB or with 
0.05 or 0.5 µg/mL of LPS at 28°C, and the positive controls consisted in cells 
incubated with 1 µg/mL of TDB at 28°C. Cells from all treatment groups were then 
harvested in RNAlater. For each sample, RNA was extracted using the RNeasy kit 
(Qiagen) according to the manufacturer’s instructions. Contaminating genomic DNA 
was removed by on-column digestion with the RNAse-Free DNAse set (Qiagen) and 
the resulting RNA was converted to cDNA from a total of 10 ng of starting RNA per 
sample using the QuantiTect Reverse Transcription kit (Qiagen). Subsequently, the 
cDNA was used to assess the relative expression of IL6 and TNFA by qRT-PCR, 
using 18S, elongation-factor-1α, CLEC4E, FcRgamma and Syk as normalisers, on a 
ABI-ViiA7 cycler (Applied Biosystems). Subsequently, only CLEC4E, FcRgamma 
and Syk were used as normalisers as they presented the most stable expression 
levels across treatments and presented similar efficiencies (within 10% of target 
genes and of each other). The primers used are listed in Table A2.2.3 and were 
designed to span across exons when possible to eliminate gDNA amplification. 
 
2.2.9. Statistical analysis 
Data analysis was performed with RStudio v0.99.486 (RStudio, Inc) and with Prism 6 
(GraphPad). Prior to qRT-PCR analysis, the stability of the internal control genes 
was assessed and the relative expression for each gene was computed using the 
Relative Expression Software Tool (REST) [130-132]. Data from flow cytometry 
analysis and the qRT-PCR were analysed using analysis of variance (ANOVA) tests, 
using RStudio and GraphPad Prism respectively. Where ANOVA indicated 
significant differences, it was followed by pairwise comparison t-tests for the flow 
cytometry data (RStudio) and by Tukey post-hoc tests for the qRT-PCR data 
(GraphPad Prism) with α 0.05 in each case.  
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2.3. Results 
2.3.1. De novo assembly 
The spleen and HK cDNA sequenced by Illumina HiSeq 2000 generated 40,801,246 
(spleen) and 37,724,291 (HK) raw reads for control and 40,072,015 (spleen) and 
38,363,780 (HK) raw reads for treatment. The read length was 100 x 2 (paired end 
reads) and the total raw data generated for spleen and HK were 19.8 Gb and 18.6 
Gb respectively, for a total of 38.4 Gb. The low quality base pairs were trimmed and 
the reads from both tissues and conditions were assembled together to generate a 
reference transcriptome for Lates calcarifer. The de novo transcript assembly 
produced a total of 163,661 transcripts, with the mean transcript length being 
approximately 1,502 bp and the longest transcript being 17,480 bp (Table 2.1). The 
transcripts differentially expressed between treatments and between organs were 
filtered and resulted in 90 transcripts and 19,713 transcripts respectively.  
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Table 2.1. Summary of Lates calcarifer transcriptome transcripts, assembly and 
annotation. 
Total number of reads (spleen) 80,873,261 total 
(40,801,246 control and 
40,072,015 treatment) 
Total number of reads (head-kidney) 76,088,071 total 
(37,724,291 control and 
38,363,780 treatment) 
GC percentage (%) 44.56 
Total number of transcripts 163,661 
Mean length of transcripts (bp) 1,502 
Longest length of transcripts (bp) 17,480 
Differentially expressed (DiffExpressed) transcripts between 
organs  
19,713 
Total DiffExpressed transcripts between organs with BLASTX hit 9,213 
Total DiffExpressed transcripts between organs with annotation 7,450 
 
2.3.2. Transcriptome GO annotation and functional annotation 
The 163,661 transcripts were grouped in 5 KEGG categories, further classified into 
31 KEGG sub-categories (Figure 2.1), 71,718 transcripts were matched through 
BLASTX hit and 53,282 transcripts generated an annotation for Gene Ontology 
(GO). Of the GO annotated transcripts, 31,451 were categorised in biological 
process, 22,056 in cellular component and 44,122 in molecular function (Figure 2.2). 
Transcripts annotated through the KEGG pathways were most numerous in the 
‘Signal Transduction’, ‘Endocrine System’ and ‘Immune System’ sub-categories. The 
detailed transcript groupings for those sub-categories are presented in Figure 2.1B, 
2.1C and 2.1D. Moreover, out of the 90 transcripts differentially expressed between 
control and treatment, 63 were matched through BLASTX hit and 42 generated an 
annotation for GO. Of the 19,713 transcripts differentially expressed between 
organs, 9,213 were matched through BLASTX hit and 7,450 generated an 
annotation for GO. Edge R analysis of the top 100 differentially expressed transcripts 
also revealed that some transcripts were differentially expressed between control 
and treatment groups, both in spleen and HK (Figure 2.3). Moreover, when spleen 
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and HK were compared for GO in regards to ‘Immune system process’ 
(GO:0002376), more transcripts were identified in spleen overall. Interestingly, 
transcripts related to ‘Leukocyte migration’ (GO:0050900) and ‘Leukocyte activation’ 
(GO:0045321) were only identified in HK whereas transcripts related to ‘Antigen 
processing and presentation’ (GO:0019882) and ‘Immune effector process’ 
(GO:0002252) were only identified in spleen (Figure 2.3C and Figure A2.2.1).  
 
2.3.3. TLR and CLR phylogeny 
The transcriptome was screened for TLRs and CLRs, due to the pivotal role TLRs 
and CLRs play in the onset of an immune response. The presence of TLR, NLR and 
RIG transcripts was established by the KEGG analysis and TLR and CLR transcripts 
were confirmed using TBLASTX through the barramundi immune transcriptome 
using human, murine or piscine (D. rerio, T. rubripes or S. partitus) mRNA 
sequences obtained from the NCBI database (Table A2.2.1 and A2.2.2). Barramundi 
TLRs and CLRs sequences were then used to construct Maximum Likelihood Trees 
(MLTs) to infer their phylogenetic relationships with TLRs and CLRs from other 
vertebrate species (Figures 2.4 and 2.5). Barramundi TLRs all grouped with their 
respective piscine and mammalian counterparts. TLR1, TLR6 and TLR10 grouped 
closely together, being more similar within a given species than within the TLR 
group. It was noted that TLR4, TLR4ba, TLR4bb and CD180 (also involved in LPS 
recognition) were not found in the barramundi immune transcriptome, although the 
fish were injected with LPS (Figure 2.4). A total of six C-type lectin receptors were 
identified in L. calcarifer, grouping to their mammalian and/or piscine counterparts 
(Figure 2.5). Two isoforms of CD209 (DC-SIGN) were observed, one closely related 
to human CD209 and the other related to piscine CD209. Furthermore, as human 
CLEC4E is inducible by LPS and participates in bacterial recognition, identifying a 
CLEC4E-like transcript in the barramundi immune transcriptome was of particular 
interest.  
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Figure 2.1. KEGG pathway transcriptome annotation. Transcript grouping into the 
different KEGG sub-categories (A). Detailed transcript grouping for the ‘Signal 
Transduction’ KEGG sub-category (B). Detailed transcript grouping for the 
‘Endocrine system’ KEGG sub-category (C). Detailed transcript grouping for the 
‘Immune System’ KEGG sub- category (D). 
�
�
�
�
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Figure 2.2. Functional annotation of Lates calcarifer transcripts using 
BLAST2GO. The transcripts were sorted into different categories including (A) 
Biological process, (B) Cellular components and (C) Molecular functions. 
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Figure 2.3. Differential gene expression analysis. (A) Edge-R scatter plot showing 
the differentially expressed transcripts across HK and spleen. (B) Top 100 
differentially expressed transcripts based on fold change across HK and spleen for 
both control and treatment groups. Note that most transcripts are differentially 
expressed between organs but some transcripts are differentially expressed between 
treatment groups, suggesting inducible genes. (C) Gene ontology of the differentially 
expressed transcripts in the ‘Immune Process’ category for spleen and HK. 
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Figure 2.4. Maximum likelihood phylogenetic relationships of the TLR 
transcripts identified in the Lates calcarifer immune transcriptome. The TLR 
sequences of L. calcarifer were aligned with the sequences listed in Supplementary 
Table A2.2.1 and are presented on the figure in bold. The TLR clusters were further 
categorised by known function (outer groupings).  
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Figure 2.5. Maximum likelihood phylogenetic relationships of the CLR 
transcripts identified in the Lates calcarifer immune transcriptome. The CLR 
sequences of L. calcarifer were aligned with the sequences listed in Supplementary 
Table A2.2.2 and are presented on the figure in bold. 
 
2.3.4. Barramundi DCs do not mature in response to LPS activation 
When barramundi leucocytes were stimulated with LPS over a period of five days, a 
lower percentage of bDCs were observed as a result of the stimulation when 
compared to non-stimulated control cells (Figure 2.6). The different concentrations of 
LPS seemed to hinder the maturation of bDCs, with higher concentrations leading to 
a significantly lower percentage of DC-SCRIPT-positive cells after five days. In 
contrast, PTG stimulation lead to a significantly higher number of bDCs than high 
concentrations of LPS stimulation after the same time, but the number was not 
significantly different from untreated cells (Figure 2.6). 
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Figure 2.6. Effect of LPS on DCs maturation assessed by flow cytometry 
reading of DC-SCRIPT FISH probe. Percentages of DC-SCRIPT positive cells 
(mean ± SEM) are compared when stimulated with different concentrations of LPS or 
PTG. Same letters represent non-statistically different treatments (p > 0.05). PTG 
was used as a control drug (n = 6). 
 
2.3.5. Mouse anti-Human Mincle antibody cross-reacts with barramundi Mincle 
In order to determine if the CLEC4E transcript identified was translated to a protein 
in barramundi cells, a SDS-PAGE was performed, followed by a Western Blot. The 
molecular weight of the putative Lates calcarifer Mincle protein was calculated using 
the Compute pI/Mw tool on the ExPASy server and was estimated at approximately 
24.2 kDa [133-135] (http://web.expasy.org/compute_pi/). When the SDS-PAGE-
separated proteins extracted from enriched barramundi leukocytes were probed by 
Western Blot with human anti-Mincle antibody, a single protein between 22 and 25 
kDa was detected (Figure 2.7). An isotype control comprising mouse monoclonal IgG 
against S. agalactiae (Abcam AB21114) and used at the same protein concentration 
as the anti-Mincle mAb did not cross-react with Mincle (Figure 2.7). These data, 
coupled with amino acid sequence (36% identity) and protein domain comparisons 
(similar structures) between human and barramundi Mincle suggest that human and 
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barramundi Mincle present homologous binding epitopes and protein structures. 
Moreover, the lack of additional bands detected in the extracts from enriched cells 
with the monoclonal antibody indicates that it is specific for Mincle in barramundi and 
suitable as a blocking agent in subsequent experiments (Figure 2.7). 
 
 
Figure 2.7. Comparison between putative barramundi Mincle and human 
Mincle. (A) Amino acid alignment between barramundi and human Mincle. Blue line 
represents the start of the ectodomain. Red box indicates motif normally involved in 
carbohydrate recognition by C-type lectins and black box represents hydrophobic 
amino acid loops, with residues highlighted in yellow being hydrophobic residues. 
The asterisks below the sequences represent the residues implicated in calcium 
binding. (B) Protein domain structure of barramundi and human Mincle predicted by 
SMART (http://smart.embl-heidelberg.de). (C) Western blotting of barramundi 
leukocytes probed with anti-human Mincle primary antibody, polyclonal non-specific 
IgG primary antibody or control with omission of primary antibody. The development 
of colouration indicates a positive binding around 25 kDa when probed with anti-
human Mincle primary antibody, which coincides with the size of barramundi Mincle.  
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2.3.6. The barramundi Mincle pathway is activated by LPS 
In barramundi leucocytes, LPS induced the transcription of TNFA and inhibited the 
transcription of IL6 in a dose dependant manner, with transcription levels induced by 
0.5 µg/mL of LPS almost identical to the transcription levels induced by the TDB 
positive control (no significant statistical difference - Figure 2.8). TDB is highly 
specific for Mincle. The cells incubated with the anti-Mincle antibody prior to 
exposure to TDB, on the other hand, had increased IL6 transcription and reduced 
TNFA transcription compared to TDB-stimulated control cells, confirming that anti-
Mincle antibody blocks the Mincle receptor in cell culture and is consequently a 
suitable negative control for Mincle activation (Figure 2.8). When Mincle was blocked 
by incubating cells with the anti-Mincle antibody and then stimulated with LPS, TNFA 
transcription levels were also lower than when the cells were incubated with LPS 
alone, suggesting that LPS can regulate TNFA through the Mincle pathway. 
However, the transcription of IL6 was inhibited by LPS by a similar amount in 
barramundi cells whether blocked with anti-Mincle antibody or not, suggesting that 
the effect of LPS on IL6 transcription levels does not depend exclusively on the 
Mincle pathway.  
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Figure 2.8. Differential expression of cytokines in response to LPS by qRT-
PCR. In each graph (IL-6 (A) and TNF-α (B)) different letters indicate statistically 
significant difference in expression level (mean ± SEM) under different conditions (p 
< 0.05, three biological replicates, i.e. cells from three different fish (n = 3)). 
 
2.4. Discussion 
Understanding how the bacterial cell wall is recognised and processed by fish hosts 
is critical to the development of more effective protective methods against bacterial 
pathogens. In this study, a transcriptomic approach was used to investigate the 
recognition and processing of two bacterial cell wall components, LPS and PTG, by 
L. calcarifer immune cells.  
 
Functional analysis of transcriptome data using Gene Ontology and KEGG 
classifications revealed that the ‘Signal Transduction’ and ‘Immune System’ sub-
categories presented a high number of transcripts after a model immunisation with a 
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mixture of PTG and LPS.  It was also noted that the ‘Endocrine System’ sub-
category also presented a large number of transcripts. For many decades, 
interactions between the endocrine and immune systems have been reported in 
humans, with hormones influencing both the function and proliferation of leucocytes 
[136]. In vitro, several hormones, such as glucocorticoids, androgens, progesterone 
and adrenocorticotropic hormones, can depress the immune response whereas 
growth hormones, prolactin and insulin have been shown to increase the immune 
response [137]. Beta-endorphin, in particular, has been shown to impact on the 
activity of natural killer cells as well as to increase the production of IFN-γ in rat 
spleen cells [138]. The high number of transcripts present in the ‘Immune System’ 
and ‘Endocrine system’ KEGG categories in this analysis suggests that endocrine-
immune interactions occur in barramundi as well. In particular, transcripts involved in 
oxytocin, insulin and thyroid hormone signalling pathways were identified in the 
highest numbers in the ‘Endocrine System’ category (88, 74 and 73 transcripts 
respectively), probably driven by cytokine production, with 105 transcripts present in 
the chemokine signalling pathway being the highest number of transcripts in the 
‘Immune System’ category (Figure 2.1). Immune derived cytokines (mostly 
interleukins) have indeed been shown to increase the production of 
adrenocorticotropic hormone, luteinizing hormone, prolactin, vasopressin and 
oxytocin in the pituitary and of corticosterone, vasoactive intestinal peptide and 
mRNA insulin-like growth factor II in the adrenal gland in vitro [137], supporting the 
information highlighted by the functional analysis. 
 
Genes differentially expressed between immune organs were also identified in the 
barramundi transcriptome, with several genes potentially inducible during an immune 
response (genes with high expression variability between control and treatment). 
Notably, most of those inducible genes in spleen were identified as coding for 
proteolytic enzymes, which are involved in regulation and modulation of the 
inflammatory response. Both chymotrypsin A and elastase 1 and 2a are endo-
peptidases belonging to the clan PA peptidases (Proteases of mixed nucleophile, 
superfamily A) and their main function is to break down polypeptides into shorter 
chains, hydrolysing peptide bonds downstream of large hydrophobic residues 
(chymotrypsin A) or downstream of smaller amino acids (elastase) [139]. PA 
peptidases play a role in several critical functions such as blood coagulation, 
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digestion and the immune response [139]. In particular, key functions of DCs, 
including maturation and cell-surface expression of several DC-specific antigens, 
heavily rely on a functional chymotrypsin-like peptidase [140]. Moreover, the 
elastase 2 gene is known to be preferentially expressed in early myeloid progenitor 
cells and to be regulated during early myeloid differentiation by a hematopoietic 
specific transcription factor [141-143]. Lastly, it is noteworthy that both chymotrypsin 
and elastase transcripts were expressed over 10-fold more in spleens that 
underwent treatment with PTG and LPS than in control spleens in the current study, 
further suggesting the involvement of chymotrypsin and elastase in immune related 
processes. 
 
Most of the known TLRs were transcribed in the barramundi spleen and HK 
transcriptome, with the exception of TLR4, which is primarily responsible for LPS 
recognition in mammals [144]. Moreover, the MD-2 protein, which typically couples 
with the extracellular domain of TLR4 and is critical to LPS binding through TLR4 
[145], was also absent from the transcriptome, strongly suggesting that barramundi 
immune cells do not recognise LPS through a TLR4 activated pathway. Another 
accessory molecule associated with LPS recognition in mammals, CD14, was also 
absent from the transcriptome. Furthermore, although zebrafish have been shown to 
recognise LPS through the RP105 protein (also known as CD180 antigen), which is 
very closely related to mammalian TLR4, with MD-1 playing the role of MD-2 [146], 
both RP105 and MD-1 were also absent from the barramundi immune transcriptome. 
Fish are particularly insensitive to LPS compared to their mammalian counterparts 
[16, 147], perhaps due to the absence of TLR4 orthologs in most fish species [116, 
147], or by TLR4-like mediated down-regulation of pro-inflammatory response in 
cyprinids such as zebrafish and common carp [147]. From the transcriptomic data 
gathered in this study, barramundi insensitivity to LPS is likely coupled to their lack of 
TLR4 and TLR4-associated molecular orthologs. It is noteworthy that DC maturation 
was inhibited by LPS in barramundi head kidney and spleen extracts, which 
contrasts with the induction of DCs maturation in mammals through the TLR4 
pathway [148], corroborating the absence of TLR4 from the barramundi 
transcriptome. As the mucosal surfaces of teleosts are continuously challenged by a 
high density of environmental bacteria (relative to their terrestrial counterparts), this 
lack of pro-inflammatory sensitivity to LPS may confer an evolutionary advantage. 
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Environmental bacteria are represented predominantly by the α- and γ- 
proteobacteria in the surface waters [149]. Consequently, continuous activation of a 
pro-inflammatory innate immune response due to this abundance of LPS at the 
mucosal surfaces would represent a substantial draw on energy reserves, and 
subsequent reduction in fitness of fish competing for energy in an oligotrophic 
environment. Nevertheless, there is good evidence of a specific adaptive response 
to LPS O-antigen in several teleost species [150-152], so LPS O-antigen is clearly 
processed through antigen-presentation during the adaptive immune phase whilst 
only weakly pro-inflammatory during the early onset of innate immunity. A gene 
coding for a molecule similar to the lipopolysaccharide binding protein (LBP) was 
also present in the transcriptome, suggesting that although LPS only triggers a weak 
inflammatory response in fish, there are still molecules that are able to recognise 
LPS in fish. Moreover, a C-type lectin inducible by LPS in rainbow trout (O. mykiss) 
was recently identified, further suggesting that fish can respond to LPS to some 
extend [153]. In order to further uncover how barramundi cells recognise bacterial 
LPS O-antigen, CLRs were investigated in the transcriptome.  
 
Several transcripts coding for putative CLRs in barramundi were uncovered (Figure 
2.5). Particular interest was given to the putative barramundi Mincle. The Mincle 
CLR, coupled with FcR-γ, is inducible by LPS in mammals, leading to the 
phosphorylation of ITAMs, the recruitment of Syk and the transcriptional regulation of 
TNFA and IL6 through the Card9-Bcl10-Malt1 complex [154]. The Mincle pathway is 
heavily dependent on protein phosphorylation and recruitment, and hence the 
transcription levels of many of the proteins necessary to this pathway were not 
expected to vary. The qRT-PCR analysis was thus targeted towards investigating the 
transcription levels of IL6 and TNFA. IL-6 has previously been shown to suppress 
TNFA transcription levels when induced by LPS, as well as to stop TNF-α from 
inducing high cellular death in vitro [155, 156]. Although IL-6 and TNF-α are both 
classified as pro-inflammatory molecules, it seems that the balance between those 
two molecules in particular plays an essential role in the conservation of 
homeostasis within the immune system, especially in preventing auto-immunity. As 
the anti-Mincle antibody bound specifically to barramundi Mincle in Western blot, and 
pre-treating barramundi cells with the anti-Mincle antibody prior to exposure to the 
Mincle-specific agonist TDB blocked induction of TNFA and repression of IL6, the 
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blocking by the anti-Mincle of TNFA induction by LPS is strongly supportive that LPS 
induce TNFA via the Mincle pathway. The results presented in this paper therefore 
support that TNFA transcription can be induced by LPS through the Mincle pathway 
in L. calcarifer (Figure 2.8B). However, the anti-Mincle antibody did not block the 
inhibition of IL6, suggesting that IL6 transcription is probably controlled through 
another molecular pathway, independent of Mincle (Figure 2.8A). Therefore, Mincle 
seems to partially supplant TLR4 in barramundi in its ability to recognise and process 
LPS, and to further induce an immune response through the regulation of 
inflammatory cytokines. Nevertheless, barramundi Mincle seems to be less sensitive 
to LPS than TLR4 in mammals, as higher concentrations of LPS were needed to 
induce a response (minimum of 500 ng/mL in L. calcarifer compared to 100 ng/mL in 
H. sapiens). Moreover, although the transcription of TNFA was upregulated by LPS 
stimulation, this upregulation was low compared to observations in mammals, 
corroborating the muted response to LPS in teleosts. Previous studies suggest that 
the involvement of the TLR4 complex in LPS recognition occurred after the 
divergence between fish and tetrapods [147], implying that other molecules might be 
involved in LPS recognition in earlier vertebrates. Beta-2 integrins such as the 
CD11/CD18 heterodimer, for example, have been shown to interact with LPS and 
have been hypothesised to play an important role in teleost LPS signalling [34, 118]. 
In humans and mice, the inflammatory caspase-4/5/11 have been shown to bind 
intracellular LPS through their CARD domain, and to induce immunity [31]. Putative 
β-2 integrins and caspases have been identified in the present barramundi 
transcriptome (data not shown) but further work is warranted in order to determine if 
those molecules can act as receptors for LPS in barramundi and other fish species 
and orders.  
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Chapter Three – Leucocyte integrins, but not caspases or NLR inflammasome 
are associated with lipopolysaccharide recognition and response in 
barramundi (Lates calcarifer) 
 
3.1. Introduction 
Teleost fish live in permanent contact with relatively high concentrations of bacteria 
compared with their terrestrial counterparts. A large-scale metagenomics survey by 
the Tara Oceans project identified that more than 90% of bacteria found in global 
oceans are gram-negative [149]. With the exception of the Chloroflexi, all gram-
negative bacteria are didermic, comprising an internal cytoplasmic membrane, a thin 
peptidoglycan layer and an outer membrane comprising lipopolysaccharides (LPS) 
[157]. Consequently, fish epithelial and barrier surfaces are continuously exposed to 
LPS. LPS is typically divided into three structural sections: lipid A, core polysaccharide 
and repeating O-antigen units [158]. The LPS lipid A, or endotoxin, is the region of 
LPS that is recognised by the innate immune system and is highly stimulatory, even 
at low doses [159]. LPS recognition in mammals occurs primarily through the toll-like 
receptor (TLR) 4, which is present on an array of phagocytic immune cells including 
antigen-presenting cells (APCs) [160]. Briefly, the lipopolysaccharide binding protein 
(LBP) mediates the interaction between LPS on the bacterial cell surface and the 
glycoprotein CD14 on phagocytic cells [161]. CD14 then concentrates LPS to facilitate 
its binding to the TLR4/myeloid differentiation protein 2 (MD-2), which in turn triggers 
the inflammatory cascade [162]. Lipid A is an essential component of gram-negative 
bacteria, but it is also highly variable, which can affect its detectability by the immune 
system [159]. In fact, there seems to be a correlation between TLR4 recognition of 
bacterial lipid A and the severity of a disease, with a lipid A poorly recognised by TLR4 
more likely to cause severe disease (reviewed in [159]). In mammals, including 
humans, lipid A encountered during infections of the bloodstream often causes 
endotoxic shock, a general inflammatory response which is characterised by fever, 
hypotension and eventually organ failures that can lead to death [163]. Fish, on the 
other hand, seem to be resistant to endotoxic shock caused by LPS [118].  
 
Fish show an attenuated regulation of inflammatory cytokines using standard LPS 
dosages employed in mammalian models, or require approximately 1000 fold higher 
LPS concentrations to induce a response similar to that observed in mammals 
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(reviewed in [118]. Recently, advances in bioinformatics have established that TLR4 
is absent from most of the published genomes and immune transcriptomes from 
teleost species [4, 118, 164] and, that when present (in Danio rerio and Gobiocypris 
rarus for example), the other molecules necessary for recognition of LPS through TLR 
signalling (LBP, CD14, and MD-2) were absent and/or truncated, non-functional [118]. 
However, there is evidence of LPS-induced cytokine production in fish [119, 165], 
which suggest that other molecules are likely involved in LPS recognition and 
processing in teleosts. In previous work, LPS stimulation induced TNF-α transcription 
through the C-type lectin Mincle in barramundi, but seemed to induce IL-6 transcription 
through other molecular pathways [164]. Thus, there is potential for alternative LPS 
receptor families, including inflammatory caspases and leukocyte integrins, to be 
involved in barramundi leucocyte activation. 
 
Caspases are cysteine proteases that mediate cell death and inflammation in 
mammals [29, 30]. Caspases are composed of a CASc domain (comprised of a large 
p20 and a small p10 subunit), as well as a variable pro-domain. Typically, in humans, 
caspases can be grouped into three sub-categories: cell death initiators, which 
possess a double death effector domain (DED) motif pro-domain or caspase activation 
and recruitment domain (CARD) motif pro-domain (caspase-2, -8, -9 and -10); cell 
death effectors, which only have a short pro-domain (caspase-3, -6 and -7); and 
inflammatory, which normally possess a CARD motif pro-domain (caspase-1, -4, -5, 
and -12). Caspase-4/5, in conjunction with caspase-1/NOD-like receptor (NLR) 
inflammasomes, are potent contributors to pyroptosis (a type of cell death), mediating 
the activation of the inflammatory cytokine IL-1b [23, 26]. Inflammatory caspases have 
also been shown to stimulate the transcription of nuclear factor-kB (NF-kB), which in 
turn promotes the transcription of other inflammatory cytokines such as interferons, 
tumour necrosis factors and interleukins (IL)-6 and -8 [27]. 
 
Leukocyte integrins are transmembrane heterodimeric glycoproteins found on the 
surface of leukocytes and play a role in several cellular interactions associated with 
immune functions. The main integrins expressed on leucocytes, b2-integrins, are 
composed of a unique ⍺ subunit (CD11a, CD11b, CD11c or CD11d), which is non-
covalently attached to a common b2 subunit (CD18) [33, 34]. Both CD11b/CD18 
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(MAC-1) and CD11c/CD18 (p150/95) have been identified as LPS receptors in 
mammals [34, 166]. MAC-1 is the most abundant integrin on neutrophils and is also 
found on natural killer (NK) cells, fibrocytes, B- and T-cells, whereas p150/95 is 
primarily found on myeloid dendritic cells and macrophages, although it is also found 
on NK, B- and T-cells [33]. Moreover, the identification of LPS binding sites on CD18 
suggests that b2-integrins are able to directly bind and process LPS, translocating NF-
kB to the nucleus and inducing inflammatory cytokine release [34, 36, 166]. More 
specifically, MAC-1 has been shown to enable LPS uptake and subsequent 
inflammatory pathway activation independently of TLR4 signalling [145] and p150/95 
has been shown to activate a cellular response after binding to LPS in a CD14-
independant manner [34].  
 
In the present study, putative barramundi caspases, NLRs and leukocyte integrins 
were investigated in the barramundi immune transcriptome [164]. Barramundi 
inflammatory caspases, inflammasomes and leukocyte integrins were identified and 
characterised, providing further insight into the processes underlying LPS recognition 
in Lates calcarifer. 
 
3.2. Materials and Methods 
3.2.1. Experimental animals and husbandry 
Barramundi (L. calcarifer) juveniles of approximately 30-50 g were obtained from 
Australian Native Finfish, Burpengary, Queensland and transported by road to the 
University of Queensland. Fish were acclimatised for 2 weeks in a recirculating 
system of eight 84 L cylindrical food-grade plastic tanks with individual aeration, all 
connected to a 260 L sump equipped with a protein skimmer and a bio-filter. The 
water temperature and the salinity were maintained at 28 ± 2°C and 15 parts per 
thousand (ppt) respectively. Water quality was checked regularly for ammonia, 
nitrite, nitrate and pH, and water exchanges were applied as required. Fish were fed 
to satiation twice daily with a commercial diet for barramundi (Ridley Aqua Feed). 
Fish were graded (segregated into different tanks by size) weekly to prevent 
cannibalism until they reached around 80-90 mm in size, after which they were 
distributed into their experimental groups.  
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3.2.2. Bioinformatics analysis 
Using the previously generated and annotated barramundi immune transcriptome 
[164], several caspases, b2-integrins (both ⍺ and b subunits) and NLRs were 
identified by homology in barramundi through local Basic Local Alignment Search 
Tool (BLAST), using human, murine, crustacean and teleostean caspases 
sequences (Table A2.3.1, A2.3.2 and A2.3.3 for caspases, NLRs and integrins 
respectively). Phylogenetic relationships were inferred by maximum likelihood from 
alignments of barramundi cDNA sequences from the transcriptome, with human 
sequences listed in Table A2.3.1 for caspases and with the cDNA sequences listed 
in Table A2.3.3 for b2-integrins. Trees were inferred in MEGA6.06 using ClustalW 
nucleotide alignment (codon) and supported by 2000 bootstrap replicates. NLR 
phylogeny was performed using only the proteins’ NACHT domain, identified using 
the National Center for Biotechnology Information (NCBI) CD-search tool 
(https://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi). Only proteins with a 
nucleotide-binding and oligomerization domain (NACHT domain) containing the 
conserved motif G-(4X)-GK-(10X)-W at the N-terminus were used for phylogenetic 
analysis (Table A2.3.2), using the Minimum Evolution method with bootstrap 
replication (2000) in MEGA6.06, after ClustalW amino-acid alignment [167]. The 
protein domains were predicted using a combination of SMART (http://smart.embl-
heidelberg.de) and CD-search tool on the NCBI website, using each corresponding 
protein sequence. Functional categorisation for caspases was based on current 
literature on human and teleostean caspases [29, 30]. Moreover, each mRNA 
sequence was aligned using the published barramundi genome [168] to ensure that 
all the caspase, NLR and integrin genes were correctly identified from the 
transcriptome (Figure A2.3.1, A2.3.2 and A2.3.3 for caspases, NLRs and integrins 
respectively).  
 
3.2.3. Adhesion assay 
Following the identification of leukocyte integrins, a cell adhesion assay was 
performed to support the presence of MAC-1 and LFA-1 on barramundi cells. 
Leukocyte integrins share common ligands but fibronectin, ESM-1 and factor X were 
identified as specific ligands for the αD, αL and αM subunits respectively [169, 170]. 
Collagen was used as a positive control as it has been identified as a ligand for the 
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αL, αM and αX subunits [33]. Briefly, wells of a high-binding 96 well plate was coated 
overnight at 4°C with either 100 µL of 20 µg/mL fibronectin, ESM-1, factor X or 
collagen, or with 100 µL undiluted Poly-L-Lysine solution or 1% BSA as negative 
controls (all from Sigma). The wells were then washed three times in 1M phosphate 
buffer saline (PBS) before blocking for 1 h at 37°C with 1% bovine serum albumin 
(BSA) to prevent non-specific binding to the plastic. Half the wells containing ESM-1 
and factor X were simultaneously incubated with antibodies specific for Integrin αM 
(polyclonal rabbit IgG anti-ITGAM antibody, OAAN00404, Aviva Systems biology) 
and integrin αL (polyclonal rabbit IgG anti-ITGAL antibody, OAAN00447, Aviva 
Systems biology) subunits respectively (diluted 1:100), as supplementary controls. 
After the wells were washed thrice in PBS, cells were isolated from spleen by 
passing the organ through a 100 µm mesh and subsequently washed in RPMI by 
centrifugation (300 x g, room temperature (RT), 5 min). The cells were then 
resuspended in RPMI at 106 cells/mL and seeded at 100 µL/well. After 1 h incubation 
at 28°C, the wells were inverted to remove the media and non-adherent cells before 
being washed twice using 300 µL of ice-cold 1M PBS containing 1 mM CaCl2 and 1 
mM MgCl2. The cells were then fixed and permeabilised using ice-cold methanol for 
10 min at RT. After three washes in 1M PBS, the wells were stained at RT for 10 min 
using a crystal violet solution (0.5%w/v crystal violet in 20% ethanol). After three 
washes by immersion in deionised water, the crystal violet retained was dissolved 
using 150 µL of 100% methanol for 15 min at RT and quantified by absorbance at 
590 nm with a Fluostar Optima plate reader (BMG Labtech, Melbourne, Australia). 
This plate assay was repeated on three separate occasions using a different fish 
each time and data collated for statistical analysis. 
 
3.2.4. Immunohistochemistry and fluorescent microscopy 
Glass coverslips were sterilised using ethanol and a flame, and were placed in each 
well of a 24-well plate. The coverslips were then coated overnight at 4°C with either 
20 µg/mL fibronectin, ESM-1, factor X or collagen, or with undiluted Poly-L-Lysine or 
1% BSA as negative controls. Spleens from three fish were homogenised into cell 
suspensions as previously described [164] and leucocytes were isolated on a Percoll 
gradient as adapted and modified from Tumbol, Baiano and Barnes [171]. Briefly, the 
cell suspension was layered over a 34% / 51% discontinuous Percoll gradient and 
centrifuged for 30 min at RT (800 x g, acc. 6, brake 0, Eppendorf 5810R). The buffy 
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layer between the two Percoll densities was collected and washed twice in PBS by 
centrifugation (400 x g, acc. 9, brake 9, RT, Eppendorf 5810R), before being 
resuspended in L-15 with 5% heat inactivated barramundi serum and incubated in a 
6-well plate overnight at 28°C. The next day, the 24-well plate containing the cover 
slips was washed thrice in PBS and blocked with 1% BSA at 37°C for 1 h. Cells 
incubated overnight were washed in PBS to remove serum and concentration was 
adjusted to 2x106 cells/mL and the cells were plated into the 24-well plate. The plate 
was incubated for 4 h at 28°C before the coverslips were fixed in PFA overnight at 
4°C.  
The coverslips were then washed three times in PBS and permeabilised in Triton X 
for 3 min at RT, before being washed again thrice in PBS. Coverslips were then 
blocked in 1% BSA for 1 h, and following a further wash in PBS, they were incubated 
with either rabbit anti-ITGAM or rabbit anti-ITGAL primary antibodies at 1:100 or with 
PBS as a negative control for 4 h at RT. After a further three PBS washes, coverslips 
were incubated with goat anti-rabbit IgG conjugated with Alexa Fluor 488 (1:500) in 
the dark at RT. After 1 h, DAPI was added at 5 µg/mL and the coverslips were 
incubated for a further 30 min for a total incubation time of 1 h 30 min.  
Coverslips were viewed with an Olympus BX41 epifluorescent microscope. Images 
were captured with an Olympus DP26/U-CMAD3 camera and optimised with the 
imaging software CellSens (Olympus Optical Co. Ltd, Japan).  
 
3.2.5. Inflammatory cytokine regulation assessed by qRT-PCR 
TNF-α, IFN-a, NF-κB, IL-1b and IL-6 were chosen for assessment by qRT-PCR due 
to their inducible nature by LPS through processing by b-integrins [34, 36, 166]. 
Spleens were sampled aseptically from three healthy juvenile barramundi and a cell 
suspension was obtained as described above. Cells were incubated with ultrapure 
LPS (E. coli 0111:B4, Sigma) at 0.05 µg/mL for 1 h at 28°C. Blank controls consisted 
of cells alone, antibody controls consisted of cells incubated with 1 µg/mL of 
polyclonal rabbit IgG anti-ITGAM or polyclonal rabbit IgG anti-ITGAL blocking 
antibody for 1 h at 28°C followed by a 1 h incubation with 0.05 µg/mL of LPS at 
28°C. Isotype controls consisted of cells incubated with 1 µg/mL of polyclonal rabbit 
IgG for 1h at 28°C followed by a 1 h incubation with 0.05 µg/mL of LPS at 28°C. 
Cells from all treatment groups were then harvested in RNAlater. For each sample, 
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RNA was extracted using the RNeasy kit (Qiagen) according to the manufacturer’s 
instructions. Contaminating genomic DNA was removed by on-column digestion with 
the RNAse-Free DNAse set (Qiagen) and the resulting RNA was converted to cDNA 
from a total of 12 ng of starting RNA per sample using the QuantiTect Reverse 
Transcription kit (Qiagen). Subsequently, the cDNA was used to assess the relative 
expression of TNFA, IFNA, NF-κappaB, IL1B and IL6 by qRT-PCR, using 
elongation-factor-1-α and Syk as normalisers, as they present the most stable 
expression levels across treatments and presented similar efficiencies (within 10% of 
target genes and of each other), on a ABI-ViiA7 cycler (Applied Biosystems). The 
primers were designed to span across exons when possible to eliminate gDNA 
amplification (Table 3.1). After primary optimisation, only TNFA, NF-κappaB and 
IL1B expression levels were assessed, as the primers for IFNA and IL6 could not be 
optimised to the template. 
 
Table 3.1. List of primers for qRT-PCR.  
Target gene Forward primer (5’-3’) Reverse primer (5’-3’) 
NF-kappaB  TGAAAGAGGCCAAGGAGCTG CGCACGTCTTATCCATCCGA 
IL1B  ACAACGTCATGGAGCTCTGG TCTTTGTCCTTCACCGCCTC 
INFA  TCAAGAGACTGTCAGGCCAC GTGAGCAGAGATGAAACCAGC 
IL6 CAGCTGACTGCCGTGATAAA TCCAGGGTTCCTCATCTTTG 
TNFA GCCATCTATCTGGGTGCAGT AAAGTGCAAACACCCCAAAG 
18S CGCCTGAATACCGCAGCTAG AGAACGGCCATGCACCACCAC 
EF-1α AAATTGGCGGTATTGGAAC GGGAGCAAAGGTGACGAC 
 
3.2.6. Statistical analysis 
Prior to qRT-PCR analysis, the stability of the internal control genes was assessed 
and the relative expression for each gene was computed using the Relative 
Expression Software Tool (REST) [130-132]. Data from the adhesion assay were 
analysed using multiple T-tests in GraphPad Prism, with statistical significance 
determined using the Holm-Sidak method, with α = 0.05. Each row was analysed 
individually, without assuming a consistent SD. Data from qRT-PCR were analysed 
through REST.  
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3.2.7. Ethics statement 
All animal work was conducted in accordance with Animal Care and Protection Act 
2001 (QLD) and the NHMRC Code of Practice 2013. Work was conducted under the 
University of Queensland Animal Ethics Committee Approval No. NEWMA/078/15 
“Understanding the early onset of adaptive immunity in fish.” 
 
3.3. Results 
Putative barramundi caspases were identified by homology and in most cases 
grouped clearly with their human counterpart (Figure 3.1), and their gene 
organisation was determined (Figure A2.3.1). However, while some barramundi 
caspases had several isoforms (caspase 3 and caspase 2) the inflammatory 
caspase 4 and the differentiation caspase 14 were not identified in barramundi. 
Moreover, although identified by homology in barramundi, caspase 5 and caspase 9 
were lacking a CARD pro-domain, thus differing from their human counterparts 
(Figure 3.1). 
 
 
Figure 3.1. Characterisation of human and barramundi caspases. (A) 
Phylogenetic relationship between human and barramundi (in bold) caspases are 
linked with (B) domain organisation of each corresponding protein and (C) functional 
categorisation based on literature. Yellow boxes correspond to a short pro-domain; 
Red boxes correspond to a DED (death-effector domain) protein domain; Blue boxes 
correspond to a CARD (caspase activation and recruitment domain) protein domain. 
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Putative barramundi NLRs were identified by homology and grouped with their 
human and murine counterparts (Figure 3.2), and their gene organisation was 
determined (Figure A2.3.2). Out of the three distinct NLR sub-families (nucleotide-
binding oligomerization domain (NOD), NLR family, pyrin domain containing (NLRP) 
and Ice protease-activating factor (IPAF)) [23], only sequences coding for proteins 
from the NOD sub-family were identified in barramundi, with members from the 
NLRP and IPAF families lacking. Although most protein domains were conserved 
between human, mouse and barramundi NLRs, some mouse and barramundi 
proteins were lacking either the pyrin domain (PYD) or caspase activation and 
recruitment domain (CARD) at the N-terminus or were lacking leucine-rich repeat 
(LRR) domains at the C-terminus (Figure 3.2).  
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Figure 3.2. Phylogenetic relationship between human, murine and barramundi 
(in bold) NLRs based on their NACHT domain. Protein domain organisation is 
depicted on the right of the phylogenetic tree. CARD: caspase activation and 
recruitment domain; NACHT: nucleotide-binding and oligomerization domain; LRR: 
leucine-rich repeat; PYR: pyrin domain; FISNA: Fish-specific NACHT associated 
domain; BIR: baculoviral inhibition of apoptosis protein repeat domain; DMP1: Dentin 
matrix protein 1; FIIND: domain with function to find.  
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Putative barramundi α- and β2-integrin subunits were identified by homology with 
their human, murine and teleost counterparts (Figure 3.3), and their gene 
organisation was determined (Figure A2.3.3). Out of the four possible α subunits 
forming leukocyte integrins (D, M, L and X), only two were identified in barramundi: 
M (forming MAC-1) and L (forming LFA-1). Both include a Von Willebrand factor type 
A, which is required for metal ion ligand binding, and several β-propellor repeats. 
Moreover, the putative barramundi integrin αM identified was missing a 
transmembrane domain, which suggests that integrin αM may be secreted rather 
than membrane bound in barramundi.  
 
Figure 3.3. Phylogenetic relationship between human, murine, teleost and 
barramundi (bold) α- and 𝛽2-integrin subunits. Protein domain organisation is 
depicted on the right of the phylogenetic tree. VWA: Von Willebrand factor type A; 
Tail: tail domain; Cyt: cytoplasmic domain. 
 
When incubated with substrates specific to the D, M and L α-sub-units, barramundi 
spleen leucocytes did not bind significantly to any of the negative controls or to 
fibronectin (specific substrate for integrin αD subunit) but did bind significantly to 
factor X and ESM-1 (specific substrates for integrin αM and L respectively) (Figure 
3.4). Interestingly, when incubated with anti-ITGAM antibody, cells from barramundi 
spleen were more adherent to the integrin αM substrate factor X (Figure 3.4). 
Similarly, cells incubated with anti-ITGAL antibody were more adherent to integrin αL 
substrate ESM-1 (Figure 3.4).  
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Figure 3.4. Adherence of barramundi spleen cells to different substrates. 
Significant differences between blank incubated and cells incubated wells are 
represented with * p < 0.05, ** p < 0.01, *** p < 0.005 and **** p < 0.001. 
 
The numbers of barramundi spleen leucocytes bound to the positive control, 
collagen (specific substrate for integrin αM, L and X subunits), was also significantly 
higher than BSA-coated control.  
 
When the adherent cells were observed by microscopy, the cells binding to Factor X 
were larger and more granular, resembling granulocytes whereas cells binding to 
ESM-1 were rounded and slightly smaller, resembling lymphocytes (Figure 3.5). 
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Figure 3.5. Micrographs of leukocytes adhering to each substrate. DAPI stain 
(nucleic acid) shown in blue and anti-ITGAM or anti-ITGAL specific antibodies stain 
shown in green. 
 
To determine whether integrins might be involved in LPS recognition and response, 
a stimulation assay was conducted and the expression of a cohort of cytokines 
determined by qPCR. The specificity of anti-ITGAM and anti-ITGAL antibodies was 
confirmed by the use of a polyclonal rabbit IgG isotype control, showing that pre-
incubation with either anti-ITGAM or anti-ITGAL specifically impacted the expression 
of IL1B through the activation of integrin αM and L respectively (Figure A.2.3.4). LPS 
stimulation upregulated the expression of IL1B and, to a lower level of TNFA, but did 
not impact the expression of NF-kappaB (Figure 3.6). Pre-incubation with anti-
ITGAM and anti-ITGAL significantly upregulated the expression of IL1B compared to 
unstimulated and isotype controls when further exposed with LPS. However, TNFA 
expression was significantly upregulated by both anti-ITGAM and anti-ITGAL 
antibodies, as well as by the rabbit IgG isotype control compared to the unstimulated 
control, suggesting that changes in TNFA expression after a short incubation with 
LPS do not depend on integrins αM and L activation. 
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Figure 3.6. Differential expression of cytokines and transcription factor in 
response to LPS stimulation. Expression of IL1B (A), TNFA (B) and NF-κappaB 
(C) in barramundi splenocytes is shown with or without pre-incubation with anti-
ITGAL, anti-ITGAM or rabbit IgG isotype antibody. Significant upregulation (as 
determined by REST analysis) of each gene is indicated underneath the relevant bar 
by ‘UP’. Significant differences between control unstimulated cells gene expression 
and stimulated cells are represented with * p < 0.05, ** p < 0.01 and *** p < 0.005. 
 
3.4. Discussion 
Inflammatory caspases have recently been shown to recognise and process 
intracellular LPS in humans (caspase-4 and -5) and in mice (caspase-11), binding to 
LPS through their CARD domain [26, 31]. In barramundi, the inflammatory caspases 
-5 and -1 were identified, and grouped tightly with their human counterparts. 
However, the CARD domain from barramundi caspase-5 was lacking, suggesting a 
potential loss of function as CARD is necessary for LPS recognition and CARD 
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oligomerisation is also necessary for caspase activation [32]. Another way for 
caspases to recognise PAMPs is through the coupling of caspase-1 with other 
specific pattern recognition molecules (mostly NLRs) through their CARD domain, 
forming functional inflammasomes [27, 172]. As barramundi caspase-1 displayed a 
CARD pro-domain, inflammasomes were plausible actors in LPS recognition so 
NLRs and other inflammasome sensor proteins were subsequently investigated in 
barramundi. To date, there are six characterised NLR-inflammasomes, formed using 
six different NLRs: NLRP1, NLRP3, NLRP6, NLRP7, NLRP12 and NLRC4/IPAF [23, 
27, 173]. Other molecules such as RIG-I, AIM2 and IFI16 have also been described 
as inflammasome sensor proteins but recognise nucleic acid, rather than 
carbohydrate-based ligands such as LPS [173]. None of the NLRs involved in 
inflammasomes were identified in L. calcarifer in the current study, suggesting that 
inflammasomes in barramundi are not involved in detecting LPS thereby implicating 
other pathways in LPS recognition in these fish. As inflammasomes typically trigger 
an inflammatory response, the lack of NLR inflammasomes in barramundi correlates 
with the weak inflammatory response observed in barramundi and other fish post-
stimulation with LPS [114].  
Leukocyte integrins are found at the surface of white blood cells and are involved in 
pathogen recognition through conformational changes after activation by ligands 
[174]. Out of the four possible genes coding for leukocyte integrin α-subunits, two 
were identified in barramundi: the subunit αM (CD11b) which forms MAC-1 and the 
subunit αL (CD11a) which forms LFA-1. Cells incubated with Factor X, a specific 
ligand for the integrin αM subunit [169], bound significantly more to Factor X than to 
negative control substrates. This suggests that barramundi leucocytes express a 
protein that is conformationally similar to the αM subunit of MAC-1, hence able to 
bind to Factor X. The same was true for cells incubated with ESM-1, a specific ligand 
for the integrin αL subunit [169], suggesting that barramundi leucocytes also produce 
a protein with binding sites similar to the αL subunit of LFA-1. Incubation of spleen 
cells with anti-ITGAL or anti-ITGAM antibody increased adhesion of barramundi 
spleen cells to the corresponding substrates. The antibodies may activate β2-
integrins by configurational change, increasing the molecules’ binding strength as 
previously reviewed [175]. Indeed, integrin αMβ2 (MAC-1) and αLβ2 (LFA-1) can 
assume two conformations, open (active) and closed (inactive), which differentially 
recognise ligands [174, 176]
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and can also influence avidity and affinity of the leucocyte integrin [174, 177], 
impacting adhesion to ligands, as detected in the adhesion assay reported here 
(Figure 3.4). However, in view of the data obtained, it seems that collagen is in fact 
not a specific ligand for either integrin αMβ2 or αLβ2. Instead, collagen seemed to 
bind spleen cells without discrimination, regardless of αMβ2 or αLβ2 being present at 
the surface of those cells (Figure 3.4).  
Currently, two binding sites for LPS have been identified on the β2 chain of 
leucocyte integrins [36]. Moreover, integrin αMβ2 has been shown to enable LPS 
recognition and activation independently of TLR4 [145], and processes depending on 
MAC-1 activation have been shown to induce the inflammatory cytokine IL-1β’s 
expression [145, 178]. When observed by fluorescence microscopy, most spleen 
cells that bound to Factor X expressed integrin αM (ITGAM) and resembled 
granulocytes, being larger and more granular than cells not expressing ITGAM, 
similarly to previous observations in peritoneal cells [179, 180]. Almost all cells that 
bound to ESM-1 expressed integrin αL (ITGAL) and were more rounded, resembling 
B- or T-lymphocytes [33]. Considering that MAC-1 has recently been identified as a 
LPS receptor in mammals [145], and that barramundi leucocytes express MAC-1, it 
is possible that LPS in barramundi is processed through MAC-1. The expression of 
inflammatory cytokines following stimulation with LPS was thus investigated by qRT-
PCR in barramundi spleen cells. The expression of IL1B was statistically higher in 
cells stimulated by LPS, however LPS did not affect TNFA expression or NF-kappaB 
activation in control cells (Figure 3.6). Moreover, prior incubation with anti-ITGAL and 
anti-ITGAM antibodies activated integrins on barramundi splenocytes evidenced by 
significantly increased expression of IL1B post-stimulation with LPS when compared 
to either unstimulated cells or isotype control cells pre-incubated with rabbit IgG 
(Figure 3.6A). Pre-incubation with antibodies (both treatments as well as the isotype 
control) resulted in a significant upregulation in the expression of TNFA when 
compared to the unstimulated control, suggesting that TNFA expression might be 
dependent on exposure to antibody rather than on incubation with LPS. Indeed, LPS 
activates outside-in signalling, binding directly to the integrin receptor and activating 
caspase-1, resulting in IL1B upregulation but not impacting the expression of TNFA 
[181]. However, before integrins can act as receptors, they need to be activated, 
which was likely effected by incubation with anti-ITGAL and anti-ITGAM antibodies 
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prior stimulation, supporting the difference in IL1B regulation by LPS between pre-
stimulated and control cells (Figure 3.6A).  
 
The C-type lectin Mincle was previously identified as a receptor for LPS in 
barramundi, but other unidentified receptors were also implicated in recognition of 
bacterial polysaccharides in perciform fish [164]. In the current study, we show that 
that leucocyte integrins likely have a critical role in LPS recognition and processing in 
Lates calcarifer and are worthy of further investigation throughout the Teleostei.  
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Chapter Four – Identification of barramundi (Lates calcarifer) DC-SCRIPT, a 
specific molecular marker for dendritic cells in fish 
Published 14/07/2015 in PLoSONE 10(7): e0132687. 
doi:10.1371/journal.pone.0132687 
The acknowledgements section was removed and collated with the general 
acknowledgements at the beginning of this thesis. 
 
4.1. Introduction 
Jawed fish are the earliest vertebrate order possessing both innate and adaptive 
immunity [74, 77]. Adaptive immunity is characterised by the development of an 
immune memory of previously encountered pathogens that allows a fast and specific 
response when reinfection by the same pathogen occurs. Adaptive immunity 
involves antigen recognition by antigen presenting cells (APCs) and an associated 
antibody response and pathogen elimination, generally performed by primed B and 
T-lymphocytes [2]. B-lymphocytes are specialised in producing antibodies that label 
pathogens and make them easier to identify by phagocytic cells [2]. T-lymphocytes 
assist in leucocyte activation or they destroy tumorous and virus infected cells, 
depending on the cell type [2]. T-cell activation is initiated by and is dependent upon 
the major histocompatibility complex (MHC) receptors which bind foreign and local 
peptides produced by protein degradation [41]. Naïve T-cells are activated after they 
are presented with foreign antigens that are bound on the MHC [41]. “Non-
professional” APCs can be any cell in the organism and can only activate cytotoxic 
T-cells by displaying antigenic structures on MHC class I receptors or via stimulation 
by cytokines [42]. In contrast, “professional” APCs are specialised in priming naïve 
T-cells and can activate both cytotoxic and helper T-cells by displaying antigenic 
structures on MHC class I and II receptors respectively and by producing co-
stimulatory molecules [43]. B-cell proliferation can also be indirectly activated by 
professional APCs [2]. The principal professional APCs in mammals are dendritic 
cells (DC), and are defined by their extended ability to engulf pathogens, present 
antigens and activate potent helper T-cells [1, 44, 45].  
 
The existence of DC-like cells in teleosts has been controversial for many years, in 
part due to the absence of specific identification tools such as cell surface receptor 
markers, and due to significant differences between the immune systems of teleosts 
 82 
and mammals. For example, the lymph nodes and the bone marrow, which are 
essential to mammalian immunity by seeding the lymphoid organs, are absent in fish 
[74, 75]. Moreover, the lymph nodes are also the major site for antigen presentation, 
thus the main site where DCs interact with T-cells in mammals [182], and their 
absence in fish is an important consideration in the study of fish acquired immunity. 
Consequently, processes such as antigen presentation are still poorly understood in 
fish, and the lack of specific cell markers makes the study of these immune 
processes even more challenging. In spite of these challenges, dendritic-like cells 
have been identified recently in head kidneys (HK) and/or spleens of zebrafish 
(Danio rerio), Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus 
mykiss) [76, 83, 183, 184]. Organs such as the HK and the spleen in fish seem to 
effectively replace the missing leucocyte-producing mammalian organs. The HK has 
a major role in immune-endocrine interactions and, in fish, supplants the bone 
marrow as the main hematopoietic organ [74]. Fish spleen, which is analogous to 
mammalian spleen and is a likely site for T-cell-APC interactions [76]. However, the 
lack of DC-specific markers in fish means that the cells require laborious functional 
and morphological characterisation making the study of antigen presentation in fish 
extremely difficult. Recently, a zinc-finger protein, DC-SCRIPT, which is 
preferentially expressed in all subsets of dendritic cells in humans [185] and in mice 
[186], was discovered. Importantly, DC-SCRIPT was found to be identical to Homo 
sapiens ZNF366, which is homologous to the teleost fish Fugu rubripes fZnf1 gene 
[185]. This, in conjunction with the lack of confinement of DC-SCRIPT to a particular 
subset of DCs, makes it a logical target as a first molecular marker for fish DCs. 
 
In the present study we identify DC-SCRIPT for the first time in a Perciform fish, the 
barramundi, Lates calcarifer and show specific expression in barramundi dendritic-
like cells (bDCs). The order Perciformes represents the largest extant group of 
vertebrates (comprising 40% of known fish species) and comprise an increasing 
proportion of the globally expanding aquaculture industry, particularly high value fish 
such as tilapias, snappers, sea bass, breams, jacks and barramundi, yet little work 
has been conducted to date on immunity in this order. Barramundi represent a good 
candidate for further research on perciform immunity as hatchery technology is well 
established, they are easy to keep under controlled conditions in recirculating 
systems and are of significant value to aquaculture throughout south east Asia [85]. 
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Improved tools for in vitro models of the cellular processes leading to specific 
adaptive immunity are therefore significant in the refinement of vaccines for the 
aquaculture industry and our understanding of antigen presentation in early diverging 
vertebrate orders.   
 
4.2. Materials and Methods 
4.2.1. Experimental animals and husbandry 
Barramundi (Lates calcarifer) juveniles of approximately 30–100 g were obtained 
from a commercial aquaculture facility near Cairns, Queensland, Australia. Fish from 
this farm are specific pathogen free fish as the direct supply of filtered bore water to 
the hatchery and farm coupled with strict biosecurity prevent exposure to common 
fish pathogens. Fish were transported to The University of Queensland by air freight 
and acclimatised for 2 weeks in a recirculating system in eight 84 L cylindrical food-
grade plastic tanks with individual aeration, all connected to a 260 L sump equipped 
with a protein skimmer and a bio-filter. The water temperature and the salinity were 
maintained at 28 ± 2°C and 15 part per thousand (ppt) respectively. Water quality 
was checked daily for ammonia, nitrite, nitrate and pH, and water exchanges were 
applied as required. Fish were fed to satiation once daily with a commercial diet for 
barramundi (Ridley Aqua Feed).  
 
4.2.2. Serum collection 
Barramundi were bled aseptically from the caudal vein and the blood was allowed to 
clot for 1 h at room temperature. Samples were centrifuged at 12,100 x g for 10 min 
and the supernatant (serum) was stored at -20°C until further use. Prior to use, 
serum was heat inactivated (HI) for 30 min at 56°C. 
 
4.2.3. Identification of Barramundi DC-SCRIPT 
DNA and RNA extraction 
DNA was extracted from cultured barramundi HK and spleen cells (in 75 cm3 flasks, 
107 cells/mL) using Nucleospin Tissue DNA kit (Machery Nagel) according to the 
manufacturer’s instructions.  Extracted DNA was subsequently used for the 
construction of four DNA-libraries as described in the Universal Genome Walker 2.0 
kit (Clontech Laboratories, Inc). RNA was extracted from HK and spleen cultured 
cells (in 75 cm3 flasks, 107 cells/mL) using the RNeasy Mini Kit (QIAGEN) according 
 84 
to the manufacturer’s instructions. Extracted RNA was subsequently synthesized into 
complementary DNA (cDNA) RACE libraries using the SMARTer RACE cDNA 
Amplification kit (Clontech Laboratories, Inc) section V. 
 
Primer design, genome walking and 5’ 3’ RACE PCR 
Initially, degenerate primers for teleost DC-SIGN were designed from conserved 
sequences derived from multiple alignments (CLUSTALW) of hypothetical DC-
SCRIPT identified by nucleotide Basic Local Alignment Search Tool (BLAST; 
http://blast.ncbi.nlm.nih.gov/) of completed teleost genomes using human DC-
SCRIPT (NM_152625.1) as the query sequence. Sequences included in the 
alignment were derived from the genomes of Pundamilia nyererei (XM_005741743), 
Maylandia zebra (XM_004547137), Haplochromis burtoni (XM_5919046), 
Oreochromis niloticus (XM_005452162), Takifugu rubripes (XM003974872) and 
Danio rerio (XM_693094.5). Amplicons derived from genomic DNA by degenerate 
PCR were sequenced and those with homology to DC-SCRIPT by BLAST were 
employed to design gene specific primers for genome walking and RACE in 
accordance with the manufacturer’s instructions (Clontech). New primers were 
designed following each round of walking or RACE to obtain sufficient sequence for 
further experimentation. 
 
mRNA Fluorescence In Situ Hybridization (FISH) and immunocytochemistry 
To identify bDCS in mixed and enriched cell cultures, mRNA FISH was employed. 
Around 500 base pairs of DC-SCRIPT cDNA sequence, downstream of the zinc 
finger region, was used to design mRNA custom FISH probes using the Stellaris® 
FISH Probe Designer tool available online at 
www.biosearchtech.com/stellarisdesigner (Biosearch Technologies). In all 32 FISH 
probes were designed and conjugated to CAL Fluor 590 (Biosearch Technologies). 
Mixed-cell populations were then allowed to adhere on round glass coverslips at 
28°C, were subsequently stimulated for 2 h with peptidoglycan (PTG; 10 µg/mL), and 
underwent immunocytochemistry (ICC) fluorescent staining procedures. Different 
treatments included anti-IgM (1:1000 primary antibody sheep IgG anti-barramundi 
IgM; 1 µg/mL secondary antibody donkey anti-sheep IgG conjugated with AlexaFluor 
405 for combined staining or with AlexaFluor 594 for separate staining), anti-MHCIIa 
(1:1000 primary antibody rabbit IgG anti-zebrafish MHCIIa (Sapphire Bioscience, 
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Product LS-C210021); 1 µg/mL secondary antibody goat anti-rabbit IgG conjugated 
with AlexaFluor 488) and in-situ hybridisation with the DC-SCRIPT probes (50 ng), 
either combined or stained separately. Antibodies and Stellaris® FISH probe 
titrations were previously performed to determine optimal concentrations. Controls 
consisted of the same procedure while omitting the primary antibodies or the 
Stellaris® FISH probe. The adherent cells were hybridised and stained, with some 
modifications, following the Stellaris® FISH probes manufacturers instructions (For 
simultaneous Stellaris FISH and immunofluorescence using adherent cells) available 
online at www.biosearchtech.com/stellarisprotocols. Briefly, the cells were fixed in 
4% paraformaldehyde (Electron Microscopy Science) for 10 min at room 
temperature (RT), washed in 1X PBS (5 min; RT) and permeabilized with Triton-X for 
3 min (Sigma; RT). The cells were then washed in 1X PBS twice (5 min; RT) and 
blocked in 5% donkey serum, 5% goat serum, 0.1% bovine serum albumin for 30 
min at RT, followed by two more washes in 1X PBS (5 min; RT) and an incubation in 
the dark at 37°C for 4h in hybridisation buffer containing 50 ng of FISH probe and 
primary antibodies at the dilutions specified above. Subsequently, the cells were 
washed three times in 1X PBS (5 min; RT) and incubated in wash buffer as 
recommended by the manufacturer (Stellaris® FISH Probes protocol) containing the 
appropriate secondary antibodies (see above) for 30 min at 37°C in the dark. When 
stains were combined, the coverslips were mounted at this point using 
VECTASHIELD® HardSet Mounting Medium (Vector Laboratories). When stains 
were separated, cell nuclei were stained with DAPI (Invitrogen; 2.5 µg/mL) for 15 min 
at RT in the dark before the coverslips were mounted using VECTASHIELD® 
HardSet Mounting Medium (Vector Laboratories).  
 
Fish injection and RNA extraction for qRT-PCR 
Barramundi were injected in the peritoneal cavity with 100 µL of either sterile 
phosphate buffered saline (PBS control) or a mixture of lipopolysaccharide (LPS; 10 
µg/mL) and peptidoglycan (PTG; 10 µg/mL) diluted in PBS. LPS and PTG were 
chosen based on both in vivo and in vitro induction of immune response in fish/fish 
cells previously reported [123, 124]. At 6 h, 24 h, 72 h and 7 d post-injection, four fish 
were sampled from both control and treatment groups. For each fish, the spleen and 
head-kidney were dissected aseptically and kept in RNAlater until further processing.  
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RNA was extracted using the RNeasy extraction kit (QIAGEN), according to the 
manufacturer’s instructions. Tissues kept in RNAlater were disrupted by serial 
passage through a 25-gauge needle mounted on a 1 mL syringe before processing. 
RNA was eluted in 40 µL of nuclease free water. 
 
Quantitative real-time PCR for relative quantification of DC-SCRIPT expression 
RNA samples were treated with DNAse (RNAse-free DNAse set, Qiagen) to remove 
any trace genomic DNA then converted to cDNA using the QuantiTect RT kit 
(QIAGEN) according to the manufacturer’s instructions. cDNA was quantified by 
Qubit Fluorimetry and 0.5 ng per sample was optimised as template to yield approx. 
100% efficiency in 10 µL real-time PCR reactions with 0.2 picomoles of each primer 
pair specific for DC-SCRIPT and three endogenous reference genes (Table 4.1) 
[187]. Primers were designed to span the intron/exon boundaries to eliminate 
amplification of any traces of genomic DNA. Amplification of 3 technical replicates 
from each of the 4 biological replicate samples per treatment and control was 
performed in 384 well plates on a ViiA 7 Real-Time PCR system (Applied 
Biosystems) using SYBRgreen MasterMIx (Invitrogen) and cycling parameters as 
follows: 95 °C for 10 min followed by 40 cycles of 95 °C for 15 s, 54 °C for 30 sec 
and 62 °C for 30 sec, then a final melt curve at 95 °C for 15 s, 60 °C for 1 min and 95 
°C for 15 s. All temperature cycling was performed with acceleration at 1.6 °C/s. The 
PCR exponential amplifications of each gene were calculated based on the slope 
estimated by the Cq value of a serial dilution in a preliminary validation experiment 
against Log10 of the cDNA amount per reaction, described by E = 10-1/slope [188]. Any 
variation in amplification efficiency was then accounted for during normalisation of 
relative gene expression differences between the treatment samples and the control 
samples. The normalisation factor was calculated based on the geometric mean of 
the relative quantities of three reference genes using REST [189, 190]. Cq data were 
analysed with REST based on a pairwise fixed reallocation randomisation test [190], 
in which the normalised relative quantities were calculated based on the ratio of the 
group means for the target gene against the normalised reference genes. The result 
represented the up- or down-regulation of the treatment group (i.e. LPS/PTG-
injected) compared to the control group (i.e. PBS injected). 
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4.2.4. Cell culture & functional assays 
Cell culture from hematopoietic organs 
Barramundi were killed by overdose of anaesthetic (Aqui-S). Fish were bled from the 
caudal vein before the spleen and HK were removed aseptically. The organs were 
placed on ice in complete L-15 medium: L-15 Leibovitz medium with phenol red 
(Invitrogen) supplemented with HI 10% foetal bovine serum (FBS), 2% Nystatin (N; 
10,000 U/mL stock) and 1% penicillin-streptomycin (PS; 10,000 U/mL stock). The 
organs were then gently pushed through a 100 µm cell strainer with the plunger of a 
1 mL tuberculin syringe to obtain a single cell suspension in supplemented medium.  
Cells were counted and adjusted to a concentration of 1 x 107 cells/mL in 
supplemented L-15 and plated in 25 cm2 or 75 cm2 culture flasks. Cells were 
incubated at 28°C for 5–14 days. During this period, non-adherent cells were 
harvested and the removed medium was replaced by fresh supplemented medium.  
 
Barramundi DCs harvesting and enrichment 
Prior to harvest, culture flasks were gently agitated and medium containing the 
suspended non-adherent cells was collected. The suspension was layered over a 
discontinuous Percoll gradient (Sigma) at d = 1.058 g/mL and d = 1.048 g/mL and 
centrifuged for 30 min at 800 x g with no brake at 23°C, as adapted and modified 
from Bassity and Clark [76]. The cells at the interface between the Percoll layers 
were collected and washed at 23 °C in fresh medium (10 min, 400 x g) before further 
use.  
 
Transwell migration assay 
For this study, two isolates of Streptococcus iniae (strains QMA0076 and QMA0248) 
from disease outbreaks in Australian barramundi farms (in Queensland and New 
South Wales respectively) were chosen. These strains had previously been 
employed in a vaccination trial in which experimental fish responded poorly to 
vaccines prepared from QMA0076, but responded strongly with consistently high 
antibody response to vaccines prepared with QMA0248 [191]. The migratory ability 
of bDCs was assessed using a 12-well Transwell culture plate (Corning) with 
membranes presenting 3 µm pores which allowed active migration between upper 
and lower compartments, but were substantially smaller than the cells (10-20 µm) to 
minimise passive transfer between the chambers. For each treatment, 1.5 mL of 
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0.5% FBS/L-15 was placed into the lower part of the Transwell and either 
lipopolysaccharide (LPS; 5 µg/mL), peptidoglycan (PTG; 10 µg/mL) or live S. iniae 
(strains QMA0076 or QMA0248 at a multiplicity of infection (MOI) of 0.1 and 1) were 
added to the medium. The control was composed of medium alone in the lower 
chamber. Barramundi DCs (500 µL of 4 x 105 cells/mL), resuspended in 0.5% 
FBS/L-15, were added to the upper chamber. The Transwell plate was then 
incubated for 4 h at 28°C to allow migration. After 4 h, the cells remaining in the 
upper chamber were removed by gently swabbing a cotton bud against the 
membrane. The cells attached on the lower part of the membrane were detached 
with trypsin (Sigma; 10 µg/mL) for 1.5 min. Cells were then stained with DAPI 
(Invitrogen; 2.5 µg/mL for 15 min) and counted on a haemocytometer using 
fluorescent microscopy.  
 
Phagocytosis assay 
The preliminary assessment of bDCs phagocytic capacity was performed in 24-wells 
plates using fluorescent latex beads. The bead stock suspension (Fluoresbrite 
Yellow Green microspheres 0.2 µm, ~5.68 x 1012 particles/mL, 2.65% latex, 
Polysciences, Inc.) was diluted 50-fold in phosphate buffered saline (PBS) pH 7.4 
and opsonised by addition of HI barramundi serum to 10% (v/v). Barramundi DCs 
concentration was adjusted to 5 x 106 cells per well in 500 µL L-15 in a 24-well tissue 
culture plate. Then opsonised beads were added to each well, at a 1:10 dilution in 
10% FBS/L-15 and plates centrifuged at 500 x g, 23°C for 5 min to bring the beads 
and cells into contact, as adapted and modified from Bassity and Clark [76]. After 2 h 
incubation at 28°C, the plates were put on ice to stop the cell activity and were 
observed by microscopy directly in culture or as cytospins (see below). 
Further analysis of bDCs phagocytic capacities was performed using flow cytometry. 
When fluorescent beads were used, the protocol remained the same as described 
above, with the following exceptions. After incubation (2 h at 28°C), the cells were 
washed from the plates in medium and transferred to 5 mL cytometry tubes before 
being put on ice to stop the cell activity until flow cytometry analysis.  
For phagocytosis of bacterial strains, S. iniae QMA0076 and QMA0248 were 
adjusted to an optical density at 600 nm (OD600) of 1 (~108 bacteria/mL). They were 
then stained with 1 µM BacLight Green (BLG)(Life technologies) for 15 min at RT 
before being washed extensively in PBS and diluted 100-fold in 10% FBS/L-15. 
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Barramundi DCs concentration was adjusted to 5 x 106 cells per well in 500 µL and 
the medium containing stained bacteria was added resulting in a final multiplicity of 
infection (MOI) of 1.0. After incubation for 2 h at 28°C, the cells were washed from 
the plates in medium, transferred to 5 mL flow cytometry tubes and put on ice to stop 
the cell activity until flow cytometry analysis.  
 
T-lymphocyte isolation by E-rosette 
After sterile removal of the spleen from euthanized barramundi, a single cell 
suspension was obtained by forcing the spleen through a 100 µm cell strainer with 
the plunger from a 1 mL tuberculin syringe. The suspension was then centrifuged on 
a d = 1.072 g/mL and d = 1.050 g/mL discontinuous Percoll gradient at 800 x g, 23°C 
for 30 min, as adapted and modified from Tumbol, Baiano and Barnes [171]. The 
leucocytes, located at the interface between the two Percoll layers, were collected 
and diluted 2-fold in L-15 medium. Cells were washed by centrifugation at 400 x g, 
23°C for 10 min. After centrifugation, the supernatant was discarded and the cell 
pellet resuspended in L-15 medium supplemented with 10% FBS/1% PS.  
To obtain a pure culture of live T-cells to test in the proliferation assay, the E-rosette 
method was used, as adapted and modified from Madsen, Johnsen, Hansen and 
Christiansen [192]. Sheep red blood cells (SRBC) in Alsever’s solution were diluted 
1:1 in complete L-15 medium. Equal volumes of spleen leucocytes and SRBC in L-
15 were then mixed in a 1.5 mL Eppendorf tube and centrifuged for 5 min at 5870 x 
g to bring the leucocytes and SRBC in contact. The tubes were then incubated at 
28°C overnight. On the next day, the cells were resuspended and layered and 
centrifuged over a d = 1.072 g/mL and d = 1.050 g/mL discontinuous Percoll gradient 
at 800 x g, 23°C for 30 min. The supernatant was discarded and the pellet containing 
the SRBC and the T-cells was washed twice in PBS. RBC lysis buffer (1 mL) was 
then added to the pellet and, when the suspension became translucent, complete L-
15 medium was added to stop the reaction. The enriched T-cells, released from the 
rosettes, were then washed twice and resuspended in L-15/10% FBS medium 
(Figure A2.4.1).  
 
T-cell proliferation assay 
Responder cells (T-cells) and stimulator cells (bDCs) from different fish were 
counted and resuspended in L-15 supplemented with 5% barramundi serum, 1% PS 
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at a concentration of 5 x 105 cells/mL. Responder cells were stained using 5 µM/mL 
carboxyfluorescein succinimidyl ester (CFSE; Sigma) for 30 min at 28°C. Cells were 
then washed twice in PBS by centrifugation. T-cells and bDCs were mixed together 
at a 1:1, 1:2, 1:4 and 1:8 stimulator to responder ratio and incubated for three days 
(experimentally determined to be optimal) at 28°C in the dark. Negative controls 
were composed of responder cells alone. On day 3, cells were analysed by flow 
cytometry using decrease in CFSE fluorescence as an indicator of proliferation.  
 
Flow cytometry 
Flow cytometry data were obtained using the BD FACSAria II (BD Bioscience). Data 
were analysed using the DIVA software. Hoechst and propidium iodine (PI) 
fluorescent dyes (both from Life Technologies) were used according to the 
manufacturer’s instructions to identify and exclude debris and dead cells 
respectively. The FITC voltages for the phagocytosis and proliferation functional 
assays were set at 419 V and 520 V respectively and the 605/12 violet voltage was 
set at 485 V for the Stellaris® FISH probe labelling. 
 
4.2.5. Microscopy and non-fluorescent staining 
Cultures were viewed with an Olympus CKX41 inverted microscope and cytospin 
slides were viewed using an Olympus BX41 epifluorescent microscope. On both 
microscopes, images were captured with an Olympus DP26/U-CMAD3 camera and 
optimised with the imaging software CellSens (Olympus Optical Co. Ltd, Japan). 
Cytospins were performed with the Cellspin I (Tharmac GmbH), stained with the 
Hemacolor staining kit (Merck Millipore), according to manufacturer instructions, and 
subsequently mounted with Permount medium (Fisher Scientific). Cytospins of cells 
previously stained with fluorochromes were mounted using DABCO anti-fading 
medium (Sigma).  
 
4.2.6. Statistical analysis 
Data analysis was performed with R v2.15.0 (R Core Team, 2012). Before analysis, 
homogeneity of variance was checked using Cochran’s test. Data from the qRT-PCR 
and the migration assay were analysed using analysis of variance (ANOVA) tests. 
Where ANOVA indicated significant differences, it was followed by pairwise 
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comparison t-tests. As variances were not homogeneous for the phagocytosis assay, 
the non-parametric Mann-Whitney U test was used. 
 
4.2.7. Ethics statement 
All animal work was conducted in accordance with Animal Care and Protection Act 
2001 (QLD) and the NHMRC Code of Practice 2013. Work was conducted under the 
University of Queensland Animal Ethics Committee Approval No. SBS/056/13/ARC 
“Cellular immunity in fish: Robust defence against infection or Achilles heel?” 
 
4.3. Results  
4.3.1. DC-SCRIPT is a potential marker for DCs in barramundi 
A putative gene for DC-SCRIPT was identified in barramundi genomic DNA and in 
cDNA derived from RNA extracted from stimulated enriched dendritic cells, by 
genome walking and RACE PCR respectively. A complete cDNA was obtained 
comprising 2385 nucleotides (nt) translating to a 795 amino acid (aa) putative protein 
with 11 conserved C2H2-like zinc fingers, a proline rich region at the N-terminal and 
an acidic region at the carboxy terminal end (Figure 4.1A). Nucleic acid binding and 
metal ion binding functions were identified with InterProScan [193]. Domain 
organisation was predicted using SMART online software (http://smart.embl-
heidelberg.de) and was compared to a panel of DC-SCRIPT/Zinc-finger protein 366 
from mammalian, aviary and fish species (Figure 4.1B). Comparison of RACE-
derived cDNA sequence with gDNA obtained by genome walking revealed that 
Barramundi DC-SCRIPT comprises 6 exons (Figure 4.1C). Complete cDNA and 
gDNA sequences have been deposited in Genbank with accession number 
KM386621. The cDNA sequence and the translated protein sequence were highly 
homologous to predicted zinc-finger protein 366 from multiple teleost and bird hosts 
(including damselfish (Stegastes partitus), puffer fish (Taifugu rubripes), rock dove 
(Columba livia) and American crow (Corvus brachyrhynchos)) and to DC-SCRIPT 
from human (Homo sapiens) and mouse (Mus musculus) using BLAST 
(http://blast.ncbi.nlm.nih.gov/). The close homology was supported by phylogenetic 
analysis using maximum likelihood (MEGA 5.2.2 for Macintosh, Figure 4.1D).  
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Figure 4.1. Amino-acid sequence alignment, domain organisation, gene 
organisation and phylogeny of DC-SCRIPT from L. calcarifer. (A) Amino acid 
sequences comparison between barramundi (L. calcarifer) and human (H. sapiens) 
DC-SCRIPT, aligned on the NCBI website (http://www.ncbi.nlm.nih.gov) by protein 
BLAST. The green box represents the nuclear targeting sequence consensus 
(KRK*) as per Chelsky et al. [194]. The black boxes represent a proline rich region 
and an acidic region at the N- and C-ends respectively. The 11 orange boxes 
represent the 11 zinc finger sequences as identified by Triantis et al. [185]. (B) 
Domain organisation of DC-SCRIPT from different species predicted using SMART 
online software. Blue rectangles represent C2H2 zinc fingers, pink rectangles 
represent low complexity regions and the green rectangle represents a coiled coil 
region. (C) Gene organisation of barramundi DC-SCRIPT. The orange boxes 
represent the exons. Numbers are representative of the number of base pairs, 
totalling 5337 bp between stop codons. (D) Phylogenetic tree is representative of a 
Maximum Likelihood analysis performed on CLUSTALW aligned sequences (MEGA 
5.2.2). 
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To determine specificity of DC-SCRIPT to barramundi DCs, mRNA FISH was used, 
employing 32 CAL Fluor 590 labelled probes downstream of the zinc finger motif to 
eliminate possible non-specific hybridisation to other zinc-finger containing 
transcription factors. Cells exhibiting dendrite-like protrusions were positively labelled 
with Stellaris® DC-SCRIPT FISH probes as well as with anti-MHCII antibody but 
were not labelled with anti-IgM antibody (Figure 4.2D). Smaller, rounded cells were 
stained with both anti-MHCII and anti-IgM antibodies, but not with Stellaris® DC-
SCRIPT FISH probes, indicative of probable B-cells (Figure A2.4.2). Macrophages 
appeared as irregularly shaped cells with regular nuclei and stained positively with 
anti-MHCII antibodies, but were negative for DC-SCRIPT and IgM (data not shown).  
To investigate DC-SCRIPT expression in haematopoietic tissues in fish, head kidney 
and spleen samples were analysed at 4 times between 6 h and 7 days post-injection 
with PTG and LPS. DC-SCRIPT was up regulated in both spleen and HK at 6 h post 
injection compared to PBS injected controls. However, after 24 h, DC-SCRIPT 
expression decreased in spleen but remained elevated in HK relative to controls. 
After 72 h, relative expression of DC-SCRIPT was lower in both spleen and HK and 
finally, after 7 d, DC-SCRIPT was once again up regulated in spleen but remained 
down regulated in HK relative to PBS injected controls (Figure 4.3).  
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Figure 4.2. Antibody labelling of putative DCs. Antibody and Stellaris DC-SCRIPT 
FISH probe labelling of putative DCs: (A) DC-SCRIPT FISH probe in red and DAPI 
(nuclear stain) in blue, (B) DAPI (nuclear stain) in blue, (C) MHCII antibody in green 
and DAPI (nuclear stain) in blue, (D-F) DC-SCRIPT FISH probe in red, MHCII 
antibody in green. Scale bars represent 50 μm. 
 
 
Figure 4.3. DC-SCRIPT expression in barramundi spleen and HK following a 
time course post-injection with LPS and PTG. Different letters represent 
statistically significant differences (p < 0.05) in gene expression (mean ± SEM). Data 
are derived from 4 biological and 3 technical replicates per treatment/control. 
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4.3.2. Morphological identification 
Identification of dendritic-like cells in hematopoietic cell cultures 
The morphological traits used to identify bDCs were the presence of dendrites on the 
cells’ surface and their irregular nuclei, based on Steinman et al. [195], Lu et al. 
[196], Ganassin and Bols [197] and Bassity and Clark [76] (Figure 4.4A-B). After 
overnight incubation of HK and spleen-derived cultures, many cells, comprising large 
poly-nucleated melano-macrophages and macrophages, had adhered and formed 
clumps. Non-adherent cells were composed of small, round cells suggestive of 
lymphocytes/thrombocytes and larger, round, monocyte-like cells. On further sub-
culture, these monocyte-like cells acquired an irregular shape with a branched 
morphology. These cells could also be enriched by isopycnic separation on a 1.058 
g/mL Percoll gradient resulting in a population of larger more granular cells, which 
suggested a low buoyant density, similarly to mammalian DCs (mDCs) [195] (Figure 
4.4C-D). 
 
 
Figure 4.4. Barramundi DC morphology and isopycnic enrichment. (A-B) 
Dendritic-like cells isolated from L. calcarifer and stained with Hemacolour. (C) 
Forward and side scatter of barramundi spleen/HK cell populations before isopycnic 
enrichment and (D) after isopycnic enrichment. 
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4.3.3. Functional identification 
Barramundi DCs are migratory and phagocytic cells 
Trans-membrane migration and flow cytometry were used to assess chemotactic 
migration and phagocytosis capacity of bDCs. When exposed to Toll-like receptor 
(TLR) ligands and bacteria in the migration assay, bDCs actively migrated through 
the pores in the membrane towards PTG (TLR2) and both S. iniae strains (p < 0.01) 
but not significantly towards LPS (TLR4) (p = 0.076) (Figure 4.5). The migration was 
defined “active” because the cells, measuring approximately 10 µm, had to pass 
through 3 µm pores in order to reach the stimulants. Notably, bDCs migration 
towards either of S. iniae strains was not dose dependent, but at MOI 0.1 there was 
a significant difference in migration between the two isolates (p < 0.05, Figure 4.5). 
When incubated with micro beads for 2 h, bDCs were able to ingest them, 
demonstrating their ability to phagocytose foreign particles (Figure 4.6). Dendritic 
cells were also able to ingest two strains of the barramundi primary bacterial 
pathogen S. iniae (Figure 4.6).  
 
 
Figure 4.5. Barramundi DCs migration towards different chemical cues. 
Different letters represent statistically significant differences. Barramundi DCs 
migrated significantly towards all cues (p < 0.001 for PTG, QMA0076 and QMA028 
at MOI 1 and QMA0248 at MOI 0.1; p < 0.01 for QMA0076 at MOI 0.1) with the 
exception of LPS, which bDCs did not migrate towards significantly (p = 0.076). 
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Figure 4.6. Phagocytic capability of bDCs. (A) Histograms showing barramundi 
dendritic cells alone (a), in presence of stained bacteria (b) QMA0076 and (c) 
QMA0248 and (d) in presence of fluorescent beads. Note that ingestion of beads 
and bacterial cells shifts fluorescence of DCs fluorescence significantly the right 
along the x-axis (z > 1.96) in b, c and d when compared to a. (B-C) Fluorescent 
microscopy and (D) inverted light microscopy of dendritic-like cells incubated with 
fluorescent beads. Scale bars represent 50 μm. 
 
Barramundi DCs trigger the proliferation of responder T-cells 
The defining role of antigen presenting cells, and especially of dendritic cells, is to 
stimulate naïve lymphocytes and trigger their proliferation. To determine if enriched 
cells were able to trigger T-lymphocyte proliferation, a proliferation assay, was 
performed. CFSE fluorescence of cells is typically reduced each generation by 50%, 
making the distinction of daughter cells possible. To determine background cell 
division, responder cells were incubated alone. After three days, the CFSE 
fluorescence of responder cells alone decreased slightly, but not significantly (p > 
0.05) when compared to fluorescence at day 0 (data not shown). However, when 
bDCs alone
bDCs incubated with beads
bDCs incubated with S. iniae
QMA0076
bDCs incubated with S. iniae
QMA0248
a b c d
A
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incubated for three days with bDCs (Figure 4.7), the CFSE fluorescence of T-cells 
decreased significantly in comparison to the fluorescence of responders alone after 
the same time. Decrease in fluorescence occurred in a dose-dependent manner, 
with maximum decrease in CFSE fluorescence achieved with a bDC:responder ratio 
of 1:1 (Figure 4.7). The CFSE fluorescence of responders and stimulators combined 
at day 3 was also significantly lower than the CFSE fluorescence of responders and 
stimulators at day 0, whereas the CFSE fluorescence of responders alone after three 
days was not significantly different from the CFSE fluorescence at day 0 (data not 
shown).  
 
 
Figure 4.7. Histograms showing the fluorescence of CFSE stained T-cells. (a) 
At day 3, the fluorescence of responders/stimulators at 1:1 ratio significantly shifted 
to the left when compared to the (d) fluorescence of responders alone (p = 0.02564). 
Effect was ratio dependent with 1:2 (b), 1:4 (c) bDCs:responders showing less 
decrease in fluorescence over three days than 1:1 (a). Data presented are 
representative of three biological replicate data sets. 
 
4.4. Discussion  
A subset of barramundi cells derived from head kidney and spleen monocytes 
expressed DC-SCRIPT and exhibited morphological and functional characteristics of 
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mammalian dendritic cells (mDCs). DC-SCRIPT is a transcriptional regulator of the 
Zinc finger family that is preferentially expressed in all subsets of human DCs [185]. 
The putative DC-SCRIPT protein identified in this study was highly similar to human 
and murine DC-SCRIPT, with a similar structure and highly conserved zinc fingers. A 
homologue has been previously identified in the fugu genome in silico, but this study 
represents the first identification of DC-SCRIPT in putative teleost DCs. DC-SCRIPT 
did not appear to be expressed in other blood cells in mixed cell cultures from 
barramundi, similar to findings in human blood cells [185, 198], making teleost DC-
SCRIPT a potentially useful molecular marker for DCs in fish. In fluorescence 
microscopy, bDCs were labelled with fluorescent mRNA probes directed against DC-
SCRIPT and were also positive for MHCII using anti-zebrafish MHCIIa. The anti-
MHCII antibody employed is a commercial polyclonal antibody raised in rabbits 
against a peptide comprising the transmembrane MHCIIa and MHCIIa-Ig superfamily 
domains from zebrafish (NP_571565.1) and was chosen as likely to be cross 
reactive with barramundi MHCII based on protein homology by BLAST with the 
barramundi MHCIIa Ig superfamily region (derived from partial gDNA sequence), and 
that of fish from several orders including other cyprinids (C. carpio), salmonids (S. 
salar) and perciforms (O. niloticus, M. zebra). Epitope mapping revealed highly 
conserved B-cell epitopes in both the MHCIIa domain and the Ig superfamily domain 
of the zebrafish peptide (Figure A2.4.2 A-B). Moreover co-labelling with specific anti-
barramundi IgM and the anti-zebrafish MHCII in barramundi B-cells was evident 
(Figure A2.4.2 C). 
 
DC-SCRIPT expression determined by qRT-PCR indicated that bDCs are present in 
spleen and HK at the beginning of an infection and that DC-SCRIPT is induced, 
possibly via cytokine signalling from primary responder cells at the site of injection, 
within 6 h post injection. As the innate and adaptive immune response develops, DC-
SCRIPT expression decreases in spleen, possibly indicative that bDCs have 
migrated from the spleen towards the site of infection. At 72 h post infection, DC-
SCRIPT expression is also down regulated in HK, also suggesting a migration from 
the HK. However, after 7 days, DC-SCRIPT is again up regulated in spleen but not in 
HK, which suggests that bDCs have migrated back to the spleen, possibly for 
maturation and antigen presentation. These kinetics appear to be consistent with 
previous studies on appearance of antibody secreting cells in tissues in European 
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sea bass [199]. This is important against a background of fish vaccination for 
sustainable disease control in aquaculture. Previously we have demonstrated that a 
number of antigens elicit poor antibody responses in vaccinated barramundi [200]. In 
human DCs, DC-SCRIPT appears to control glucocorticoid (GC) suppression of 
antigen presentation by binding to the GC receptors [201]. It will be interesting to 
determine how DC-SCRIPT is expressed in fish DCs post-vaccination with vaccines 
that elicit both strong and poor antibody responses. Novel adjuvants that enhance 
DC-SCRIPT expression may be a way of promoting presentation of critical but poorly 
immunogenic antigens. 
 
Barramundi cells, cultured from spleen and HK, were able to differentiate into highly 
motile, irregular shaped cells with low buoyancy, similar to mDCs and rainbow trout 
dendritic cells  (tDCs) [76, 195-197]. These cells could also arise in HK and spleen 
cultures individually as well as in blood leucocyte cultures, although no functional 
studies have been performed yet on these culture and blood-derived cells. As 
observed in cultures from rainbow trout head kidney, anterior trunk kidney, spleen, 
and mouse spleen, barramundi DCs seemed to be generated from hematopoietic 
tissues without addition of an exogenous growth factor source [76, 202]. This could 
indicate the presence of endogenous growth factors in primary barramundi spleen 
and HK cultures. This theory is supported by the quick de-differentiation of these 
cells when cultured in fresh supplemented medium (L-15/10%FBS/1%PS) after 
enrichment and by the slow/non differentiation of spleen and HK cultures into bDCs 
when the medium was changed every day instead of every 4–5 days (data not 
shown).  
 
In addition to identifying DCs by their morphological properties, the current study 
characterised their function as putative APCs, using a proliferation assay. 
Classically, in mixed leucocyte reactions, CFSE histograms present several peaks, 
each representing a unique cell division. In this study, however, CFSE histograms 
only presented one peak, which shifted to the left when T-cells were exposed to 
bDCs for 3 days. This dissimilarity with other studies is likely explained by the 
method used to isolate the T-cells subsequently used in the proliferation assays. As 
no T-cell markers are available in barramundi to enable enrichment of T-cells from 
mixed leucocyte populations we used the E-rosette method to obtain a 
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homogeneous population of viable T-cells. E-rosetting is a method that relies on the 
binding of T-cells CD2 by a LFA-3 homologue present at the surface of sheep red 
blood cells, forming “rosettes” [203]. This method has been extensively used in 
humans and mice until the commercialisation of magnetised beads, and results in 
high yields of viable active T-cells [192, 204]. More recently, the E-rosette method 
has also been used to isolate T-cells from mud catfish peripheral blood, indicating 
that this technique is efficient not only in mammals but also in fish [205]. In contrast, 
many previous studies obtain responder cell populations by removing B-cells from 
mixed leucocyte cultures by FACS or magnetic beads sorting, resulting in a mixed 
leucocyte population. The presence of cells other than T-cells in the MLR can 
account for the presence of several well-defined CFSE peaks through differing cell 
division rates. In contrast in this study, bDCs were able to stimulate proliferation of 
the whole T-cell population, resulting in the CFSE fluorescence decreasing by half 
after 3 days compared to T-cells alone, or bDCs plus T-cells at day 0. This suggests 
that isolated cells are functionally equivalent to mDCs.  
 
Another key characteristic of APCs that is critical to antigen presentation is their 
ability to sense non-self substances and migrate towards them by chemotaxis [44]. 
Barramundi DCs were attracted to TLR-ligands and whole bacteria and were able to 
phagocytose particulates including bacteria and opsonised beads. Barramundi DCs 
did not migrate towards LPS, which suggests that bDCs were unable to recognise 
and bind TLR4 ligands in contrast to mammalian DCs. TLRs are proteins capable of 
recognising a range of exogenous and endogenous ligands, including pathogen 
associated molecular patterns (PAMPs). In mammals, the lipopolysaccharide binding 
protein (LBP), located in serum, mediates the interaction between LPS on bacteria 
surface and the glycoprotein CD14 on phagocytic cells [161]. Additionally, TLR4 
must be coupled with the myeloid differentiation protein 2 (MD-2) to functionally 
interact with LPS [162]. The lack of significant attraction of bDCs to LPS in the 
present study is likely due to a lack of LBP in the culture system or to a lack of 
CD14/MD-2 on bDCs surface: to date, CD14 and MD-2 are absent from all fish 
genomes sequenced [147]. It may also be that higher concentrations of LPS than 
used in the present study are required to activate fish immune cells [206]. The lack of 
reaction to LPS by bDCs could present an issue both for future vaccine design and 
for in vitro studies on L. calcarifer, as TLR4 ligands are frequently used to stimulate 
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DCs for in vitro studies in mammals [122, 207]. Further work is warranted to 
determine whether barramundi do indeed have intermediate LBP that could be 
included in the assays system to mediate interaction with TLR4. 
 
Finally, the characterisation of DCs in L. calcarifer provides a baseline for future 
vaccine design against S. iniae and other pathogens. Vaccination in fish has 
experienced some failures due to rapid evolution of key immunogens and 
consequent vaccine escape [60, 61]. For example, killed whole-cell vaccines against 
S. iniae, which is a major pathogen of warm water fish, are often compromised by 
rapid-evolution of novel serotypes [61, 208]. Vaccines against S. iniae are effective 
against the specific serotype in the vaccine, with the fish adaptive immune system 
responding to the capsular polysaccharide (CPS), which is immunodominant [61, 
108, 209]. However, the CPS is highly variable and new CPS variants of S. iniae 
rapidly emerge, leading to reinfection and disease outbreaks in previously 
vaccinated fish [61, 108]. Moreover, although there are conserved critical virulence 
factors in S. iniae, such as the surface-expressed M-protein, the immune system 
does not seem to develop an effective response against them [191]. Enhancing 
antigen presentation of non-immunodominant conserved virulence factors is 
therefore a critical step in the development of broadly cross-protective vaccines 
against these highly variable and rapidly mutating strains. The main cells that need 
to be targeted during vaccination are APCs, and in particular dendritic cells that will 
activate pathways leading to immune memory [1, 2]. The capacity to evaluate 
multiple antigens across a single population of APCs in vitro, rather than vaccinating 
cohorts of fish with each strain or antigen has immense value in terms of rapid high 
throughput screening of putative antigens. In vitro experiments also have great merit 
in terms of animal welfare as these assays greatly reduce animal numbers required 
and refine (reduce the stress of) the procedures conducted on animals, in line with 
the ethical requirements of the three R’s (Replacement, Reduction and Refinement).  
The identification of a molecular marker for dendritic cells in barramundi provides a 
potentially useful tool for new flow-cytometric investigations of antigen presentation 
in fish. Work is ongoing to determine the function of DC-SCRIPT in bDCS and 
elucidate its role in antigen presentation. 
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Chapter Five – Evidence for affinity selection of IgM in fish: A high avidity 
secondary antibody response to T-dependent antigen with antibody-mediated 
suppression 
 
5.1. Introduction 
The introduction of mass vaccination in the salmonid industry based on water-in-oil 
emulsions is one of the major success stories in the growth of the global salmon 
farming industry [53], from a few hundred thousand tonnes during the early 1990s to 
more than 1.3 million metric tonnes in 2012 [70]. The practice of vaccination by 
intraperitoneal injection has been slowly transferring to non-salmonid species and 
this is an important transition with the major growth in finfish aquaculture now 
occurring in warm-water species [53, 210, 211]. The role of the oil-adjuvant in the 
success of vaccination of salmonids is often underplayed, but it was the stability and 
slow release of the antigen allowing single injection protection throughout the 2-4 
year grow-out period that made vaccination an economical option for preventing 
disease in fish, and lead to almost universal adoption by salmon farmers within a few 
years. In contrast to salmon farming, warm water finfish have a much shorter grow-
out period. Many fish species are farmed only for plate size and the farming cycle, 
from hatchery to market, is less than one year, often between 6 and 9 months [93, 
212, 213]. This can lead to issues in vaccine efficacy: the rapid onset of protection 
and low cost of aqueous vaccination makes them attractive, but protection is short-
lived with disease occurring in vaccinated fish after only 3-6 months [208]. In 
contrast, water-in-oil emulsion vaccines are perceived as expensive. Moreover, the 
slow antigen release afforded by water-in-oil emulsions, coupled with the difficulties 
in achieving sufficiently high antigen dose for target pathogens such as 
Streptococcus agalactiae and S. iniae, reduces vaccine efficacy early in the farming 
cycle, and can lead to lower protection than desired. It is timely, therefore, to 
investigate the kinetics of immune response in warm water finfish to determine 
whether vaccines can be better formulated to address disease prevention in this 
rapidly developing industry.  
 
Successful vaccination relies on eliciting long-term immune memory and is 
dependent upon correct activation and interplay of both innate and adaptive 
immunity. Innate immunity is typically characterised by the development of a non-
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antigen-specific inflammatory response, following exposure to foreign particles, 
through production of cell-signalling molecules (cytokines) and recruitment of 
phagocytes and lymphocytes [214]. This initial response is also crucial in eliciting the 
antigen-specific adaptive response, as it provides the basis for foreign particle 
recognition on which the adaptive response relies. Some pro-inflammatory cytokines, 
such as interleukin (IL)-1β, have been shown to stimulate T-lymphocytes, both in 
teleosts and mammals [215, 216], thus linking innate and acquired immunities. 
Moreover, the binding of pathogen-associated molecular patterns (PAMPs) by 
pattern recognition receptors (PRRs), which constitute the base of innate immunity, 
triggers an array of molecular cascades, some of which initiate the expression of 
genes involved in maturation of dendritic cells (DCs), that are critical to presentation 
of some antigen types [1, 217]. In humans, DC maturation is activated by cytokines 
(e.g. CD40 L and IFN-γ) and pathogen products  such as capsular polysaccharide or 
nucleic acids [1]. DCs are the primary antigen presenting cells (APCs) responsible 
for the priming and proliferation of antigen-specific T-lymphocytes, allowing the 
formation of immune memory, and are thus at the core of the adaptive response on 
which vaccination is based (reviewed in [1]). Indeed, the adaptive response occurs 
when T-cell receptors, located at the surface of T-lymphocytes, recognise PAMPs 
bound on major histocompatibility complex (MHC), located at the surface of APCs. 
MHC class II (MHCII) molecules found at the surface of DCs, in particular, prime 
CD4+ helper T-lymphocytes, which results in localised inflammation and B-
lymphocyte activation [105]. B-lymphocytes are crucial in the elimination of foreign 
particles, as they produce antibodies, which non-specifically bind to foreign particles 
during their first encounter, but can quickly become antigen-specific after B-cell 
maturation [218]. Through a process termed affinity maturation, the binding site of 
the antibodies is mutated to create a stronger bond with the specific antigen [219]. 
Briefly, variable (V), diversity (D) and junction (J) immunoglobulin (Ig) genes already 
have many isotypes present in the genome, which allows B-cells to produce around 
1010 different antibodies through selective gene rearrangement, without all those 
antibodies having to be individually encoded in the genome [220]. This represents 
the primary antibody repertoire. Moreover, V(D)J genes also possess hyper-mutable 
regions within their coding sequence, which allows for further affinity maturation 
through a process called somatic hypermutation [218, 221]. When a foreign particle 
is detected, only the B-cells that have higher affinity due to initial V(D)J 
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rearrangement and accumulated mutations are selected to become memory B-cells 
within the germinal centres [218, 222]. This selection shifts the B-cell population from 
a very diverse antibody pool to a clonal population producing antibodies targeted 
against a specific antigen [219]. Specific memory B-lymphocytes stay in the 
organism and diversify into plasma B-cells upon re-encounter with the same antigen, 
improving and accelerating the immune response due to the faster production of 
higher affinity antibodies [219].  
 
This process, however, only occurs with T-lymphocyte dependent antigens. From an 
immunological point of view, there are two kinds of antigens, T-lymphocyte 
dependent (TD) and T-lymphocyte independent (TI). Most proteins and peptides are 
TD, requiring T-cell activation by presentation through MHCII to induce B-cell 
proliferation and differentiation into plasma and memory cells [223, 224]. Antibodies 
produced against TD antigens typically have high affinity and undergo isotype 
switching from IgM to IgG in mammals [224]. On the other hand, TI antigens include 
most carbohydrates, and do not require any T-cells to induce an immune response. 
There are two types of TI antigens, type 1 and type 2, based on their ability to 
interact with B-cells. TI type 1 can induce B-cell proliferation and differentiation into 
plasma cells, in both naïve and mature cells, whereas TI type 2 can only activate 
mature B-cells, most likely through Ig crosslinking [223]. In either case, the 
antibodies produced by TI induced B-cells are highly antigen-specific and do not 
generally show a strong avidity. Moreover, TI antigens fail to induce immune 
memory, as B-cells do not differentiate into memory cells, which is characterised by 
a lack of response to challenges with the same antigen [224, 225]. Fortunately, it has 
previously been shown that coupling TI antigens with a protein carrier could lead to a 
T-dependent response, combined with the development of memory B-cells 
producing antibodies against that TI antigen [226]. This model is based on hapten-
carrier antigens, which include an often small non-immunogenic hapten and a bigger 
immunogenic carrier protein [227]. Vaccines based on the hapten-carrier model have 
already proven to be successful, for example in the prevention of meningococcal 
diseases caused by Neisseria meningitidis [226]. Indeed, polysaccharide vaccine 
usually do not confer immune memory, but conjugate vaccines against N. 
meningitidis serotype C have proven to induce antibody production, confer immune 
memory and even to help with herd immunity [228]. As rapid advances and 
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decreases in cost of whole genome sequencing enable the identification of new 
protein antigens (likely processed via T-dependent pathways) for improved, cross-
protective vaccination, it is likely that hapten-carrier vaccine will before increasingly 
used in aquaculture, especially against TI capsular polysaccharides. Thus, a better 
understanding of T-dependent primary and secondary responses is required in fish 
systems. 
 
In the current study, primary and secondary antibody responses against a model T-
dependent antigen were determined in barramundi (Lates calcarifer) over the course 
of a three-month prime-boost trial in the presence and absence of commercial 
adjuvants. Speed, magnitude and quality (avidity) of antibody elicited during primary 
and secondary responses was assessed. Moreover, the affinity of those antibodies 
was also determined, as well as the proportion of their isomers under the differing 
conditions. Finally, the barramundi transcriptome and genome were examined for 
immunoglobulin coding genes [164, 168], identifying the heavy chain V(D)J genomic 
region in barramundi for the first time.  
 
5.2. Materials and Methods 
5.2.1. Experimental animals and husbandry 
Barramundi (L. calcarifer) juveniles of approximately 30–50 g were obtained from 
Australian Native Finfish, Burpengary, Queensland and transported by road to the 
University of Queensland. Fish were acclimatised for 2 weeks in a recirculating 
system of eight 84 L cylindrical food-grade plastic tanks with individual aeration, all 
connected to a 260 L sump equipped with a protein skimmer and a bio-filter. The 
water temperature and the salinity were maintained at 28 ± 2°C and 15 parts per 
thousand (ppt) respectively. Water quality was checked regularly for ammonia, 
nitrite, nitrate and pH, and water exchanges were applied as required. Fish were fed 
to satiation twice daily with a commercial diet for barramundi (Ridley Aqua Feed). 
Fish were graded (segregated into different tanks by size) weekly to prevent 
cannibalism until they reached around 80-90 mm in size, after which they were 
distributed into their experimental groups. 
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5.2.2. Vaccine formulation 
A hapten-carrier complex was employed as a model T-dependent antigen in all 
vaccine groups, as previously employed in sea bass [229] and rainbow trout [230]. 
Dinitrophenol covalently linked to keyhole limpet haemocyanin (DNP-KLH) was 
dissolved in phosphate buffered saline, pH 7.4 such that the final antigen 
concentration when mixed with adjuvant at the correct ratio was 100 µg/mL 
(equivalent to 10 µg/fish post-injection). Adjuvants requiring water in oil (w/o) 
emulsions (Montanide ISA 763A VG, Essai 1616101 and Essai 1616102) were 
formulated with antigen by weight (Table 5.1) and mixed for 3 min at 15,600 rpm 
using an IKA Ultra Turrax T25 mixer fitted with an S25 N-18G head. To prepare 
w/o/w emulsion with adjuvant Montanide Essai 1632102, antigen and adjuvant were 
first warmed to 31°C in a water bath. The adjuvant was then stirred under low-shear 
at 350 rpm with the 4 blade impeller head. The aqueous antigen phase was then 
added quickly and stirring continued at 350 rpm for 5 min. The emulsion was then 
transferred to a cooling water bath at 20°C for 1 h prior to storage at 4°C. For the gel 
adjuvant Montanide Gel 1632101, the adjuvant was added to the antigen solution 
and stirred at room temperature for 10 min at 200 rpm using the 4 blade impeller 
head. Antigen only control was mixed 1:1 with sterile PBS for injection. All formulated 
vaccine mixtures were stored at 4°C and inspected over 5 days for emulsion stability 
before further use. 
 
Table 5.1. Vaccine treatment groups in the prime-boost experiment. 
Vaccine Adj:Ant Ratio (w/w) Experimental purpose 
PBS N/A Background nonspecific 
response 
Antigen (DNP-KLH) 50:50 (PBS) Response without adjuvant 
Antigen + ISA 763A VG 70:30 Water in oil emulsion 
Antigen + essai w/o/w 
1632102 
50:50 Water in oil in water emulsion 
Antigen + essai gel 1632101 50:50 Gel adjuvant 
Antigen + essai w/o 1616101 60:40 Water in oil experimental 1 
Antigen + essai w/o 1616102 60:40 Water in oil experimental 2 
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5.2.3. Vaccination 
Fish missed their routine feed the evening prior to vaccination to ensure an empty 
gut and thereby minimise the chance of accidental vaccination into the gut. For 
vaccination, barramundi fish were anaesthetised with Aqui-S according to the 
University of Queensland SOP AHP44. Fish were vaccinated by intraperitoneal 
injection with 100 µL of antigen vaccine in aqueous form, antigen vaccine formulated 
with either adjuvant (ISA 763A VG, Essai w/o 1616101, Essai w/o 1616102, Essai 
w/o/w 1632102 or Gel 1632101), or PBS control. This volume has been shown to be 
safe for IP injection and cause minimal stress to the barramundi of this size 
(evidenced by no stress-induced darkening and by rapid return to feeding post 
vaccination, within a few hours). Periodically, 6 fish from each treatment group were 
removed and re-vaccinated (“challenged” or boosted) with DNP-KLH to elicit a 
secondary specific immune response. Revaccination occurred 1 week, 2 weeks, 9 
weeks and 13 weeks post initial vaccination.  
 
5.2.4. Sampling 
Seven days after primary vaccination, 6 vaccinated fish per treatment were 
euthanised and sampled for blood. Moreover, seven days after challenges, 6 re-
injected and 6 non-re-injected fish per treatment were also euthanised and blood 
collected. Fish were euthanised by overdose of Aqui-S and bled from the caudal 
vein. Blood was allowed to clot overnight at 4°C and sera collected by centrifugation 
at 7,500 x g for 10 min and frozen at -20°C until subsequent antibody analysis by 
ELISA.  
 
5.2.5. Enzyme linked immunosorbent assay 
Antibody response was detected via indirect ELISA. A series of optimisation 
experiments was first conducted to optimise resolution of positive and negative 
control sera. Binding surface (Greiner high and medium binding plates), primary 
antibody dilution (8 x to 256 x), blocking reagent (1% bovine serum albumin, 2% 
normal donkey serum, 5% skim milk) and development time for the p-
nitrophenyphosphate (pNPP) chromogen (10-50 min) were optimised, whilst dilution 
of secondary antibody (sheep vs. barramundi IgM, 1:2,000) and tertiary antibody 
conjugate (donkey anti-sheep IgG alkaline phosphatase conjugate, Sigma A5187, 
1:15,000) were fixed. Following optimisation experiments, a standard protocol was 
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devised for experimental samples as follows: Greiner high binding 96 well ELISA 
plates were coated overnight at 4°C with DNP-BSA dissolved at 5 µg/mL in 
carbonate bicarbonate buffer, pH 9.0 (100 µL/well). Plates were washed thrice in tris-
buffered saline containing 0.01% Tween 20 (TBST) and then blocked with 1% BSA 
(100 µL/well) for 1 h. Plates were rinsed with TBST, then primary antibody at 1:128 
dilution in TBST was added to each well and incubated overnight at 4°C. Plates were 
then thrice washed in TBST before adding secondary antibody sheep anti-
barramundi IgM, diluted 1:6,400 in TBST and incubating for 1 h at RT. After three 
further washes, antibody-conjugate reagent (donkey anti-sheep IgG) diluted 
1:15,000 in TBST was added and the plates incubated for 1 h.  Plates were then 
washed five times in TBST and once in TBS. Then 100 µL chromogen (pNPP liquid 
substrate, Sigma) was added to each well using a multi-channel pipette and the plate 
immediately placed in the incubator tray of a temperature controlled 96-well plate 
reader (BMG Fluostar Optima) and incubated at 28°C and the absorbance of each 
well read at 405 nm every 10 min for 30 min. Addition of chromogen was staged to 
enable sequential reading of plates. A standard positive control and negative control 
were included in triplicate on each plate to enable inter-plate calibration and 
normalisation of optical density post-hoc. 
 
5.2.6. Avidity assay by chaotrope titration ELISA 
Antibody avidity was quantified via indirect ELISA by titration of ammonium 
thiocyanate (NH4SCN) as follows: Greiner high binding 96 well ELISA plates were 
coated overnight at 4°C with DNP-BSA dissolved at 5 µg/mL in carbonate 
bicarbonate buffer, pH 9.0 (100 µL/well). Plates were washed three times in tris-
buffered saline containing 0.01% Tween 20 (TBST) and then blocked with 1% BSA 
(100 µL/well) for one hour. Plates were rinsed with TBST, then primary antibody at 
1:128 dilution in TBST was added to each well and incubated overnight at 4°C. 
Plates were then washed three times in TBST before adding four dilutions of 
ammonium thiocyanate (0.5 g/mL, 0.3 g/mL, 0.1 g/mL and 0.05 g/mL diluted in TBS 
pH 6) in order to obtain an avidity curve for each serum. The plates were then 
incubated for 15 min at RT and washed thrice in TBST before addition of secondary 
antibody sheep anti-barramundi IgM, diluted 1:6,400 in TBST and incubating for 1 h 
at room temperature. After three further washes, antibody-conjugate reagent 
(donkey anti-sheep IgG) diluted 1:15,000 in TBST was added and the plates 
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incubated for 1 h.  Plates were then washed five times in TBST and once in TBS. 
Then 100 µL chromogen (pNPP liquid substrate, Sigma) was added to each well 
using a multi-channel pipette and the plate immediately placed in the incubator tray 
of a temperature controlled 96-well plate reader (BMG Fluostar Optima) and 
incubated at 28°C and the absorbance of each well read at 405 nm every 10 min for 
40 min. Addition of chromogen was staged to enable sequential reading of plates. A 
standard positive control and negative control were included in triplicate on each 
plate to enable inter-plate calibration and normalisation of optical density post-hoc. 
Titration curves were fitted for antiserum and control from the normalised data by 
non-linear regression in Prism 7 (Graphpad) and an avidity index calculated as the 
concentration of ammonium thiocyanate that resulted in 50% reduction in ELISA 
optical density. 
 
5.2.7. Immunoglobulin polymer composition by SDS-PAGE 
To detect the proportion of monomer, dimer, trimer and tetramer among Ig molecules 
in barramundi sera, three serum samples of fish vaccinated with ISA 763A VG, Essai 
1632101 gel and Essai 1616102 w/o adjuvanted vaccines, sampled on day 28 and 
98, were chosen, in both challenged and non-challenged groups. Optimisation 
experiments were conducted to optimise the resolution of the barramundi IgM protein 
bands, by varying the gel concentrations (12%, 10%, 6% and 4%) and the 
concentrations of fish sera (1:64 – 1:256). Diluted sera (1:64) were mixed with non-
reducing sample buffer and were loaded on 6% sodium dodecyl sulphate-
polyacrylamide gels (SDS-PAGE). An electrophoretic separation was conducted at 
140 V and 40 mA for approximately 3 h, until the samples had been appropriately 
separated through the gel. Resulting gels were stained in Coomassie Brilliant Blue 
250R (Bio-Rad, UK). Immunoglobulin band intensities were semi-quantitatively 
analysed densitometrically by ImageJ (National Institutes of Health, USA). The 
intensity of each band was calculated as a proportion of total IgM for a given sample 
(proportion of total Ig = intensity of the polymer investigated in the sample/total 
intensity of all Ig polymers in the sample). 
 
5.2.8. LPS immunisation and ELISA 
Lipopolysaccharide (LPS) from E. coli 0111:B4 (Sigma) was dissolved in PBS, such 
that the final antigen concentration was 100 µg/mL (equivalent to 10 µg/fish). 
 111 
Similarly, DNP-KLH was dissolved in PBS, to a final concentration of 100 µg/mL. 
Fish missed their routine feed the evening prior to vaccination to ensure an empty 
gut, thereby minimising the likelihood of accidental vaccination into the gut. For 
vaccination, barramundi fish were anaesthetised with Aqui-S according to the 
University of Queensland SOP AHP44 and were vaccinated by intraperitoneal 
injection with 100 µL of either LPS of DNP-KLH vaccine. Negative controls consisted 
of fish mock-vaccinated with PBS. Fourteen and 21 days after vaccination, 6 
vaccinated fish per treatment (including PBS control) were euthanised and blood 
drawn from the caudal vein. Blood was allowed to clot overnight at 4°C and sera 
collected by centrifugation at 7,500 x g for 10 min and frozen at -20°C until 
subsequent antibody analysis by ELISA.  
Antibody response was detected via indirect ELISA. Equal volumes of Polymyxin B 
(1 mg/mL) and LPS 0111:B4 (Ultra-pure – 10 µg/mL) were mixed and incubated at 
RT, on a magnetic stirring plate for 30 min. A Greiner high binding 96 well ELISA 
plate was then coated overnight at 37°C with either LPS dissolved at 1 µg/mL in 
carbonate bicarbonate buffer, or with DNP-BSA dissolved at 5 µg/mL in carbonate 
bicarbonate buffer (100 µL/well). The plate was washed thrice in tris-buffered saline 
containing 0.01% Tween 20 (TBST) and then blocked with 1% BSA (100 µL/well) for 
one hour. The plate was rinsed with TBST, then primary antibody at 1:128 dilution in 
TBST was added to each well and incubated overnight at 4°C. The same PBS 
control sera were added to both LPS and DNP coated wells, to allow for comparison 
between both anti-LPS and anti-DNP antibodies. The plate was then thrice washed 
in TBST before adding secondary antibody sheep vs barramundi IgM, diluted 
1:6,400 in TBST and incubating for 1 h at room temperature. After three further 
washes, antibody-conjugate reagent (donkey anti-sheep IgG) diluted 1:15,000 in 
TBST was added and the plates incubated for 1 h.  Plates were then washed five 
times in TBST and once in TBS. Then 100 µL chromogen (pNPP liquid substrate, 
Sigma) was added to each well using a multi-channel pipette and the plate 
immediately placed in the incubator tray of a temperature controlled 96-well plate 
reader (BMG Fluostar Optima) and the absorbance of each well read at 405 nm. 
This procedure was repeated for sera samples from 14 and 21 days post 
vaccination. 
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5.2.9. Immunoglobulin genomic assembly and mapping 
The immunoglobulin coding region was identified in the barramundi genome though 
Basic Local Alignment Search Tool (BLAST) using Ig coding sequences identified 
from the annotated transcriptome. Within this genomic sequence, the variable (V) 
and junction (J) regions were identified using the TigGER package in R 
(http://tigger.readthedocs.io/en/0.2.10/) [231]. Briefly, the barramundi transcriptome 
sequences were first IMGT-gapped formatted, using Danio rerio as a reference on 
the IMGT/HighV-QUEST online software (http://www.imgt.org) [232-234]. IMGT-
gapped V(D)J regions from Danio rerio were also imported as references, before 
performing the inferGenotype command on TigGER. The resulting V and J 
sequences were subsequently mapped to the barramundi genome in BAM format 
using the MAP with BWA-MEM on the Galaxy web interface (https://galaxy-
qld.genome.edu.au/galaxy) [235], before being visualised in Artemis. Constant 
immunoglobulin regions were identified by homology using BLASTx, open reading 
frames containing those constant regions were identified and subsequently mapped 
to the genome as described above before being visualised in Artemis.   
 
5.2.10. Statistical analysis 
ELISA and avidity assay data were analysed via two-way analysis of variance 
(ANOVA). A Sidak’s post-hoc was then performed to examine the differences 
between boosted and non-boosted fish sampled on the same day from the same 
treatment group.  
Densitometry data derived from electrophoretic separation of barramundi IgM were 
analysed via one-way type I ANOVA to examine whether the polymerisation forms of 
IgM were different in fish sera samples (challenged and non-challenged) within each 
adjuvant group. Tukey’s post-hoc tests were also conducted to compare specific Ig 
forms between samples within the same adjuvant group.  
 
5.3 Results 
To assess vaccine effectiveness, antibody levels in the serum of immunised 
organisms are often evaluated by routine ELISAs. In the current study, barramundi 
serum antibody titres were measured post-immunisation, comparing different 
vaccine formulations using the same model antigen. Control fish that received only 
PBS via intraperitoneal injection showed that background serum antibody was 
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detectable and significant compared to primary serum-free reagent controls. Whilst 
there was some variation in ELISA OD through the trial ranging between 0.35 and 
0.7, the variation was not significant over time. Vaccinated fish, either with the 
antigen in aqueous phase or with the addition of adjuvants, developed serum 
antibody titres significantly higher than the PBS handling controls, in spite of the 
background, indicative of a specific response to the antigen (Figure 5.1). In the 
absence of adjuvant, the primary serum antibody response to DNP peaked at or 
before the first sample point of 21 days and then decreased throughout the 100 days 
of the experimental period (Figure 5.1B). However, with addition of adjuvants, the 
primary response peaked around 28 days, and was maintained throughout the 
experiment with all the adjuvants except for the Essai 1632102 w/o/w, for which 
antibody levels decreased after the 28 day peak (Figure 5.1F). The addition of the 
Essai 1632101 gel adjuvant resulted in a higher primary response than for any other 
treatment, with those high levels maintained for the duration of the experiment 
(Figure 5.1G). When fish were vaccinated, a secondary injection with aqueous DNP-
KLH resulted in significantly higher antibody titres at 98 days in all cases (Figure 
5.1B-G). Overall, secondary injection in PBS control fish did not significantly increase 
antibody titres, except in one individual fish at day 98, which resulted in a significant 
statistical test (Figure 5.1A). Surprisingly, the addition of adjuvants resulted in 
significantly lower levels of secondary antibodies at 28 days, coinciding with the peak 
of the primary antibodies in all adjuvanted treatments except for the Essai 1616102 
w/o (Figure 5.1E). 
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Figure 5.1. Kinetics of primary (green) and secondary (red) antibodies 
following vaccination. Vaccine treatments used were PBS (A), DNP-KLH in 
aqueous solution (B), or DNP-KLH with ISA 763A VG (C), with Essai 1616101 w/o 
(D), with Essai 1616102 w/o (E), with Essai 1632102 w/o/w (F) or with Essai 
1632101 gel (G). Each secondary antibody measure corresponds to a sampling 7 
days post-challenge with DNP-KLH in aqueous solution. Stars represent statistically 
significant differences between primary and secondary antibody titres (mean ± SEM) 
at a given time point with *: p < 0.05, **: p < 0.01, ***: p < 0.005 and ****: p < 0.001. 
 
Because of the particularities observed by ELISA for the vaccines adjuvanted with 
Essai 1616102 w/o (no inhibition of the secondary response at 28 days post-
vaccination) and Essai 1632101 gel (increased primary response maintained over 98 
days), avidity was also determined for those treatments, along with the three control 
treatments (PBS, aqueous DNP-KLH vaccine and ISA 763A VG adjuvanted 
vaccine). Overall, the avidity of natural antibodies (produced by PBS control) was 
very low and consistent throughout the experiment. A similar pattern was observed 
with the aqueous vaccine (Figure 5.2A and 5.2B), with consistently low avidity which 
was not significantly different from the PBS control. However, with the addition of 
adjuvants, the avidity was significantly improved, with significant differences 
observed between PBS controls and primary antibody avidity overall, as well as 
between primary and secondary antibody avidity for all adjuvanted treatments at day 
98 (Figure 5.2C-E). Moreover, for the Essai 1616102 w/o adjuvant, the avidity of 
secondary antibodies was also significantly higher than the one of primary antibodies 
at day 70, displaying an overall avidity superior to all other treatments (Figure 5.2D).  
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Figure 5.2. Avidity of primary (green) and secondary (red) antibodies following 
vaccination. Vaccine treatments used were PBS (A), DNP-KLH in aqueous solution 
(B), or DNP-KLH with ISA 763A VG (C), with Essai 1616102 w/o (D), or with Essai 
1632101 gel (G). Each secondary antibody measure corresponds to a sampling 7 
days post-challenge with DNP-KLH in aqueous solution. Stars represent statistically 
significant differences between primary and secondary antibody titres (mean ± SEM) 
at a given time point with **: p < 0.01 and ****: p < 0.001. 
 
IgM protein bands separated by SDS-PAGE were identified in Western blot by 
specific anti-barramundi IgM antibody. The barramundi serum Ig was composed of 
monomers, dimers, trimers and tetramers (Figure A2.5.1). IgM monomers comprised 
most of the total antibody (48%), while trimers were the lowest proportion (12%) in 
barramundi serum. On day 98, non-challenged fish vaccinated with ISA 763A VG 
adjuvant had significantly higher proportion of tetramers in sera than those in 
challenged fish (p < 0.05) (Figure 5.3A). On days 28 and 98, in fish vaccinated with 
Essai 1616102 w/o adjuvant, non-challenged fish had significantly higher proportion 
of dimers and trimers, and fewer monomers than re-injected fish (p < 0.05) (Figure 
5.3B). In fish vaccinated with Essai 1632101 gel adjuvant, there were fewer 
monomers in fish at day 98 compared to non-challenged fish from day 28 (p < 0.05) 
(Figure 5.3C).  
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Figure 5.3. Isomer composition of barramundi immunoglobulin. Samples were 
taken at 28 and 98 days, from not-challenged (primary) or challenged (secondary) 
fish vaccinated with DNP-KLH and ISA 763A VG (A), Essai 1616102 w/o (B) or 
Essai 1632101 gel (C). For each sample, the proportion of monomer, dimer, trimer 
and tetramer is represented (mean ± SEM). Tables represent statistical analysis, 
with each isomer analysed separately across the different conditions for each 
treatment. Different letters represent statistically significant differences in the 
proportion of each isomer (p < 0.05).  
 
When fish were vaccinated with LPS, there was a significantly higher titre of anti-LPS 
antibodies after 14 days than when fish were mock-vaccinated with PBS (Figure 
5.4A). Additionally, it was worth noting that the level of anti-LPS antibodies 
decreased back significantly after 21 days, reaching levels similar to the mock-
vaccinated fish. Interestingly, the titre levels of anti-DNP antibodies were much 
higher during the same time course, with no difference in antibody levels between 
day 14 and day 21 (Figure 5.4B). 
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Figure 5.4. Antibody titres post vaccination with either LPS or DNP-KLH. PBS 
used as a mock-vaccination control. Titres against LPS (A) and DNP-KLH (B) are 
represented. Each fish (n = 6) is plotted with mean ± SEM represented in black for 
each treatment. Significant differences between time points are represented with ** p 
< 0.01.  
 
V, J and C gene segments were all identified from a 270 kilo-base (kb) region of 
Scaffold 42 in the barramundi genome available from http://seabass.sanbi.ac.za 
[168], subsequently referred to as barramundi igh locus. A region of 200 kb at the 5’ 
end of the igh locus contained 43 VH gene segments identified using the TigGER 
package on R (Figure 5.5) [231]. Most of those V genes were duplicates (23 out of 
43) and they ranged mostly between V1 and V5, with one V10, one V11 and one 
V13 genes identified through homology with Danio rerio VH genes. At the 3’ end of 
the igh locus, C genes were identified by sequence homology, along with J regions 
identified by the TigGER package on R [231]. The four constant region gene 
segments identified included Cα, C𝜏, Cμ and Cδ. Several Cμ and Cδ regions were 
identified in barramundi igh locus, suggesting a gene duplication in barramundi, as 
previously seen in other fish species (reviewed in [236] and [237]). Associated with 
each of the constant region genes, upstream J regions were also identified, 
reminiscing of the arrangement of Ig gene segments in zebrafish [238]. Interestingly, 
the gene presently identified as C𝜏 in barramundi shares a relative position in the igh 
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locus with the previously identified Cζ region from zebrafish [238]. However, when 
performing a phylogenetic analysis using sequence homology with 2,000 bootstrap 
replicates, this gene identified in barramundi closely clustered with Salmo trutta C𝜏 
rather than with Danio rerio Cζ, corroborating its identity as barramundi C𝜏 (Figure 
5.6). 
 
 
Figure 5.5. Gene arrangement of the barramundi igh locus. Gaps and genes are 
to scales and arrows represent the direction of the genes. Variable genes are 
represented in green, junction genes in blue and constant genes in red.  
 
Figure 5.6. Phylogenetic arrangement of constant immunoglobulin genes from 
different teleost and avian species. Colours represent the different constant 
genes, with Cα in light red, Cμ in dark red, Cδ in blue, Cζ in yellow and C𝜏 in orange. 
Stars represent genes from barramundi (Lates calcarifer). 
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5.4 Discussion 
Little is known about prime-boost responses in teleost fish and this is the first 
sequential analysis of prime-boost response to our knowledge. Previous studies 
have been conducted in European sea bass [199] and in rainbow trout [230], but 
both of these studies employed a single homologous boost applied many weeks 
after primary exposure. Both experiments demonstrated rapidly increasing antibody 
response either by ELISA [230] or by ELISPOT quantification of antibody positive 
cells [239]. In the current study, fish were boosted at 14, 21, 63 and 91 days post 
primary immunisation and secondary response examined 7 days post-boost. 
Significant increase in secondary antibody compared to primary antibody was only 
detected in fish boosted 91 days post-primary immunisation.  
Adjuvants had a significant effect on the kinetics and magnitude of both the primary 
and secondary immune response. Primary immune response was elevated by all 
adjuvants tested compared to aqueous antigen alone, in line with previous research 
[73, 240-242]. The gel adjuvant resulted in a significantly higher and more sustained 
primary antibody response than any of the oil adjuvants tested. A decrease in 
secondary antibody production was detected at the 21-day post-vaccination boost 
with all adjuvants except Essai 1616102. Interestingly, in our vaccine trials against 
Streptococcus iniae in barramundi, challenges are routinely carried out at this time 
and protection is usually around 100% against a homologous bacterin [200]. 
However, it is likely that at least some of the antigen present in complex vaccines, 
notably peptidoglycan, LPS or other capsular polysaccharide, are presented through 
TLR-mediated T-independent routes. In contrast, the current study investigates only 
the T-dependent pathways of B-cell response. It may be that protection at that time 
(± 600 degree-days) post-primary immunisation is compromised, for vaccines in 
which protection is entirely founded on response to T-dependent antigens (e.g. 
recombinant proteins and most viral antigens). In this case, timing of vaccination well 
in advance of the disease season should be a priority to allow the primary response 
to pass, thereby reducing risk of feedback inhibition. Moreover, investigation of other 
adjuvants, such as Essai 1616102 w/o and the gel adjuvant (due to the very high 
and extended primary response) may well be worthwhile in full challenge models 
against S. iniae in barramundi and S. agalactiae in tilapia. It was also interesting that 
the secondary response appeared to only be significantly higher than the primary 
response when the secondary exposure occurred at least 12 weeks post primary 
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immunisation. This suggests that there may be a pre-requisite for memory formation 
that takes substantial time in fish, at least in Perciform fish.  
Secondary immunisation at 14 days resulted in no significant change in circulating 
antibody. In contrast, secondary injection at 21 days resulted in significant decrease 
in circulating antibody in all treatment groups with exception of those groups 
vaccinated with antigen alone or with Essai 1616102 w/o emulsion. This decrease in 
circulating antibody may result from feedback mechanisms caused by antibody 
complexing at the peak of the primary response [243]. In mammals, only high affinity 
IgG antibody results in complexes and negative feedback, and this is likely due to 
antibody masking antigenic epitopes, preventing further B-cell responses when 
circulating antibody levels are already high [244]. This phenomenon has not 
previously been reported in fish, due to the absence of Ig Gamma heavy chains in all 
fish classes studied to date [245]. However, while fish do not have IgG and do not 
undergo classical isotype switching from IgM to IgG, there is evidence for affinity 
maturation of antibody over time in trout [246]. Consequently, it seemed likely that, at 
21 days post vaccination in barramundi at 28°C, the combination of high levels of 
circulating primary antibodies coupled with some affinity maturation was sufficient to 
result in complexing and negative feedback. Complexing would likely occur until 
circulating antibody levels subsided sufficiently to permit a normal secondary 
immune response post boost. In humans and mice, antibody-mediated suppression 
of secondary response is generally associated with particulate antigens, such as 
erythrocytes [247], but has been noted also for soluble or subunit antigens when 
delivered with adjuvant [248]. The level of suppression of immune response is 
correlated directly with IgG affinity for the antigen [249] and both primary and 
secondary antibody responses are supressed but T-cell priming appears to occur 
normally [244]. Consequently, suppression may result from one or more of three 
scenarios. 
(1) By masking antigenic epitopes, high or same affinity antibody may prevent 
specific B-cells from recognizing and binding to the antigen. (2) Opsonisation of the 
antigen in IgG/antigen complexes may facilitate capture and elimination via Fc 
receptor mediated phagocytosis, consequently removing antigen from immune-
sensitised areas prior to recognition by B-cells. (3) IgG/antigen complexes may co-
crosslink the B-cell receptor (BCR) with the inhibitory FccRIIB, also expressed on the 
B-cell surface resulting in negative regulation of the B-cell [250]. 
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Epitope masking would function without the IgG(Fc) (or in fish, IgM(Fc))-portion of 
the antibody whereas the two latter mechanisms would require intact IgG/IgM(Fc)-
portions. Whilst studies examining suppressive function of Fc-deleted monoclonal 
antibodies have provided conflicting results, IgG suppresses antibody response 
equally well in both wild-type mice and mice lacking all known Fc-receptors, 
including FccRIIB [251]. It appears, then, that most of the adjuvants used in the 
present study resulted in high affinity antibodies that suppressed secondary 
response during peak response by epitope masking. Although largely investigated in 
mammals in the context of high-affinity IgG, under certain conditions, IgM may also 
suppress antibody response provided it is of sufficiently high affinity [249, 252]. To 
test this, an avidity assay was performed by ELISA. Interestingly, we found that the 
avidity of the antibodies was not significantly different at day 21 between the primary 
and the secondary response, except for the samples adjuvanted with Essai 
16161062 w/o. Therefore, when the avidity of primary and secondary antibodies was 
of similar strength, meaning that B-cell receptors (BCRs) from affinity selected 
primed B-cells would not bind preferentially to antigens, amounts of circulating 
antibodies were decreased, supporting that the immune suppression observed was 
due to epitope masking.  
Whilst epitope masking via high affinity IgM explains the immune suppression noted 
with most of the adjuvants, it does not account for the lack of suppression detected 
when water-in-oil emulsion formulated with Essai 1616102 w/o and antigen was 
used as the primary immunogen. This lack of suppression did not result from a low 
avidity IgM response, as the primary antibody response at that time was similar in 
terms of avidity and higher in terms of magnitude than obtained with ISA 763A VG. 
However, the avidity of the secondary antibodies was higher for Essai 1616102 w/o 
at that time, suggesting that this adjuvant allowed for a faster antibody affinity 
maturation. Antibodies, particularly IgM, can also promote immune response to 
complex antigens such as KLH when antigen dose is suboptimal [253]. This appears 
to be mediated through complement, as functional C1 and C2 receptors of the 
classical pathway are required for IgM-dependent immune-enhancement [253]. It is 
thus possible that Essai 1616102 w/o adjuvant slowed the release of the antigen to 
maintain the dose at sub-optimal levels, thereby invoking a faster IgM somatic 
hypermutation and increasing IgM avidity more quickly. In mice, secreted IgM and 
complement collaborate to form immune complexes that facilitate interaction with 
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follicular dendritic cells and accelerate formation of germinal centres [254]. Fish do 
not have classical secondary lymphoid germinal centres where class switching and 
affinity maturation occur as they do not have lymph nodes or peripheral lymphatic 
system. However, melanomacrophage centres (MMC) in spleen, head-kidney and 
occasionally liver [255-257] have been implicated in antigen processing and it is 
postulated that these may be primordial germinal centres in early vertebrates [243]. 
Because Essai 1616102 w/o resulted in significantly higher avidity antibody, it is 
likely that the adjuvant promoted the accelerated development of germinal centres. 
As affinity maturation occurs in germinal centres under the mediation of follicular T-
helper cells (Tfh) [258, 259], a faster development of germinal centres would result in 
faster affinity maturation. Histological examination of spleen and HK over time post-
vaccination, using antibodies to identify cell types, may clarify a role for MMCs in 
antibody response. Moreover, analysis of tissue samples from the present study by 
deep-sequencing for a broad array of cytokine signals associated with follicular DC 
and T-lymphocytes would be particularly relevant. In mice, IgM-immune complexes 
first locate to the spleen where they interact with complement receptors on B-cells in 
a complement dependent manner [254] and it is possible that Essai 1616102 w/o 
promoted complement activation for improved collaboration with IgM. This may also 
be a critical step in successfully initiating adaptive immune responses.  
The results highlighted in the current study suggest affinity maturation and selection 
for high affinity IgM is both possible in fish and can be promoted by some adjuvants, 
both novel findings. The mechanisms that underlie this affinity selection process in 
fish need to be unravelled as this process presents interesting questions on the 
evolution of adaptive immunity in higher animals. Moreover, only by understanding 
how affinity maturation is initiated can we actively develop better adjuvants to target 
these pathways for more effective immunisation, and even modulate them if immune 
suppression proves to be problematic during vaccine deployment in aquaculture. 
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Chapter Six – General Discussion 
 
Amongst all vertebrate taxa, the fishes are the earliest extant class that have both 
innate immunity and adaptive immunity based on major histocompatibility complex 
(MHC), T-cell receptors and antibody. Whilst there are many such similarities with 
the immune systems of higher vertebrates, there are also fundamental differences, 
not least amongst the diversity of immunoglobulin light and heavy chains. Moreover, 
the bony fishes themselves are the most diverse of the vertebrate taxa and there are 
substantial differences in immune process between divergent orders of the Teleostei. 
Most studies of teleostean immunity to date focus on model species such as 
zebrafish, or high value commercial species like Salmonids. For example, locally 
induced immunoglobulins at the mucosal surface of a poikilothermic animal was first 
described in salmonids [260]. Salmonids include many commercial aquaculture 
species such as Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus 
mykiss), which are high value but are limited to temperate climates. Moreover, 
zebrafish have been widely employed as a model research animal due to their small 
size, ease of husbandry and breeding, leading to early sequencing of the genome 
[261] and a diverse array of tools for research. Zebrafish are part of the 
Cypriniformes, which include some commercial aquaculture species such as carps 
that are critical to food supply in some developing countries and popular for 
recreational fishing throughout Europe. Cypriniformes also mostly include fish 
popular with the international aquarium fish trade (such as loach, goldfish and koi) 
and, though representing a substantial global trade, they are not fundamental to 
global food security. From an immunological perspective, functional dendritic cells 
were first characterised in fish in the zebrafish [83], followed more recently by 
rainbow trout [76]. However, of more than 20,000 extant species of teleost fish, 
Salmonids are only comprised of around 220 species and Cypriniformes of around 
4,250 species. In contrast, Perciformes include over 10,000 species, including many 
commercially important fish such as the European sea bass (Dicentrarchus labrax), 
tilapia (Oreochromis niloticus and O. mozambicus), sea bream (Sparus aurata), 
many grouper species (Epinephelus spp.), various snappers (Pagrus spp.), jacks, 
trevally and pompanos (Caringidae), along with the Australian barramundi or Asian 
sea bass (Lates calcarifer). As one of the latest diverging bony fish orders (second 
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only to Beloniformes) [92] this incredibly diverse order represents highly adapted and 
successful animals that are foundational to food supply throughout the world.  
 
Global population growth is concentrated in tropical and subtropical regions of the 
world, and with increased per capita consumption of sea food, production of fish for 
human consumption needs to double by 2030 to meet goals for food security [70]. It 
makes sense that aquaculture of warm and tropical species should be a focus for 
sustainable development due to proximity to growing populations and the higher 
productivity that can be achieved in warmer climates. In these regions, farming of 
Perciform species dominates high value aquaculture production. Here, it is critical to 
replicate the success of vaccination for disease prevention experienced in salmon 
aquaculture [53] to improve farm animal welfare, reduce economic losses and 
eliminate antibiotics from food production in line with the One Health ethos adopted 
in 2009 [262]. Furthering our nascent understanding of Perciform adaptive immunity 
will therefore be critical to optimising vaccine performance in these animals in a 
warm water environment. 
 
For this thesis, the interlink between innate and adaptive immunity in barramundi, an 
iconic Australian fish, but popular throughout tropical and subtropical South-East 
Asia, was explored. As a foundation on which to build the understanding of the 
immune response in barramundi, an immune transcriptome was generated from 
pronephros and spleen after injection with PTG and LPS, or with saline, in order to 
capture the full scope of the transcripts activated over time during an antibacterial 
response (Chapter 2, [164]). Many genes linked to the endocrine, immune and 
nervous systems were regulated in the transcriptomes, underlining the importance of 
a holistic approach to maintaining healthy aquaculture animals. The neuro-
endocrine-immune axis has become a fertile area of research in humans and mice 
over the last few decades, with interactions between systems evidenced by shared 
signalling molecules and receptors [137, 263]. For example, cytokines released by 
immune cells following a secondary immune response can induce a set of 
behaviours associated with disease by crossing the blood-brain barrier and binding 
to corresponding receptors in the brain, leading to reduced appetite and social 
interactions, and increased sleeping patterns among other symptoms [263]. 
Hormones can also play an important role in regulating an immune response. 
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Indeed, leptin, an adipose hormone, has been shown to critically control the balance 
between immunity and other physiological functions [264]. As such, leptin has been 
postulated as a key factor in the development of seasonal responses to disease, with 
loss of body fat associated with loss of immune functions, such as the production of 
antibody [265, 266]. This is further evidenced by the finding of leptin receptors on 
specific leukocytes, such as monocytes, neutrophils, DCs, B- and T-cells and natural 
killer cells [267-272]. With the bulk of neuro-endocrine-immune studies focussing on 
humans or model rodents, however, it is hard to draw conclusions about those 
interactions in other animal species, especially those used as agriculture or 
aquaculture products. Nonetheless, the nervous, endocrine and immune systems in 
barramundi were all regulated in response to bacterial components, providing a 
stepping stone for further investigations into those interactions (Chapter 2, Figure 
2.1, [164]).   
 
6.1 LPS recognition in teleosts 
The transcriptome analyses, supported by corresponding analyses of the barramundi 
genome (published elsewhere during my doctoral studies [168]), revealed that the 
molecules classically involved in lipopolysaccharide (LPS) recognition (as part of the 
TLR-4 recognition system) in mammals were absent from barramundi. However, 
teleosts, including barramundi, are able to mount an inflammatory response to LPS, 
albeit when relatively high concentrations are employed. Lipopolysaccharides are a 
major component of the outer membrane in gram-negative bacteria. Typically, LPS 
molecules are composed of a core polysaccharide linked to an inward facing 
phospholipid termed lipid A, as well as an outer carbohydrate O-antigen consisting of 
up to 25 repeating sugar units [163, 273]. In most cases, the core polysaccharide 
and lipid A show conserved structures across species, whereas the O-antigen is 
more variable [273]. However, lipid A structure is also known to be somewhat 
dependent on the bacteria’s external environment, with adaptability to the host 
potentially leading to intra-specific variability [274, 275]. The lipid A portion of LPS 
has been shown to be the main toxic moiety in mammals (reviewed in [273]), 
inducing the release of many inflammatory cytokines such as TNF-α, IL-1β and IL-6, 
triggering the production of reactive oxygen species such as nitric oxide and 
activating the C3 and C5 complement cascades [163]. In fact, the inflammatory 
response produced by LPS in mammals is so potent that it often results in endotoxic 
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shock, a generalised inflammation of the bloodstream which leads to severe 
hypotension, organ failure and potentially death [163].  
 
In mammals, LPS recognition and processing by the immune system have been 
extensively studied since the early 1990s, with LPS-binding protein (LBP) and CD14 
identified as key components of the LPS receptor complex in mammals [161, 276]. In 
the late 1990s, TLR4 was identified as the key signalling receptor for LPS and the 
identification of MD-2 as a molecule required for LPS signalling completed our 
current knowledge of the TLR4 associated LPS receptor complex [160, 277]. Briefly, 
LPB binds several LPS molecules together which then aggregate on CD14 before 
binding in turn to the MD-2/TLR4 complex and triggering signal transduction leading 
to immune activation (reviewed in [278]).  
 
LPS recognition in fish, however, has proven more problematic to elucidate. Several 
studies using LPS to stimulate fish cells in vitro have shown that doses of LPS 
necessary to induce a cellular and molecular response in fish were 100-1000-fold 
higher than doses needed in mammals [114, 119, 165, 279, 280]. Moreover, several 
molecules associated with the TLR4 associated LPS recognition complex in 
mammals could not be identified in fish. For example, LBP is lacking in trout and cod 
(reviewed in [118]) and, more importantly, TLR4 is lacking from most fish species 
(reviewed in [4, 116, 147]) including from barramundi, on which this thesis is based 
[164]. However, several studies have also demonstrated cytokine activation in fish 
post-stimulation with LPS [18, 119, 281-283], indicating other receptors are likely 
involved in LPS recognition in teleosts [164, 284]. Moreover, recent evidence 
suggests that LPS is an essential component in some fish vaccines, for example 
against enteric redmouth disease (ERM) caused by Yersinia ruckeri [125]. Indeed, 
exposure to highly purified LPS O-polysaccharide from Y. ruckeri was enough to 
confer complete protection in rainbow trout despite the apparent lack of TLR4 in 
those fish, implicating alternative co-stimulatory pathways [8, 116].  
 
Because LPS remains the main immunogen in many effective fish vaccines in spite 
of lacking classical pro-inflammatory TLR4 LPS recognition molecules, we 
investigated how fish might alternatively recognise and process LPS. With our 
transcriptomic work and the timely publication of Lates calcarifer genome, we were 
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able to show that barramundi lack all the classical LPS recognition molecules, 
including TLR4, MD-2 and CD14 [164]. Moreover, we identified several receptors 
that, complementarily, could account for the recognition of LPS in barramundi, 
namely Mincle and leucocyte integrins (Chapter 2, [164]). Putative DCs were also 
identified in barramundi and, although LPS did not seem to greatly activate those 
cells in vitro, injection with combined LPS and PTG in vivo did induce migration of 
DCs towards spleen (secondary immune organ), potentially for T-dependent 
processing of those bacterial components (Chapter 4, [114]). Additionally, 
barramundi were able to mount an antibody response against LPS when injected 
intraperitoneally, even without the addition of oil adjuvant (Chapter 5), confirming that 
LPS is processed by the adaptive immune system in Lates calcarifer.  
 
LPS comprises a major specific protective antigen during adaptive immune response 
to gram-negative bacterial fish pathogens. However, a plethora of alternate PRRs 
have been found to bind to LPS in mammals, which provided some direction for 
further investigation of the barramundi transcriptome. The C-type lectin receptor 
Mincle was identified as a LPS receptor in barramundi that is present on dendritic 
cells and consequently may underlie early adaptive immune processing of LPS as an 
antigen via T-dependent pathways (Chapter 2, [164]). However, whilst LPS affects 
expression of both TNF-α cytokine and IL-6, it was only able to block the effect on 
TNF-α, but not IL-6 expression through Mincle with a specific anti-Mincle antibody, 
which implicates other receptors in LPS recognition and response (Chapter 2, [164]) 
thus stimulating further investigation.  
 
Among the caspases identified in barramundi, two were inflammatory caspases, 
caspase-5 and caspase-1. Caspase-5 had previously been identified as a LPS 
receptor through its CARD domain, however, the caspase-5 identified in barramundi 
lacked a CARD domain, thus is unlikely a functional pro-inflammatory LPS receptor 
in barramundi. Caspase-1 typically combine with NLRs to form inflammasomes. Six 
NLRs, all belonging to the NOD family, were identified in the barramundi 
transcriptome. However, none of these NLRs are known to form inflammasomes, 
suggesting there are no inflammasomes in barramundi. There are four leucocyte 
integrins in mammals, composed of a different α-subunit and a common β-subunit. 
The β-subunit, as well as two of the α-subunits were identified in barramundi. 
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Barramundi leucocytes adhered to ligands specific to integrin-αM and -αL, and were 
also successfully labelled with specific fluorescent antibodies against the α-subunits. 
Moreover, when spleen cells were activated using integrin antibodies before 
stimulation with LPS, the pro-inflammatory cytokine IL-1β was up-regulated, strongly 
suggesting that leukocyte integrins play a role in LPS processing in barramundi, and 
potentially other teleost fish (Chapter 3).  
 
Putative DCs were identified for the first time in barramundi and their migratory 
pattern post-injection was determined, thanks to the localisation of DC-SCRIPT, a 
specific DC marker (Chapter 4, [114]). Evidence strongly suggested that spleen in 
barramundi has a role very similar to lymph nodes, where antigen presentation 
occurs, as barramundi DCs migrated back to the spleen within seven days post-
injection. Interestingly, it was shown that barramundi DCs responded to some 
bacterial peptides such as PTG whereas they did not respond strongly to LPS, 
further confirming the likely lack of strong inflammatory LPS receptors in barramundi 
(Chapter 4, [114]).  
 
6.2 Antibody production and implications for immune memory in fish 
After investigating PRRs and APCs in barramundi, subsequent work focused on the 
development of adaptive immunity post vaccination (Chapter 5). The kinetics and 
magnitude of the secondary immune response were investigated through a long-
term immunisation experiment in barramundi. The production of antibodies is a 
crucial part of foreign antigen clearance and secondary antibodies are an indication 
that memory B-cells have been formed during the first encounter with this antigen. 
The genomic region coding for the variable (V), junction (J) and constant genes of 
barramundi immunoglobulin heavy chain was identified through genome analysis, 
identifying over 40 V regions and four different constant regions (Chapter 5, Figure 
5.5). Some of those constant region genes were present several times, suggesting a 
genome duplication in barramundi, similarly to findings in several other fish species. 
Moreover, through a partnership with industry, different experimental adjuvants were 
also tested to determine if commercially available adjuvants could be improved for 
warm water fish species production. It was shown that barramundi process TD 
antigens, likely through antigen presentation from DCs to T-cells, and that memory 
B- and T-cells were subsequently present, as demonstrated by the detection of 
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secondary antibodies post challenge. It was also shown that barramundi can 
produce primary antibodies against TI antigens such as LPS, with a significantly 
higher titre of LPS antibodies just 14 days post vaccination. However, it was also 
shown that some adjuvants were more suited to barramundi than others, with higher, 
more sustained production of primary antibodies in Essai 1632101 gel, and a faster, 
more potent secondary antibody response is Essai 1616102 w/o. Interestingly, the 
strength of the bond between antigen and antibody (avidity) also differed based on 
the adjuvant used, suggesting that the formulation of those adjuvants, rather than 
their preparatory mode, impacts the onset of adaptive immunity (Chapter 5).  
 
The production of antibodies has been closely linked to the secondary immune 
response in mammals and other vertebrates. In fact, antibodies production is a key 
component of adaptive immunity, with jawed fish (including Chondrichthyes and 
Teleosts) being the earliest diverging phyla with an immunity based on antigen 
recognition by major histocompatibility complex and antibodies [285]. Antibodies, 
also known as immunoglobulins are large Y-shaped quadripartite molecules that 
include two small light chains covalently bound to two larger heavy chains (Figure 
6.1). The tip of the junction between light and heavy chains form what is known as 
an antigen binding site or paratope, and are highly variable to accommodate for the 
incredibly large diversity of antigens (Figure 6.1).  
 
 
Figure 6.1. Graphical representation of an antibody. Antibodies can be either 
membrane bound (on B-cells) or secreted in blood plasma. 
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Antibodies are present in two different forms, membrane-bound at the surface of B-
cells (also known as B-cell receptors (BCRs)) or secreted by plasma cells and 
circulating freely in blood plasma. Natural antibodies, which are present in the animal 
without prior external stimulation [286], are part of the first line of defence in 
vertebrates’ innate humoral system, including teleosts [287]. In mammals, natural 
antibodies are mostly comprised of immunoglobulin M (IgM), can bind to an array of 
unspecific foreign particles, have low binding strength, and are produced in a small 
subset of B lymphocytes, B-1 cells [288-291]. Because they are constantly exposed 
to foreign microorganisms, fish are thought to have high level of circulating natural 
antibody [292-294]. To induce the production of specific antibodies on the other 
hand, B-cells need to be activated by antigen presenting cells and often require co-
stimulation by T-cells (discussed in more details towards the end of this section). In 
mammals, there are three major known mechanisms that increase the diversity of 
the antigen binding site, namely V(D)J recombination, somatic hypermutation and 
class switching [285]. Those mechanisms allow for the optimal binding of foreign 
antigens and fast response of the immune system upon re-encounter of the same 
antigen, and form the base of adaptive immunity in mammals. There is preliminary 
indication that antibodies in rainbow trout (Oncorhynchus mykiss) have increased 
affinity over time after an immunisation [295-297], similarly to what was observed in 
barramundi (Chapter 5, Figures 5.1 and 5.2). Therefore, it is suggested that there is 
one or several mechanisms in fish, potentially the same as in mammals, that 
contribute to the improvement of antibody affinity post-immunisation, despite critical 
differences between teleost and mammals.  
 
Variable, diversity and junction (V(D)J) recombination is the mechanism that forms 
the base of the antibody repertoire diversity. Because of the diversity of antigens in 
existence, the diversity of antibodies needs to be equally large. Consequently, each 
light and heavy chain immunoglobulin gene includes many variable and junction 
gene segments (44 and 6 in humans respectively). Moreover, heavy chain genes 
also include diversity gene segments (27 recorded in humans), bringing the number 
of possible combinations to around 3x1011 different immunoglobulin molecules.  
 
Somatic hypermutation (SHM) is a mechanism that increases the affinity of 
antibodies to antigens by allowing high mutation rates at the complementary-
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determining regions (CDRs) of the immunoglobulin, thus expanding the antibody 
repertoire even further [298]. Those mutations occur in germinal centres (GCs) in 
proliferating B-cells at a rate that is 105-106 times higher than the mutation rate in the 
rest of the genome, and require the enzyme activation-induced cytidine deaminase 
(AID) [298-302]. Within the thousands of slightly different B-cells produced as a 
result to V(D)J recombination and somatic hypermutation, only the B-cells with the 
greatest affinity (binding strength) to the antigen are selected to mature into plasma 
cells and memory B-cells [298, 301]. 
 
Class switching, also known as isotype switching, occurs post-activation of mature 
B-cells in mammals, once the V(D)J recombination and SHM have already occurred. 
Unlike during V(D)J recombination and SHM, only the constant region of the heavy 
chain in the immunoglobulin molecule is affected, changing from one class of Ig to 
another (e.g. from IgM to IgG). Because the variable region of the Ig molecule is not 
affected, the antigen specificity stays the same but the molecule can now interact 
with different effector cells, allowing for a stronger and faster response of the 
immune system. Immunoglobulin diversity in fish has been extensively reviewed in 
the last decade [106, 236], with the sequencing and publication of teleost genomes 
helping to establish Ig diversity and structure in many fish species. Three classes of 
Ig have currently been identified in teleosts, IgM [77], IgD [303] and IgT/Z [238, 304]. 
IgM and IgD have both been identified as primordial classes of Ig, as they are well 
conserved across the vertebrates with homologs found even in Chondrichthyan 
[236]. On the other hand, IgT/Z is restricted to fish species, and is thought to be 
associated with mucosal immunity, playing a role similar to IgA in mammals [236]. 
Surprisingly, IgG and IgE have not been identified in teleosts to date, despite their 
ability to mount potent immune responses against secondary infections and fish 
being affected by parasites [305]. Classical GCs are also absent in fish [292, 301], 
however, melanomacrophage centres (MMC) present in abundance in fish head-
kidney, spleen and liver, are structurally similar to mammalian GCs and have often 
been termed “primitive GCs” in the literature [243, 306-309]. Moreover, AID-positive 
cells normally found in mammalian germinal centres have been found in or close to 
melanomacrophage centres in fish spleen, suggesting that MMCs perform a GC-like 
function in fish [300, 310-313]. Nonetheless, to date, MMCs have not been 
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documented to host SHM [313], but a systematic investigation of MMCs in fish could 
lead to a definite characterisation of their function [314].  
 
The typical structure of Ig heavy chain loci comprises of a region containing variable 
genes at the 5’ end, followed by diversity, junction and constant clusters for each 
different constant region (Cμ/δ and Cτ/ζ) at the 3’ end [236, 238]. The same typical 
Ig locus organisation was observed in barramundi (Chapter 5, Figure 5.5). There 
seems to be an incredible heterogeneity of loci number, organisation and splicing 
patterns for immunoglobulin in teleost fish, likely contributing to the natural antibody 
diversity found in fish [236]. Moreover, several IgM molecules can be produced in 
zebrafish, due to different transcription patterns, which increases the number of 
immunoglobulin isotypes expressed [315]. Although different functions for those 
isotypes have not been determined yet, it is possible that heterogeneous IgM 
isotypes may account for the lack of IgG in fish.  
 
The production of antibodies against a given antigen and the magnitude of this 
response have been used extensively to determine the ability of an organism to 
respond and fight against said antigen. Indeed, as antibodies can immobilise 
antigens and act as beacons for antigen clearance by immune cells, the quantity and 
quality (i.e. binding strength) of antibodies produced over time can be directly 
correlated with the effectiveness of an immune response. Antibody quantification, 
over the course of primary and secondary immunisation (kinetics), has been used in 
mammals and fish for many decades to this effect [68, 316-318]. Because fish are 
poikilothermic, the water temperature in which the animal lives directly dictates the 
rate of metabolic responses, including during an immune response [310]. This 
parameter makes the study of immune kinetics even more crucial in fish, as big 
variations are expected between species living in different climates. More 
importantly, the formulation of vaccines as oil emulsion with an adjuvant can also 
impact the speed at which antibodies are produced, both after primary and 
secondary immunisations. Work on immune kinetics and adjuvants in fish has mostly 
focused on salmonids, which are raised in cold water ranging from 2oC to 18oC [53, 
319]. On the other hand, sub-tropical and tropical aquaculture fish such as 
barramundi (Lates calcarifer), catfish and tilapia are farmed at much higher 
temperatures ranging between 28°C and 32°C [320]. Because increased 
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temperature correlates with increased metabolic rate, the response of warm water 
fish to pathogen is likely to be proportionately faster. However, oil adjuvants, known 
to slow the onset of the immune response but to prolong its duration, are still used in 
vaccines for warm water fish species [321]. Because of the discrepancies in farming 
cycle (6 to 9 months for warm water fish versus 2 to 3 years for cold water fish), and 
because the kinetics of immune responses are affected by adjuvant use and water 
temperature, it is likely that warm water fish vaccinated with vaccines optimised for 
cold water fish will not develop a full immune response during their farming cycle, 
putting them at risk of disease even if vaccinated. 
Consequently, investigation of antibody kinetics using different adjuvant formulations 
and compositions in warm water fish species was warranted, to maximise vaccine 
efficiency (i.e. antibody production post vaccination) for the industry. Interestingly, 
this thesis highlighted that adjuvants not only affected the magnitude of antibody 
production, but also affected the quality of binding (affinity) of the resulting antibodies 
(Chapter 5). Furthermore, there also seemed to be a difference in antibody kinetics 
depending on the type of antigen used in the vaccine formulation. Antigens can be 
either T-cell dependent (TD), meaning that B-cell proliferation against those antigens 
is dependent on prior T-cell activation, or T-cell independent (TI), which means that 
the antigens can activate B-cells directly without needing T-cells stimulation. Most 
protein and peptides are TD antigens, and the antibodies produced against those 
antigens typically have higher binding strength and they undergo isotype switching in 
mammals [223, 224]. TI antigens, on the other hand, include mostly carbohydrates, 
and are divided into two categories, type 1 and type 2, based on their interactions 
with B-cells. TI type 1 antigens can induce naïve and mature B-lymphocyte 
proliferation and differentiation into plasma cells, whereas TI type 2 antigens can 
only activate mature B-cells [223]. In both cases, the antibodies produced against TI 
antigens do not have a strong avidity and are highly antigen-specific (they do not 
cross-react with other antigens). Moreover, there is generally a lack or low response 
to secondary exposure to TI antigens, suggesting they fail to induce immune 
memory and to drive B-cells differentiation into memory cells [224, 225]. As most 
microbial vaccines are formulated with inactivated bacteria, and the primary 
protective antigens are primarily carbohydrates such as capsular polysaccharide or 
LPS O-antigen, vaccine design ought to consider how to induce a TD response 
using such TI antigens.  
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Previous research has shown that the development of memory B-cells against a TI 
antigen is possible, by coupling the TI antigen with a protein carrier [226]. Vaccines 
based on the hapten-carrier model, with a generally smaller non-immunogenic 
hapten and a bigger immunogenic protein carrier, have already proven to be 
successful in mammals, for example in the prevention of meningococcal diseases 
caused by the bacterium Neisseria meningitidis [226, 227]. Polysaccharide vaccines 
(which include most Streptococcal vaccines) are generally poorly immunogenic and 
the resulting serum antibody response is short lived [322, 323], but a conjugate 
vaccine combining the protein carrier CRM197 and N. meningitidis serotype C 
oligosaccharide successfully induced antibody production, conferred long term 
immune memory and even helped with herd immunity [228]. In aquaculture, there 
are many bacterial pathogens hindering the development of the industry, such as 
Yersinia ruckeri, Aeromonas spp., Photobacterium spp. and Streptococcus spp. to 
only name a few [110, 208, 324, 325]. However, the immuno-dominant antigens in 
these bacteria are composed primarily of carbohydrates (namely capsular 
polysaccharide and lipopolysaccharide) [158], which highly strain-variable and likely 
TI, resulting in highly type-specific, low quality antibody response. Consequently, one 
issue with designing highly effective vaccines against such pathogens is that their 
carbohydrate layer will be detected preferentially by the host’s immune system 
(immuno-dominant) but they will not induce a strong secondary immune response 
based on memory cells (T-independent). It is thus possible that a hapten-carrier 
approach may be developed for the aquaculture industry against bacterial 
pathogens, as the need for more efficient polysaccharide vaccines arise and the 
costs associated with producing conjugate vaccines decrease. Moreover, with recent 
advances in whole genome sequencing for fish-pathogenic bacteria [326, 327], 
conserved protein antigens in these pathogens are being identified. The challenge 
facing vaccine design and formulation will lie in how to encourage the fish to process 
these conserved TD-antigens in place of the immuno-dominant type-specific TI-
polysaccharides.  
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6.3 The future of vaccines for warm water fish aquaculture 
Loss due to disease is one of the major hindrances to the aquaculture industry [54], 
with loss of stock sometimes reaching over 75% in a single outbreak (e.g. infectious 
hematopoietic necrosis virus in salmonids or viral nervous necrosis in barramundi) 
[51, 90]. Overall, vaccination has been shown to be the most effective way to control 
for disease in aquaculture. Indeed, since the introduction of vaccination in the 1990s, 
some pathogens such as Vibrio and Aeromonas spp. in the salmon industry have 
been largely controlled, which has allowed for a steady increase in production [53]. 
Moreover, vaccination against bacterial diseases, which account for the majority of 
disease outbreaks in aquaculture, has also benefited the environment by limiting the 
use of antibiotics and their possible spread to the adjacent marine life [53]. Vaccine 
formulation and administration mode are also of utmost importance, with oil-based 
vaccines injected intraperitoneally being the current optimal combination for long-
term protection in cold water species. However, oil-based adjuvants need to be 
adjusted to warm water species, as discussed above (Section 6.2). Additionally, 
individual injection into the peritoneal cavity can be labour intensive and single dose 
vaccines too expensive, especially in warm water species, where the fish are only 
farmed for a few months and the value of the final fish product is relatively low. Such 
economical parameters mean that intraperitoneal vaccination, although very effective 
at stopping disease occurrence, is less cost-effective for the industry, which 
highlights the need for easier administration routes and cheaper vaccine 
formulations.  
 
In the last few decades, research has thus focussed on assessing and improving 
immersion and oral vaccinations, both routes allowing for faster immunisation of high 
number of animals, decreasing costs and intensity of labour. Unfortunately, most 
studies have shown that fish do not respond as well to immersion and gut (oral or 
anal) vaccination compared to intraperitoneal or intramuscular injections [69, 328, 
329], as evidenced by lower levels of antibodies detected by ELISA and lower 
relative percent survival (RPS) post challenge. However, in some of those trials, the 
RPS post oral vaccination and boost was still around 60%, demonstrating that 
immunisation through this route, although not optimal, is possible [329, 330]. The 
main challenge with oral vaccination is that antigens administered this way are often 
degraded in the foregut due to very low pH levels before they can arrive to the 
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hindgut, where they may be absorbed [331-333]. Moreover, oral vaccination 
stimulates mucosal immunity first, which could be an issue if the pathogen directly 
enters the host’s bloodstream through cutaneous lesions, a potentially frequent 
occurrence under poor husbandry, rapidly changing water conditions and high 
stocking densities [334]. On the other hand, stimulating the host’s mucosal immunity 
could be beneficial, as healthy gut, skin and gills, which are potential first points of 
entry into the host, are protected by a mucus layer. Furthermore, it has been shown 
that oral vaccination, in some cases, elicited an increase in antibody levels not only 
in gut mucus, but also in skin mucus and even serum [335], suggesting that oral 
vaccination has the potential to induce a generalised immune response in the host. 
Recent research has also identified vectors that seem suitable to the delivery of oral 
vaccines. For example, alginate microspheres and chitosan nanoparticles appear 
like effective vectors for DNA vaccine delivery, both when administered manually into 
the mouth of the fish and when incorporated to food pellets [242, 336, 337]. The use 
of bacterial spores, obtained from species such as Bacillus subtilis, genetically 
modified to express antigens of interest have also been successful in eliciting 
protection when administered as oral vaccine, with the added benefit of bacterial 
spores also acting as adjuvants [335, 338, 339]. Despite those promising steps 
towards oral vaccination, major concerns are still associated with the use of oral 
vaccines, such are the cost-effective production of large quantities of antigen needed 
or the possible development of immune tolerance in the gut. Further work is thus still 
necessary to optimise oral vaccines production and delivery, but due to the 
attractiveness of this administration route, research will undoubtedly focus on oral 
vaccines in the next decades. 
 
Vaccine formulation (i.e. antigen(s) and adjuvant(s) included in a vaccine) is crucial 
to vaccine effectiveness. Indeed, even if an antigen is delivered appropriately to the 
immune system, the vaccine will not be effective if the antigen is not recognised on 
the pathogen once an infection occurs. With the development of bioinformatics and 
the easier access to sequencing technologies, it is becoming increasingly easy to 
identify potential antigens, through a process termed reverse vaccinology [340]. As 
fish pathogen genomes are becoming increasingly available, novel antigens that are 
not necessarily immuno-dominant but still immunogenic can be detected and purified 
for use in trials. Using the same principle, antigens that are shared among different 
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pathogen strains can also be identified, allowing for the simpler development of 
cross-protective vaccines, for example against Group B Streptococcus [341]. 
Moreover, with new knowledge on fish immunity available, it is also easier to quickly 
screen for effective antigens, by conducting small injection trials and assessing 
expression levels of immune genes in plate based assay, before committing to larger 
and more expensive vaccine/challenge trials. Indeed, the regulation of cytokines and 
chemokines during an immune response have now been well characterised, and 
often even liked with RPS post-challenge in fish [242, 335, 342, 343]. Therefore, 
based on immune molecule profiling, it is now possible to infer immunogenicity of a 
large quantity of antigens using qRT-PCR, before conducting full scale vaccine trials 
on the most promising of those antigens. 
 
Based on this thesis, barramundi have the potential to mount an immune response 
against protein-based antigens (i.e. TD antigens), with immune memory and affinity 
maturation of antibodies occurring (Chapter 5). Recombinant protein antigens have 
also been shown to induce immune protection in other fish species such as flounder, 
carp and channel catfish [344-346], suggesting that TD antigens are good vaccine 
candidates in teleosts. On the other hand, carbohydrate-based vaccines (including 
most whole-cell killed bacterial vaccines), especially those including LPS as their 
main antigen (i.e. TI antigens), should be treated with caution. Although our research 
suggests that barramundi can recognise and process LPS (Chapter 2 and 3), it is 
doubtful that a fish vaccine containing only carbohydrate-based antigens would be 
efficient in the long term and is likely to be highly strain specific [61], most likely 
because they do not activate TD immune memory. Further research could thus focus 
on the development of glycoconjugate vaccines [224], as combining highly 
detectable TI antigens with TD protein carriers could significantly improve the 
efficacy of vaccines used in aquaculture. Moreover, using the right adjuvant for the 
vaccination target species will be crucial in ensuring disease protection, especially 
with the development of warm water species aquaculture requiring faster protection. 
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Appendix 1.1. Conference abstract for the research presented at the third 
FRDC Australasian Aquatic Animal Health Scientific Conference, Cairns, 6-10 
July 2015 
 
Conference abstract for the citation: 
Zoccola E, Delamare-Deboutteville J, Barnes AC. Identification of barramundi (Lates 
calcarifer) DC-SCRIPT, a specific molecular marker for dendritic cells in fish. 
Presented at the third FRDC Australasian Aquatic Animal Health Scientific 
Conference, Cairns, 6-10 July 2015. 
 
Identification of barramundi DC-SCRIPT, a specific molecular marker for 
dendritic cells in fish 
 
Antigen presentation is a critical step bridging innate immune recognition and 
specific immune memory. In mammals, the process is orchestrated by dendritic cells 
(DCs) in the lymphatic system, which initiate clonal proliferation of antigen-specific 
lymphocytes. However, fish lack a classical lymphatic system and there are currently 
no cellular markers for DCs in fish, thus antigen-presentation in fish is poorly 
understood. Recently, antigen-presenting cells similar in structure and function to 
mammalian DCs were identified in various fish, including rainbow trout 
(Oncorhynchus mykiss) and zebrafish (Danio rerio).  
The present study aimed to identify a potential molecular marker for DCs in fish and 
therefore targeted DC-SCRIPT, a well-conserved zinc finger protein that is 
preferentially expressed in all sub-types of human DCs. Putative dendritic cells were 
obtained in culture by maturation of spleen and pronephros-derived monocytes in 
barramundi (Lates calcarifer). DC-SCRIPT was identified in barramundi by homology 
using RACE PCR and genome walking. Specific expression of DC-SCRIPT was 
detected in barramundi cells by Stellaris mRNA FISH, in combination with MHCII 
expression when exposed to bacterial derived peptidoglycan, suggesting the 
presence of DCs in L. calcarifer. Moreover, morphological identification was 
achieved by light microscopy of cytospins prepared from these cultures. The cultured 
cells were morphologically similar to mammalian and trout DCs. Migration assays 
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determined that these cells have the ability to move towards pathogens and 
pathogen associated molecular patterns, with a preference for peptidoglycans over 
lipopolysaccharides. The cells were also strongly phagocytic, engulfing bacteria and 
rapidly breaking them down. Barramundi DCs induced significant proliferation of 
responder populations of T-lymphocytes, supporting their role as antigen presenting 
cells. DC-SCRIPT expression in head kidney was up-regulated 6 and 24 h following 
intraperitoneal challenge with peptidoglycan and lipopolysaccharide and declined 
after 3 days. Expression was also down-regulated in the spleen at 3 days post 
challenge but increased back at 7 days. This may indicate initial migration of 
immature DCs from head kidney and spleen to the injection site, followed by return 
to the spleen for maturation and antigen presentation.  
DC-SCRIPT may be a valuable tool in the investigation of antigen presentation in 
fish and facilitate optimisation of vaccines and adjuvants for aquaculture. 
 
Appendix 1.2. Conference abstract for the research presented at the ASFB-
OCS joint conference, Hobart, 4-7 September 2016 
 
Conference abstract for the citation:  
Zoccola E, Kellie S, Barnes AC. Lates calcarifer transcriptome reveals the Mincle 
CLR as an alternative to the classical LPS recognition pathway. Presented at the 
ASFB-OCS joint conference, Hobart, 4-7 September 2016. 
 
Lates calcarifer transcriptome reveals the Mincle CLR as an alternative to the 
classical LPS recognition pathway  
 
Aquaculture, currently supplying over half of the world’s fish supply, is acknowledged 
as one of the major foundations of future food security for a growing population. 
However, successfully developing this industry requires the reduction of stock loss 
due to diseases, in particular in the fast developing sector of warm water fish 
aquaculture. Vaccination has previously shown some potential but it requires a 
deeper understanding of the development of immunity in warm water fish. An 
immune transcriptome was thus generated against lipopolysaccharide (LPS) and 
peptidoglycan (PTG) to elucidate potential pathways involved in the onset of 
adaptive immunity, on which vaccination relies. The immune transcriptome, 
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generated from barramundi primary immune organs, was assembled and annotated, 
generating 163,661 transcripts. Putative proteins from the TLR and CLR families 
were identified in barramundi. Interestingly, TLR4, responsible for LPS recognition, 
was absent from the transcriptome. Using qRT-PCR, barramundi Mincle (a CLR) 
was identified as an alternative to the classical TLR4 mediated LPS recognition 
pathway as LPS induced the transcription of IL-6 and TNF-α through Mincle.  
 
Appendix 1.3. Conference abstract for the research presented at the fourth 
FRDC Australasian Aquatic Animal Health Scientific Conference, Cairns, 10-14 
July 2017 
 
Conference abstract for the citation: 
Zoccola E, Li A, Barnes AC. Linking antibody response and efficacy of the adaptive 
immunity in vaccine development: How adjuvants modulate the immune response in 
barramundi. Presented at the fourth FRDC Australasian Aquatic Animal Health 
Scientific Conference, Cairns, 10-14 July 2017. 
 
Linking antibody response and efficacy of the adaptive immunity in vaccine 
development: how adjuvants modulate the immune response in barramundi 
 
Vaccination of finfish has been a successful practice for reducing both disease 
outbreaks and antibiotic use in aquaculture. Vaccination relies on activation of 
adaptive immunity, usually by injection, which results in immunological memory that 
can provide the animal with long-term protection against the pathogen in the vaccine. 
However, full efficacy of vaccines in aquaculture, similarly to humans and other 
terrestrial animals, is dependent upon the use of adjuvants added to the injection 
mix. Indeed, oil emulsion adjuvants were a core enabling technology that 
underpinned the adoption of single injection multivalent vaccines that offered lifetime 
protection in salmonid aquaculture. In warm water aquaculture, where expansion is 
most rapid, vaccination faces a new set of challenges, not least the shorter farming 
cycle and the increased metabolic rate at high temperature. Consequently, there is a 
need to explore alternatives to emulsions that were developed for cold-water 
salmonids. 
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In order to evaluate effects of adjuvants on development of immunity in a warm 
water species, a vaccination prime-boost experiment was conducted in barramundi 
at 28 °C using a model antigen formulated with five different adjuvant treatments. 
The different treatments included four new experimental adjuvants (one gel, one 
water-in-oil-in-water (w/o/w), and two water-in-oil (w/o1 and w/o2)) along with a 
current commercial adjuvant (w/o; ISA763AVG). These were formulated with DNP-
KLH antigen in aqueous solution. Barramundi juveniles (96 each) were vaccinated 
with the vaccine treatments, an antigen control (non-adjuvanted aqueous vaccine) or 
a PBS injection control. After a holding period, replicate cohorts of fish were boosted 
using the DNP-KLH aqueous control vaccine and blood was collected subsequently 
from both non-boosted and boosted fish to assess the primary and secondary 
immune responses respectively over time by measuring antibody via indirect ELISA. 
Generally, barramundi had very high background antibody binding by ELISA. 
Adjuvants significantly slowed the development of primary immunity with antigen-
only peaking before the 21 days initial sample point. Inclusion of any adjuvant in the 
vaccination delayed the antibody response by around 7 days with antibody peaking 
at or later than 28 days post immunisation. The gel adjuvant resulted in a 
significantly elevated and prolonged immune primary immune response compared to 
all other treatments, with significantly higher circulating antibody remaining in serum 
until the end of the trial (3 months). In terms of secondary response, boosts resulted 
in depleted circulating antibody at 28 days, coincident with peak primary antibody 
levels in all adjuvant treatment groups except w/o2. This is likely explained by 
complexing of antigen with high affinity antibody resulting in inability to mount a 
secondary B-cell response. There are consequently implications for timing of 
vaccination when using oil adjuvants with T-dependent antigens (eg. virus, 
recombinant proteins, capsular polysaccharides). All adjuvants resulted in strong 
secondary response when animals were boosted 3 months post-primary 
immunisation. Further work to determine the affinity of the resulting antibody 
responses is currently ongoing. Further vaccine and challenge trials should 
investigate the efficacy of the gel and w/o2 compared to ISA 763A at differing times 
post immunisation. These results imply that vaccination strategy for T-dependent 
and independent vaccines can be optimised for warm water fish. 
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Appendix 1.4. Conference abstract for the research presented at the 18th 
International Conference on Diseases of Fish and Shellfish, Belfast, 4-7 
September 2017 
 
Conference abstract for the citation: 
Zoccola E, Kellie S, Barnes AC. Mechanisms of lipopolysaccharide recognition and 
processing in barramundi (Lates calcarifer). Presented at the 18th International 
Conference on Diseases of Fish and Shellfish, Belfast, 4-7 September 2017. 
 
Mechanisms of lipopolysaccharide recognition and processing in barramundi 
(Lates calcarifer) 
 
Aquaculture, currently supplying over half of the world’s fish supply, is acknowledged 
as one of the major foundations of future food security for a growing population. 
However, successfully developing this industry requires the reduction of stock loss 
due to diseases, particularly in the fast-developing sector of warm water fish 
aquaculture. Vaccination has previously shown some potential but it requires a 
deeper understanding of the development of immunity in warm water fish, in 
particular when exposed to complex and diverse antigens such at 
lipopolysaccharides (LPS). Moreover, fish have a subdued innate response to LPS, 
but adaptive response is generally high and type-specific, warranting further 
investigation in the way fish recognise and process LPS. 
An immune transcriptome was generated against bacterial cell wall polysaccharides 
to elucidate potential pathways involved in the onset of adaptive immunity, on which 
vaccination relies. Putative sequences coding for proteins from the TLR, CLR, NLR 
and integrin families were identified in barramundi by homology with other teleosts 
and mammals. Those proteins were further investigated as potential 
receptor/initiators of the immune response in barramundi by qRT-PCR and western 
blotting. 
TLR4, responsible for LPS recognition, was absent from the barramundi 
transcriptome. Proteins normally involved in the formation of inflammasomes (potent 
inflammatory inducers), NLRPs, were also absent from the transcriptome. Using 
qRT-PCR, barramundi Mincle (a CLR) was identified as a partial alternative to the 
classical TLR4 mediated LPS recognition pathway as a high dose of LPS induced 
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TNF-α expression via Mincle. However, IL-6 regulation, whilst still regulated in 
response to LPS, did not depend upon the Mincle pathway, suggesting other routes 
of activation. 
LPS induces TNF expression in barramundi via the Mincle CLR, but induces IL6 via 
a different route that has yet to be elucidated.  As the adaptive response to LPS is 
type-specific and critical to protection in many fish vaccines, determining pathways 
for LPS processing in fish may aid with modulating response. This might enable 
better immune targeting of more conserved protein antigens in new cross-serotype 
vaccines. 
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Appendix 2.2. Supplementary information for chapter 2 
 
Table A.2.2.1. TLRs accession numbers from NCBI database. 
Organism Name NCBI accession number 
Homo sapiens TLR1 NM_003263.3 
 TLR2 NM_003264.3 
 TLR3 NM_003265.2 
 TLR4 U88880.1 
 TLR5 NM_003268.5 
 TLR6 NM_006068.4 
 TLR7 NM_016562.3 
 TLR8 NM_016610.3 
 TLR9 DQ019992.1 
 TLR10 NM_030956.3 
 CD180 NM_005582.2 
Mus musculus TLR1 AY009154.1 
 TLR2 NM_011905.3 
 TLR3 NM_126166.4 
 TLR4 NM_021297.3 
 TLR5 NM_016928.3 
 TLR6 NM_011604.3 
 TLR7 AY035889.1 
 TLR8 AY035890.1 
 TLR9 NM_031178.2 
 TLR11 NM_205819.3 
 TLR12 NM_205823.2 
 TLR13 NM_205820.1 
 CD180 NM_008533.2 
Danio rerio TLR1 NM_001130593.1 
 TLR2 NM_212812.1 
 TLR3 NM_001013269.3 
 TLR4ba NM_001131051.1 
 TLR4bb NM_212813.2 
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Table A2.2.1. continued   
 TLR5 NM_001130595.1 
 TLR7 XM_003199261.3 
 TLR9 NM_001130594.1 
 CD180 LN624114.1 
Takifugu rubripes TLR1 AC156430.1 
 TLR2 XM_011617903.1 
 TLR3 AC156436.1 
 TLR5 AC156437.1 
 TLR7 AC156438.1 
 TLR8 AC156438.1 
 TLR9 AC156439.1 
 TLR14 AC156431.1 
Rattus norvegicus TLR11 NM_001144779.2 
 TLR12 NM_001108682.1 
Cyprinus carpio TLR4ba KF582561.1 
 TLR4bb KF582562.1 
Alligator sinensis TLR6 XM_006029236.2 
Alligator 
mississippiensis TLR10 XM_006029243.1 
Sus scrofa TLR6 AB208698.2 
Chiloscyllium griseum TLR6 HG964646.1 
Stegastes partitus TLR7 XM_008275650.1 
Salmo salar TLR13 NM_001140388.1 
 
Table A.2.2.2. CLRs accession numbers from NCBI database. 
Organism Name NCBI accession number 
Homo sapiens CD209 NP_066978.1 
 Lymphocyte antigen 75 NP_002340.2 
 Mannose receptor, C-type 1 NP_002429.1 
 CD207 NP_056532.4 
 Lectin-like receptor 1 (DECTIN1) NP_922938.1 
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Table A2.2.2. continued   
 DC-associated C-type lectin 2 (DECTIN2) NP_001007034.1 
 C-type lectin domain family 4, member C NP_987099.1 
 C-type lectin domain family 1, member A NP_057595.2 
 C-type lectin domain family 4, member E NP_055173.1 
Mus musculus Lymphocyte antigen 75 NP_038853.2 
 Mannose receptor, C-type 1 NP_032651.2 
 CD207 NP_659192.2 
 C-type lectin domain family 4, member E NP_064332.1 
Danio rerio CD209 ADB55613.1 
Tetraodon nigroviridis CD209 ADB55615.1 
Takifugu rubripes Lymphocyte antigen 75 NP_001177292.1 
Sus scrofa CD207 NP_001123429.1 
Bos taurus C-type lectin domain family 1, member A NP_001069549.1 
Stegastes partitus C-type lectin domain family 4, member E XP_008274887.1 
 
Table A2.2.3. Primers used for qRT-PCR. 
Target gene Forward primer (5’-3’) Reverse primer (5’-3’) 
CLEC4E (Mincle) GACCCAGCTACTGGATTGGA CTTGCGTTTGCGTCTTGTAG 
FcRgamma AAGACTGTCCCACATCCTGG CCTGCTTCAGACTCACACCA 
Syk AACTGGGCTCTGGGAATTTT GTTGAGAGGTCCCAGCTCAG 
IL6 CAGCTGACTGCCGTGATAAA TCCAGGGTTCCTCATCTTTG 
TNFA GCCATCTATCTGGGTGCAGT AAAGTGCAAACACCCCAAAG 
18S CGCCTGAATACCGCAGCTAG AGAACGGCCATGCACCACCAC 
EF-1α AAATTGGCGGTATTGGAAC GGGAGCAAAGGTGACGAC 
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Figure A2.2.1. Gene ontology trees for ‘Immune system process’ (green boxes) 
from BLAST2GO. Organs represented are (A) spleen and (B) head-kidney. Darker 
shades of orange represent higher nodescore values. 
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Appendix 2.3. Supplementary information for chapter 3 
 
Table A2.3.1. NCBI accession numbers used to identify barramundi caspases and 
to infer phylogeny. 
Organism Name NCBI accession number 
Homo sapiens Caspase 1 NM_033292.3 
 Caspase 2 NM_032982.3 
 Caspase 3 NM_004346.3 
 Caspase 4 NM_001225.3 
 Caspase 5 NM_004347.3 
 Caspase 6 NM_001226.3 
 Caspase 7 NM_001320911.1 
 Caspase 8 XM_005246885.1 
 Caspase 9 NM_001229.4 
 Caspase 10 NM_032974.4 
 Caspase 14 NM_012114.2 
Litopenaeus vannamei Caspase 4 KC660105.1 
 Caspase 5 KC660104.1 
Mus musculus Caspase 11 Y13089.1 
Danio rerio Caspase a AF233434.1 
 Caspase b NM_152884.2 
 
Table A2.3.2. NCBI accession numbers used to identify barramundi NLRs and 
to infer phylogeny. 
Organism Name NCBI accession number 
Homo sapiens NOD1 AF113925.1 
 NOD2 NM_022162.2 
 NOD3 XM_017023027.1 
 NOD4 EF452236.1 
 NOD5/NLRX1 EF452237.1 
 CIITA NM_001286402.1 
 IPAF/NLRC4 NM_021209.4 
 NAIP NM_004536.2 
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Table A2.3.2. continued   
 NLRP1 NM_033004.3 
 NLRP2 NM_017852.3 
 NLRP3 NM_004895.4 
 NLRP4 NM_134444.4 
 NLRP5 NM_153447.4 
 NLRP6 NM_138329.2 
 NLRP7 NM_139176.3 
 NLRP8 NM_176811.2 
 NLRP10 NM_176821.3 
 NLRP11 NM_145007.3 
 NLRP12 XM_017027460.1 
 NLRP13 NM_176810.2 
 NLRP14 NM_176822.3 
Mus musculus NOD1 NM_172729.3 
 NOD2 NM_145857.2 
 NOD5/NLRX1 NM_001163743.1 
 CIITA NM_001243760.2 
 IPAF/NLRC4 NM_001033367.3 
 NAIP NM_008670.2 
 NLRP1 NM_001004142.2 
 NLRP2 NM_177690.3 
 NLRP3 NM_145827.3 
 NLRP4 NM_001004194.2 
 NLRP5 NM_011860.3 
 NLRP6 NM_001002894.2 
 NLRP9 XM_006539938.2 
 NLRP10 NM_175532.3 
 NLRP12 NM_001033431.1 
 NLRP14 NM_001002894.2 
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Table A2.3.3. NCBI accession numbers used to identify barramundi leukocyte 
integrins and to infer phylogeny. 
Organism Name NCBI accession number 
Homo sapiens Integrin alpha L NM_002209.2 
Table A2.3.3. continued   
 Integrin alpha M J03925.1 
 Integrin alpha X NM_001286375.1 
 Integrin alpha D NM_001318185.1 
 Integrin beta 2 NM_000211.4 
Mus musculus Integrin alpha L NM_001253872.1 
 Integrin alpha M X07640.1 
 Integrin alpha X NM_021334.2 
 Integrin alpha D NM_001029872.3 
 Integrin beta 2 M31039.1 
 
 
Figure A2.3.1. Gene organisation of barramundi caspases. The orange boxes 
represent the exons and the black lines the introns. 
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Figure A2.3.2. Gene organisation of barramundi NLRs. The orange boxes 
represent the exons and the black lines the introns. Red boxes represent exons 
present in the transcriptome but not in the genome. 
 
 
Figure A2.3.3. Gene organisation of barramundi integrins. The orange boxes 
represent the exons and the black lines the introns. Red boxes represent exons 
present in the transcriptome but not in the genome.  
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Figure A2.3.4. Differential expression of immune genes in cells stimulated by 
different antibodies. Rabbit IgG anti-ITGAL and rabbit IgG anti-ITGAM are used as 
treatments and polyclonal rabbit IgG is used as an isotype control. Significant 
differences between treatments and control are represented with * p < 0.05. 
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Appendix 2.4. Supplementary information for chapter 4 
 
 
Figure A2.4.1 E-rosettes. (A) Inverted light microscopy of rosette formations. (B-C) 
Rosettes stained with Hemacolour. Scale bars represent 50 μm in (A) and 20 μm in 
(B) and (C). In each case, putative T-cells are surrounded by sheep erythrocytes. 
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Figure A2.4.2 Rabbit Anti-zebrafish MHCIIa (Sapphire Bioscience). A) 
Synthesised peptide amino acid sequence, showing MHCIIa antigen (green) and 
MHCII-Ig superfamily domains (purple). Alignment: B) subsection of exon from L. 
calcarifer partial gDNA sequence is highly conserved across D. rerio, L. calcarifer, M. 
zebra and O. niloticus. B-cell epitope region is indicated (shaded, bold) showing very 
high conservation across several fish orders (Standard ClustalW2 notation to 
indicate similarity/identity). C) Co-staining of B-lymphocyte from L. calcarifer with 
rabbit anti-zebrafish MHCIIa antibody (green), sheep anti-barramundi IgM (blue).  
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Appendix 2.5. Supplementary information for chapter 5 
 
 
Figure A2.5.1 SDS-PAGE gel of barramundi IgM showing separation into 
tetramers, trimers, dimers and monomers.  
 
